Altair Nanotechnologies GUTE NEWS!!!! - 500 Beiträge pro Seite

[isonics]

Schaut euch mal das Volumen heute in USA an!
Da kauft jeder der noch ein paar Dollar hat...
Altair hat in den letzten Tagen gute Meldungen gebracht und profitiert wie viele andere Nanotech-Werte vom Beginn des Hypes!
Schaut Euch das Unternehmen mal an, ist wirklich interessant aber SEHR SEHR risikoreich!

Ebenfalls aussichtsreich ist Tegal, ein führender Nanotech-Ausrüster! Hier steht die Aktie in den USA kurz vor der Explosion, die viele andere Nanos in den letzten Tagen erlebt haben.

JETZT GEHT ES LOS!!! NANO-HYPE-ALARM!!!

[proFEiT]

woher willst du das wissen?

man weiss es nicht

[nanogirl]

Wirklich der Hammer was in den letzten Tagen mit den Nanotechnologie-Aktien abgegangen ist! Ich lege mir heute noch ein paar Tegals ins Depot, die könnten wirklich noch anziehen. Im Moment macht es richtig Spaß ein Depot voll mit Nanotech-Werten zu haben

[guterricher]

Ja es macht Spaß zuzusehen es wird immer mehr
Aber was sind die guten News.

[spekulant2001]

Ganz schön volatil

http://www.wallstreet-online.de/si/charts/chart.php?ct=&tr=1…

[goldi77]

langsam scheinen es die leute zu begreifen!

für den investor, der grosses risiko scheut:

Harris & Harris-die einzige börsennotierte nanotechnologie-holding in den USA.

man erinnnere sich an CMGI in den glanzvollen tagen.
...nur ein kleiner denkanstoss...

---->IPO´s werden folgen
---->weniger risiko des totalausfalls als bei einzelwerten

siehe auch im nano-board

[meikelgu]

Hallo-nachdem der Kurs jetzt die letzten Tagen/Wochen gestiegen ist scheint er ja auf hohem Niveau zu konsolidieren. Wie seht ihr die weitere Entwicklung? Auffallend waren die hohen Umsätze. Hat die Aktie jetzt eine neue Qualität und einen neuen Bekanntheitsgrad erfahren?

[Musikpalette]

Die Entwicklung sieht sehr hervorragend aus.

[meikelgu]

Als hätte ich es gerochen heute morgen. Aber mich interessieren eher, ob auch Nachrichten dahinter stehen. Sonst hat das Ganze keinen grossen Wert. Diese Erfahrung haben wir ja wohl alle genug gemacht in den letzten Monaten.
Wer kann mir Infos liefern oder sagen, wo ich Infos finde. Danke.

[Musikpalette]

Altair Nanotechnologies Receives Positive RenaZorb Animal Test
Results; RenaZorb, A Nanotechnology-Based Drug Candid
B: Altair Nanotechnologies Receives Positive RenaZorb Animal Test Results; RenaZ
rb, A Nanotechnology-Based Drug Candidate For Phosphate Control in Kidney Dialys
s Patients, Shows Phosphate Binding In Dogs And 5/6 Nephrectomized Rats

RENO, Nev., Jun 03, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies,
Inc. (Nasdaq:ALTI) announced today that it has negotiated an agreement allowing
the disclosure of new animal testing data to interested third parties. Under the
previous non-disclosure agreement with the participating pharmaceutical company,
the animal testing data could not be disclosed. Altair developed three versions
of RenaZorb designated RenaZorb "A", "B", and "H". The study, completed in early
March 2003, was conducted in dogs and 5/6 nephrectomized rats utilizing three
versions of the drug candidate.

"The test results demonstrate indisputably that RenaZorb is effective in
lowering urinary phosphate in kidney impaired (5/6 nephrectomized) rats and in
healthy dogs," said Altair President Dr. Rudi E. Moerck. "This new collection of
test results provides potential licensees within the pharmaceutical industry a
more extensive set of in vivo data for evaluating RenaZorb`s phosphate binding
capabilities. "Additionally," continued Dr. Moerck, "the new test results have
provided Altair with important data that will permit further improvement of the
dosage form to enhance both the efficacy and potency of the drug candidate."

Altair continues active discussions pertaining to the licensing of RenaZorb with
numerous pharmaceutical companies. These companies are in various stages of
conducting due diligence of RenaZorb and management expects to receive their
response in the near future. Altair estimates that the current market for
phosphate binding drugs used for ESRD ranges from $400 to $600 million and could
potentially reach $1 billion with a cost effective drug presenting improved
dosing and patient compliance.

Non-calcium phosphate binders are indicated for patients who suffer from
end-stage renal disease (ESRD). These patients have difficulty in eliminating
dietary phosphate through their kidneys and elevated phosphate can cause bone
pain and spontaneous fractures. Currently, the only FDA approved phosphate
binder is Renagel(tm) (Genzyme). Shire Pharmaceuticals has received an
approvable letter from the FDA for Fosrenol(tm), which like RenaZorb, is a
lanthanum based pharmaceutical.

Altair Nanotechnologies, Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair
Nanotechnologies is positioning itself through product innovation within this
emerging industry to become a leading supplier of nanomaterials and technology
worldwide. Altair owns a proprietary technology for making nanocrystalline
materials of unique quality both economically and in large quantities. The
company is currently developing special nanomaterials with potential
applications in pharmaceuticals, fuel cells, solar cells, advanced energy
storage devices, thermal spray coatings, catalysts, paints and environmental
remediation. For additional information on Altair`s nanoparticle materials,
visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical
information. Forward-looking statements, which are included in accordance with
the "safe harbor" provisions of the Private Securities Litigation Reform Act of
1995, may involve risks, uncertainties and other factors that may cause the
company`s actual and future results to be materially different than suggested by

the forward-looking statements in this release. These risks and uncertainties
include, without limitation, the successful testing, FDA approval and
commercialization of RenaZorb, the company may be unable to attract or form
relationships with pharmaceutical companies, or have the funds necessary to
development additional products or create product opportunities within the
pharmaceutical industry, in addition to other risks identified in the company`s
most recent Annual Report on Form 10-K, as filed with the SEC. Such
forward-looking statements speak only as of the date of this release. The
company expressly disclaims any obligation to update or revise any
forward-looking statements found herein to reflect any changes in company
expectations or results or any change in events.

The Altair Nanotechnologies Inc. company logo can be found at:
http://media.primezone.com/prs/single/?pkgid=511


By Staff
CONTACT: Altair Nanotechnologies
Tracy LaFollette
[phone]
[e-mail]

Investor Relation Resources, LLC
Marty Tullio
[phone]
[e-mail]


(C) 2003 PRIMEZONE, All rights reserved.

[meikelgu]

Na, das sieht doch im Vorfeld heute wieder mal garnicht schlecht aus :-)
Charttechnisch sieht es auch ganz gut aus, wenn das bei solchen Wertn was zählt!

[meikelgu]

Hallo-wohin geht die Reise mit der Altair - Aktie?Kann mir jemand sagen, was die nächsten 3 Monate an Naachrichten/Zahlen auf dem Programm stehen, die den Kurs beeinflussen können. Bin für jede Info dankbar.

[moneymanni]

Hallo,

kauft ihr die Aktie in den USa?
In Deutschland kaun zu haben oder? (besser gesagt auch loszuwerden:-)
Handelsvolumen ist ein Witz.

Der Wert interessiert mich.
Ich bitte um Tips

Gruß Manni

[meikelgu]

Hallo-die Aktie kann auch in Frankfurt geordert werden. An manchen Tagen sind auch dort Umsätze in grösserer Stückzahl vorhanden. Auf jeden fall limitieren. Kauf in USA natürlich möglich; aber informieren dich vorher über die anfallenden Kosten (Mindestgebühren). Hab meine Stücke damals auch in USA bezogen. Also, viel Erfolg. Denke, die Aktie hat noch gutes Potential und könnte bei anziehenden Märkten gut laufen (generell die Nanotechnologie könnte zum Renner werden).

[meikelgu]

Hallo-

kann mir jemand sagen, wann Zahlen oder Infos zum Titel rauskommen?

[Albatossa]

Hallo Leute,

nach dieser Nachricht habe ich eine Startschuß gehört!

Gruß Albatossa



Altair Nanotechnologies Pays Off All Convertible Debt; With $588,000 payment to Doral 18, LLC, Altair regains all pledged assets

Monday , September 15, 2003 10:15 ET
RENO, Nev., Sep 15, 2003 (PRIMEZONE via COMTEX) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has repaid Doral 18, LLC, the remaining $588,000 in convertible debt. Pursuant to the terms of governing security agreements, Doral is required to release all of Altair`s pledged assets, which include titanium mineral leases and patents for pigment and nanomaterials.

With this transaction, Altair is debt free except for a promissory note to purchase the building that houses its Reno production facilities from BHP Minerals International, Inc. Under that agreement, interest begins accruing in August 2005 with the first payment due in February 2006.

Altair`s Chief Financial Officer Ed Dickinson said the company paid off the debt with funds received from the exercise of warrants. " We have sufficient resources to fund operations through the end of 2003," he said. " With our stock advancing, we anticipate warrant exercises that could provide adequate financing through 2004." Mr. Dickinson added, " We also expect income through additional government funding, increased product sales and product development contracts."

" With the exception of the building agreement, this marks the first time the company has been debt free since purchasing its pigment and nanomaterials technology from BHP Minerals four years ago," said Dr. William Long, Altair`s Chairman and Chief Executive Officer. " With no more convertible debt, we expect to emerge as a technological leader not only in nanotechnology and nanomaterials but also in titanium dioxide pigment." Dr. Long credits the company`s employees, shareholders, technology platform and economical production process for Altair`s survival through a challenging economic environment for technology companies.

[Albatossa]

[Albatossa]

Altair`s Nano-Sized Zirconium Oxide now Available for Dental Applications
Wednesday September 17, 1:49 pm ET


RENO, Nev., Sept. 17, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (NasdaqSC:ALTI - News) announced that commercial nano-sized zirconium oxide is available for dental applications including fillings and prosthetic devices.

Altair`s president, Dr. Rudi E. Moerck, said, ``Nano-sized zirconium oxide is ideal for dental applications because of its strength and transparency to light, but it is opaque to x-rays, making it an excellent material for UV-cured dental fillings.``

ALTAIR NANOTECHNOLOGIES INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, paints and environmental remediation. For additional information on Altair`s nanoparticle materials, visit http://www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the ``safe harbor`` provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual and future results to be materially different than suggested by the forward-looking statements in this release. These risks and uncertainties include without limitation the company`s ability to obtain the necessary funding to penetrate the dental marketplace, to find partners selling product into the dental marketplace, or create product opportunities within its target markets, in addition to other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

[taipanz]

ALTAIR NANOTECHNOLOGIES wird gemeinsam mit der britischen HYDROGEN SOLAR ein Unternehmen gründen. Die neue Firma soll auf Basis der Tandemzelltechnologie einen Sonnen-Wasserstoff-Generator entwickeln. Die britische HYDROGEN besitzt dafür die weltweiten Rechte; entwickelt wurde die Technik an der schweizerischen EPFL. Die Technologie basiert auf zwei Zellen, die wie ein Sandwich zusammenkleben: die erste hält blaues und violettes Licht ab, während grün-rote Lichtstrahlen durchgehen und auf der zweiten Zelle auf farbsensitive Titandioxid Nanokristalle treffen. Diese Kristalle wird die neue Firma weiterentwickeln. Partner in den USA wird die amerikanische "University of Nevada" in Reno.
Zeit: Juni 2003.
Quelle: ALTAIR, HYDROGEN.

Das ist das Einzige was ich über Altair gefunden habe,
weis Jemand mehr über diese Firma.

Gruß T.

[taipanz]

ALTAIR?S Nano-sortierte DAS ZIRKONIUMCOxid JETZT, das FÜR ZAHNMEDIZINISCHE ANWENDUNGEN VORHANDEN Ist
Reno, Nanovolt? September 17, 2003? Altair Nanotechnologies Inc. (NASDAQ:ALTI) verkündete, daß kommerzielles nano-sortiertes Zirkoniumoxid für zahnmedizinische Anwendungen einschließlich der Füllungen und der prothetischen Vorrichtungen vorhanden ist.

Präsident Dr. Rudi E. Moerck Altair?s, das?Nano-sortiertes Zirkoniumoxid gesagt wird, ist für zahnmedizinische Anwendungen wegen seiner Stärke und Transparentes ideal zu beleuchten, aber es ist zu den Röntgenstrahlen undurchlässig und bildet es ein ausgezeichnetes Material für kurierte zahnmedizinische UVFÜLLUNGEN?


ALTAIR NANOTECHNOLOGIES INC..

Nanotechnology taucht schnell als einzigartiger Industriesektor auf. Altair Nanotechnologies ist
Positionierung durch Produktinnovation innerhalb dieser auftauchenden Industrie, um ein führender Lieferant von nanomaterials und von Technologie weltweit zu werden. Altair besitzt eine eigene Technologie für nanocrystallinematerialien der einzigartigen Qualität und in den großen Quantitäten ökonomisch bilden. Die Firma entwickelt z.Z. spezielle nanomaterials mit möglichen Anwendungen in den pharmazeutischen Produkten, in den Kraftstoffzellen, in den Solarzellen, in vorgerückten Energiespeichervorrichtungen, in den thermischen Sprayschichten, in den Katalysatoren, in den Farben und im Klimaremediation. Zu zusätzlicher Information über nanoparticlematerialien Altair?s, Besuch www.altairnano.com.

[Albatossa]

Hallo taipanz,

den man bei Yahoo.com in den Chart von Altair geht findet man sehr viele Meinugen und Berichte. Leider halt alles auf Englisch was einwenig Mühe macht.

Gruß Albatossa

[taipanz]

Danke, Albatossa

Gruß T.

[taipanz]

wenn nachrichten kommen werde ich sie auf deutsch ins board stellen

gruß T.

[Albatossa]

Hallo taipanz,

immerhin hält sie sich auch bei schlechten Umfeld!

Gruß Albatossa

[Albatossa]

Hallo Leute,

der Trend ist immernoch vorhanden!

[Albatossa]

Man kann immer noch gut günstig einsteigen. Selbst der Taipan hat Altair entdeckt und gibt ein Kursziel von 3 Euro für die nächste 6Monate bekannt und 10 Euro auf sicht von 2Jahren! Taipan empfiehlt agressives kaufen und kein Stoplosslimit zusetzen, sondern bei korrekturen kräftig nachzukaufen! Und genau das mache ich auch!

[Albatossa]

An der Nasdaq geht langsam aber sicher die Post ab bei steigende Umsätze! Wer zu spät kommt den bestraft das Leben!

[Albatossa]

Heute war der Kauftag!

[b742418]

Hallo!

Da tut sich heute ja was ...

Weiss jemand was genaues?

Schöne Grüsse!

[Albatossa]

halloallo b74

[meikelgu]

Jemand Informationen?
Wie gehts weiter mit der Aktien??

[Albatossa]

Hallo meikelgu,

mir ist leider auch nichts bekannt!

[wolfskin1967]

hallo,
bin auf der suche warum diese aktie in der letzten zeit so steigt!?! bis jetzt hab ich aber noch immer keine info`s gefunden, wäre echt super wenn mir einer meine frage beantworten könnte
danke

[Albatossa]

[matrixpeter]

Abwarten nach steigenden Kurse stellt sich meist auch eine Nachricht ein.
Nehmme jedoch an das Nanotechfonds in den wert einsteigen als alternativ investments im Nanotechbereich.
Meine Meinung dazu:Nachkaufen liegen lassen ,nicht hinschauen, und in 2-5Jahre verkaufen zu wesentlich höheren Kurse wie heute.(erwarte in den Nächsten Jahren eine nanotechhüpe wie 1999-2000 im internet bereich.
Halte altair schon 2 jahre und kaufe konsiqent nach.
Also bis in 1-2 jahre.

[wolfskin1967]

na dann lasst uns mal abwarten und hoffen!

[b742418]

Lt. dem Börsenbrief "Taipan" soll es ja ein 1000 % Kandidat sein!

[meikelgu]

Hi-kaufen und liegen lassen kann schon richtig sein. Allerdings kann man auch mal Gewinne mitnehmen und wieder frisch einsteigen. Mittelfristig denke ich auch, daß noch viel Potential ist. Eine "gute Story" wird an der Börse immer gesucht. Und da ist die Nanotechnologie ganz vorne dabei momentan. Habe die Aktie auch schon ca. 2 Jahre. Aber irgend etwas scheint "im Busch" zu sein. Erwarte eigentlich täglich eine Nachricht. Wenn ihr was wisst, wäre auch ich dankbar für Informationen.

[Albatossa]

#37

auch Taipan Leser?

[hwc2]

@ALBATOSSA

auf welchem Parkett erwirbst du die Aktie?

Gruss

HWC2

[meikelgu]

Hallo-denke, mit etwas Glück ist die Konsolidierung abgeschlossen und nach einer Seitwärtsbewegung kanns wieder aufwärts gehen. Was meint ihr?

[hwc2]

Na wenn sich das nicht gut anhoert!!

$3,6 Mrd. für die Nanoforschung
National Nanotechnolgy Act - $3,6 Mrd. für die Nanoforschung


Erst vor wenigen Tagen unterzeichnete Präsident Bush ein Dokument, das die Nanoforschung in den nächsten vier Jahren mit $3,6 Milliarden beglücken wird und so ganz nebenbei die USA an die Spitze in einem der wohl zukunftsträchtigsten Forschungsbereiche katapultieren soll. Der Gesetzentwurf sieht vor, Forschungsprogramme die sich mit der Entwicklung von Technologien im Nanomaßstab beschäftigen durch die Vergabe staatlicher Fördergelder drastisch zu beschleunigen.


Damit setzt sich das fort, was die Amerikaner stets tun wenn sie eine große Sache riechen, nämlich riesige Summen an finanziellen Mitteln zu investieren, um auf diese Weise die Vorherrschaft gegenüber dem Rest der Welt zu erringen. In der IT-Branche, der Biotechnologie und der Biomedizin ist dies den Amerikanern bereits hervorragend gelungen und durch die jüngste Regierungsinitiative könnte sich dieser Erfolg auch in der Nanotechnologie wiederholen.


Obwohl der National Nanotechnology Act erst kürzlich unterzeichnet wurde und finanzielle Mittel noch nicht geflossen sind, reagierten bereits die Börsen entsprechend. Die Nachfrage nach den Papieren der wenigen an der Börse gelisteten Nanotech-Companies war nach Veröffentlichung der gigantischen Fördersumme immens. Die Aktie von Harris & Harris, einem Venture Capitalist der sich auf die unterschiedlichsten Nanotech-Companies spezialisiert hat, stieg innerhalb nur weniger Tage auf ein Allzeithoch.


Es sieht fast so aus, als wenn sich vor allem die großen Investoren im Vorfeld eines erhofften Nanotech-Booms bereits entsprechend positionieren wollten. Vielleicht ein erstes Signal auch für den privaten Investor so langsam auf den gerade anfahrenden Zug aufzuspringen. Noch sind die meisten Nanotech-Unternehmen noch relativ günstig bewertet und die Vergabe der ersten Fördergeldern wird wohl schon im nächsten Jahr eine Menge Investoren in die Branche ziehen.


Noch steht die Nanoforschung am Anfang einer großen Zukunft, doch erste Erfolge gibt es bereits und mit den nötigen finanziellen Mitteln werden schon in absehbarer Zeit erste Produkte den Sprung vom Forschungs- und Entwicklungsstadium in die Vermarktung vollziehen. In den nächsten vier Jahren, auf diesen Zeitraum ist die staatliche Förderung angesetzt, wird deshalb mit ersten durchschlagenden Erfolgen zu rechnen sein. Eine Tatsache, von der vor allem große Investoren profitieren möchten. Einige sind ja bereits eingestiegen, doch so nach und nach werden weitere folgen, bereits investierte werden ihre Positionen ausbauen. Wer dann als Kleinanleger den richtigen Riecher beweisen konnte und bereits fest im Sattel sitzt, sollte vom Aufschwung in der Nanotechnologie von Anfang an profitieren.


Protegiert wurde der National Nanotechnology Act von Senator Ron Wyden, einem leidenschaftlichen Verfechter von Nanoscience, der sich schon seit geraumer Zeit für eine beschleunigte Entwicklung nanotechnologischer Entwicklungen einsetzt. Im Oktober war es ebenfalls Senator Wyden, der dem Nanotech-Unternehmen FEI bei der Eröffnung seines „World Campus and Technology and Product Solutions Center“ in Hillsboro, Oregon, unter die Arme griff.



Alle weltweit führenden Forschungsinstitute wie die National Institutes of Health, die Centers for Disease Control, das Scripps Institute, die Ohio State University und das Stanford Nanocharacterization Laboratory nutzen die FEI Tools für ihre Forschungen. In den vergangenen fünf Jahren konnte FEI seine Umsätze von $169 Millionen auf $341 Millionen steigern. Die Wachstumsrate des Unternehmens lag in dieser Periode bei 16,4%. Doch FEI ist nur eines von vielen aussichtsreichen Zukunftswerten, die sich in der Nanoforschung angesiedelt haben. Zwar ist bisher erst eine Handvoll davon an der Börse gelistet, doch schon bald werden weitere Börsengänge folgen, und wer weiß, vielleicht löst die Nanotechnologie ja schon bald wie einst das Internet die nächste Börsenhype aus.


Wenn sie wissen möchten welche Unternehmen in der Nanobiotechnologie die Nase vorn haben und möglicherweise schon bald zu den neuen Börsenlieblingen aufsteigen könnten, sollten sie unseren nächsten Nanobio-Report nicht versäumen. Unter www.Biotech-Experte.de können sie diesen schon demnächst anfordern.


Stets die aktuellsten News aus dem Pharma- und Biotechsektor, bestens recherchiert und mit dem nötigen wissenschaftlichen Sachverstand auf ein selbst für Laien verständliches Niveau aufbereitet, finden sie unter www.Biotech-Experte.de.


Simone A. Hörrlein
Staatl. gepr. LebChem (Univ.)
(Life Scientist)


Gruss HWC2

[Albatossa]

Hallo hwc2,

#40
das entscheidet immer mein Taschenrechner ob es Frankfurt oder die Nasdaq ist!

[jog_]

NEWS RELEASE FOR ALTI:

Congress Funds $2 Million in Omnibus Appropriations Bill for Altair Nanotechnologies` and Western Michigan University`s Nanoscience Research
Tuesday December 16, 10:30 am ET

RENO, NV--(MARKET WIRE)--Dec 16, 2003 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) was notified by Western Michigan University (WMU) of grant funding for their joint development of nanosensors for detecting chemical, biological and radiological agents in the environment. The project is a collaboration involving WMU, Altair Nanotechnologies and the University of Nevada, Reno. The $2 million was included in the Omnibus Appropriations Bill passed by the U.S. House of Representatives December 9, 2003. WMU and Altair have a joint partnership for seeking Federal support for nanotechnology research and development and will utilize the new grant funding equally.

"We would like to sincerely thank Nevada Senator Harry Reid and Michigan U.S. Representative Fred Upton for their continuous support and hard work in assisting WMU and Altair in obtaining the funding for our joint nanotechnology research efforts, efforts that could have a significant impact on homeland security and national defense," said Altair President Dr. Rudi E. Moerck.

"In addition to being awarded government grant funding, Altair has improved its current cash position by approximately $2.1 million over the past few weeks," said Dr. Moerck. "As our stock price has continued to improve, shareholders have taken advantage of the share price increase by exercising warrants and stock options. Today, we have adequate funds available to the company through October 2004."

Western Michigan University

WMU is a Carnegie-designated Doctoral/Research-Extensive university and one of only 102 public research universities to be included in this top classification. WMU is a national leader in nanobioenvironmental chemistry research and has established the Nanotechnology Research and Computation Center to further this research.

Altair Nanotechnologies, Inc.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Ist doch ganz freundlich, oder??????

Grüsse jog_

[meikelgu]

Hi-habt ihr auch diese email aus dem Verteiler von alti erhalten, die dann gleich widerrufen wurde? Kann mich mal jemand aufklären, was da im Gange ist?? Danke.

[jog_]

Altair Nanotechnologies Restructures to Exclusively Focus on Nanotechnology and Materials Science
Friday December 19, 7:00 am ET

RENO, NV--(MARKET WIRE)--Dec 19, 2003 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News), a company engaged in developing metal oxide based nanomaterials, titanium dioxide pigment technology, and manufacturing techniques for novel nanomaterials and nanostructures, announced that management and the company`s Board of Directors have initiated a restructuring of the company.

Restructuring

The Board of Altair Nanotechnologies Inc. has approved a plan to restructure the company. Management has been directed to identify and effect one or more strategic transactions, most likely a sale or joint venture contribution, involving the disposition of the company`s rights in its exploration stage mining project in Tennessee as well as the centrifugal jig. The purpose of the restructuring is to permit the company to concentrate all of its resources on nanotechnology and materials science. Employees associated with these assets will be reassigned within the company.

Board of Directors

Dr. Rudi E. Moerck, currently President of Altair Nanotechnologies, has been appointed to the company`s Board of Directors. He will replace Edward Dickinson, who will continue in his function as Chief Financial Officer of the company. Dr. Moerck was named President of Altair in April 2002 and has assumed the responsibility for shaping the company into a leader in the emerging sector of nanotechnology and materials science.

Dr. Moerck received his Bachelors of Science in biology from Florida Southern College and holds a Ph.D. in physical organic chemistry from the University of Florida. He completed Postdoctoral Fellowships with the National Science Foundation and the National Institutes of Health at Ohio State University, and taught premedical organic chemistry at Ohio State and Ohio Wesleyan University. He has over 25 years of pharmaceutical and fine chemicals experience.

The company is seeking to augment its Board of Directors with individuals that reflect the focus of the restructured company.

Reorganization

The reorganization is intended to maximize management focus on nanomaterials, nanotechnology and material science in the most promising markets including: materials and technology for TiO2 pigment, TiO2 electrodes for titanium metal, pharmaceutical delivery structures (TiNano Spheres™, pharmaceuticals (RenaZorb™, dental materials and nanostructured materials for lithium ion batteries and fuel cells. When the restructuring is complete, the company will be organized into a one-division operation with a dedicated nanotechnology and advanced material science mission and focus.

"We are confident in the capability and enthusiasm of all employees and the commercial potential of our intellectual property," said Dr. Moerck. "We are committed to make consistent progress toward the generation of revenue from commercial sales as soon as practicable."

Dr. Moerck went on to note that Douglas K. Ellsworth was appointed Vice President of Business Development for Altair Nanotechnologies, Inc. and that C. Patrick Costin has resigned his positions as Vice President of Altair Nanotechnologies Inc. and as a Director of Altair Nanomaterials.

Termination of Mining Projects

Management has approved the sale or other disposition of all mining activities. In conjunction therewith, management is evaluating all obligations, including any environmental obligation that may be incurred in conjunction with such termination. Management does not believe that any obligation would be material to its financial position.

ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

[Albatossa]

Es geht schon wieder los!

[jog_]

nun steigen auch institutionelle bei alti ein.

mfg jog_

[Albatossa]

Hallo jog_

der taipan hat alti mit einen Kursziel von 10 Dollar versehen!

[Mr.Perfect]

hier kann`s ja auch noch schön weiter nach oben gehen, genau gleich wie biophan

c-ya mr.perfect

[Albatossa]

[Albatossa]

Gibt es hier nur noch stille Geniesser?

[jog_]

hi albatossa,

die 10€ sind dort aber langfristig gemeint, d.h. 1-3jahre.
das halte ich für gut möglich, da das papier eines der favoriten des chefredakteurs ist. der weiss schon was gut ist.

auf rb. gibt es sogar meinungen, daß dies bereits in diesem, laufenden jahr erreicht werden kann.

ich denke mal, spätestens wenn eines der patente von alti marktreife bekommt,gehts noch darüber hinaus.
solang heisst es warten. aber wir werden ja bereits jetzt ganz gut belohnt.

mfg jog_

[jog_]

DAS SPÄTESTE VON LEBED! APPI erreichte, $0.04 heute aber wurde unten von einem grossen Verkäufer am Ende des Tages gedrueckt. Recht, bevor das Ende, das der Verkäufer und Bitten herausgenommen erhält, von $0.034 bis $0.037 hochschob. Ich erwarte ein geöffnetes Morgen um ungefähr $0.037 und damit es $0.04 während der upcoming Tage bricht. Sobald es Nachrichten ich gibt, glauben Sie, daß es $0.05 bricht und anfängt, in Richtung zu bis $0.10 zu bewegen. ALTI beendete heute bei $3.56 und war so hoch wie $3.74 während des Tages. Vor ALTI ist jetzt herauf 287% von, als ich ursprünglich die Firma im profilierte Mai und up 62% von, als ich zwei Wochen das verkündete, das es mein zweiter Lieblingsvorrat für 2004 ist. Ich glaube, daß ALTI auf ihm ist Weise bis $10 dieses Jahr ist. Mein anderer Lieblingsnanotechnology Vorrat JMAR beendete heute bei Recht $3.23 an der Höhe. Vor JMAR ist jetzt herauf 127% von, als ich die Firma an November profilierte 25. und up 90% von, als ich zwei Wochen das verkündete, das es auf meiner oberen Liste 10 für 2004 ist. Ich glaube, daß JMAR $10 dieses Jahr auch möglicherweise sehen könnte. ----- Jonathan Lebed Lebed.biz Stab

[Albatossa]

[jog_]

Hört sich gut an:

15 Jan 2004, 09:17 AM EST

Altair Nanomaterials, Inc. Enters Into Agreement with
Titanium Metals Corporation




Reno, NV – January 15 , 2003 – Altair Nanotechnologies, Inc. (NASDAQ:ALTI) announced today that its subsidiary, Altair Nanomaterials Inc. has entered into a contract with Titanium Metals Corporation (NYSE: TIE) for development of a low cost manufacturing process for titanium dioxide pellets, critical to the successful commercialization of the FCC Cambridge process for production of titanium metal. The contract will be funded under Titanium Metals Corporation’s primary U.S. Department of Defense (DOD), Defense Advanced Research Projects Agency (DARPA) contract. Altair will receive $150,000 during the initial six months phase of the agreement. Several follow-on phases should proceed concurrently and sequentially.

As previously announced, Titanium Metals Corporation has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to lead a program for developing an innovative new titanium electrolysis technology originated at Cambridge University and now referred to as the FFC Cambridge Process. The process uses titanium dioxide (TiO2) feedstock. Approximately 1.67 pounds of titanium dioxide feedstock are required to make one pound of titanium metal.

DARPA awarded Titanium Metals Corporation $12.3 million for a four-year development program. Titanium Metals Corporation leads a team of researchers from major defense contractors, including General Electric Aircraft Engines, United Defense Limited Partners and Pratt & Whitney, as well as the University of California at Berkeley and the University of Cambridge, in this development program. The FFC Cambridge Process has the potential to significantly reduce the cost of titanium metal and dramatically expand its use in a wider range of applications that include lightweight armored military vehicles, the manufacture of automotive components and components for utility plants, oil and gas drilling, and lightweight and durable consumer goods.

The agreement between Titanium Metals Corporation and Altair Nanomaterials follows the completion of a development program in which Altair provided Titanium Metals Corporation with samples of customized titanium dioxide cathodes under a July 30, 2003 Memorandum of Understanding.

Under the terms of the agreement, Altair will provide low-cost TiO2 to make customized electrodes for the Titanium Metals Corporation project. Altair believes its ability to control TiO2 particle size, shape and crystalline structure, using its patented process to make TiO2 pigment and nanoparticles, could have a significant benefit to the program. Altair’s new proprietary technology enables production of optimized porosity and custom shaped electrode precursors from either commercial titanium tetrachloride (TiCl4) or from titanium ore digestion solutions, and is described in Altair’s pigment patent, US Patent 6,375,923. “We are excited to be participating in this next-generation technology and are pleased to be working with one of the world’s largest titanium metal producers and aerospace and military industry leaders”, says Altair’s president Dr. Rudi Moerck.

Titanium is the 10th most abundant element in the earth’s crust and the 4th most abundant structural metal. Titanium metal has unique physical and chemical properties including high strength-to-weight ratio, good corrosion resistance and excellent ballistic armor protection while offering appreciable weight reduction over conventional steel and aluminum alloys. It is as strong as steel, but 45 percent lighter. It is 60 percent heavier than aluminum, but twice as strong. Titanium is expensive only because the current process for refining the ore to metal is a multi-step, high temperature batch process.

According to the AMPTIAC Quarterly, a Department of Defense-sponsored publication, current global production of titanium metal is approximately 50,000 tons per year at a market value of $600 million. AMPTIAC estimates that, due to the current state of manufacturing, titanium is produced at only about 1/20th of its current potential world volume. It is widely believed that a reduction of cost in the manufacturing process will expand the use of titanium metal in a wider range of applications that include lightweight armored military vehicles, the manufacture of automotive components and components for utility plants, oil and gas drilling, and lightweight and durable consumer goods.

[Albatossa]

Hallo jog_,

es ist gut!

[Albatossa]

Hallo Leute,

die Aktie von Altair kommt wieder auf touren!

[jog_]

hoffentlich dieses mal nachhaltiger.

Davor war ja nach etwa 2x10%+ auch Chartmäßig der Absturz
vorauszusehen. Vom schlechten Marktumfeld wurde der Trend noch unterstützt.

Mal sehen was er dieses mal für eine Formation ausbildet.
jog_

[UnabderFisch]

ALTI hat " GOOD NEWS"


ALTAIR NANOTECHNOLOGIES’ ALGAE PREVENTION TREATMENT CONFIRMED EFFECTIVE IN TESTING

NanoCheck™ proven in both independent and in-house laboratory testing


RENO, NV. – March 11, 2004 – Altair Nanotechnologies (NASDAQ:ALTI), a leader in nanotechnology, nanomaterials and material science announced today that the safety and effectiveness of its NanoCheck™ swimming pool algae prevention compound has been validated in independent testing. Altair also announced that it expects to support a large scale program for swimming pool testing this summer. The success of this testing could result in the commercial launch of NanoCheck in the first quarter of 2005.

“We are pleased to announce that independent testing confirms and validates our NanoCheck algae prevention technology,” said Altair President Dr. Rudi E. Moerck. “The test results demonstrate the ability of NanoCheck to supplement and improve currently available swimming pool treatments to prevent algae growth. The results continue to reaffirm the growing acceptance and real-world applications of our nanotechnology platform across multiple vertical markets.”

“The first phase of the microbiological performance testing confirms NanoCheck’s ability to retard and prevent algae growth through absorption of phosphates from water,” continued Dr. Moerck. “The promising results serve as the springboard for additional testing focused on providing a safe, algae-free environment in swimming pools and spas. Testing of NanoCheck, which is not a biocide, confirmed that it is virtually insoluble in water, a necessary characteristic for materials used for the treatment of swimming pools."

Unwanted algae growth in swimming pools is a dilemma for pool owners worldwide. The National Swimming Pool and Spa Institute reports the market consists of approximately eight million pools and four million existing spas and hot tubs worldwide, with an additional 360,000 pools and approximately 260,000 spas and hot tubs being installed on a yearly basis.

ABOUT NANOCHECK
Altair’s NanoCheck™ is a unique nano-structured compound that effectively aids in the prevention of algae growth in swimming pools and reduces filter fouling caused by biomass accumulation. NanoCheck, when used with conventional swimming pool treatments, affords enhanced protection against algae infestation. The compound is highly insoluble in water and works in conventional pool filtration systems. The algae prevention compound is not a biocide, is safe and effective, and requires no pool downtime during the algae prevention treatment. NanoCheck, used with the check-mark symbol is a registered trademark of Altair Nanotechnologies.

ABOUT ALTAIR NANOTECHNOLOGIES, INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company’s actual and future results to be materially different than suggested by the forward-looking statements in this release. These risks and uncertainties include the successful demonstration of NanoCheck’s ability to reduce or prevent the growth of algae in field testing, the commercialization of the product within the swimming pool industry, the ability of Altair to find a partner to distribute NanoCheck and the other risks that are identified in the company’s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

Hurrahh ALTI

[jog_]

ALTI könnte auch ein Übernahmekandidat werden.

[muhsin]

Altair Nanotechnologies Announces Plans to Form Life Sciences Division and Spin Off Mineral Recovery Systems Group 16 March 2004, 07:30am ET



Altair Nanotechnologies Inc. (NASDAQ: ALTI)), a company engaged in developing nanomaterials, titanium dioxide pigment technology, and manufacturing technologies for unique nanostructures, announced four additional steps in its restructuring program: 1) The decision to form a new life sciences division alongside its existing nanomaterials division as part of its initiative to focus on specific vertical markets, 2) The decision to spin off its mineral assets to its shareholders, 3) The resignation of Altair Chief Executive Officer Dr. William P. Long, and 4) The appointment of Dr. Rudi E. Moerck to senior executive officer upon Dr. Longs resignation.

The new life sciences division will focus on the continued development of pharmaceutical delivery structures (TiNano Spheres™), dental materials and new nano-based pharmaceuticals including Altair`s lead drug candidate, RenaZorb™. "We realized that with the diversity of our markets, we will better direct our development, sales, marketing and out-licensing efforts by organizing these various markets into two divisions led by industry-specific management," said Altair President Dr. Rudi E. Moerck. "Altair will immediately implement a search for a senior vice president for the new life sciences division."

The Altair nanomaterials division will focus on materials science and on markets such as TiO2 pigment, TiO2 electrodes for titanium metal, nano-structured materials for lithium ion batteries and fuel cells, along with NanoCheck™ for the prevention of algae growth. The division will continue under the direction of Senior Vice President Douglas K. Ellsworth.

Altair plans to distribute (or spin off) to its shareholders the capital stock of a subsidiary holding the assets of the current Mineral Recovery Systems (MRS) division. Altair intends to solicit shareholder approval for the spin off and complete the filings necessary to make MRS a reporting company. MRS will hold the rights to the exploration-stage mineral deposit in Camden, Tennessee, the ownership of the Altair centrifugal jig and related intellectual property for agglomeration of titanium dioxide.

Dr. William P. Long will resign his position as Chief Executive Officer and member of Altair`s board of directors as of May 1, 2004. Dr. Long is expected to serve as the President of MRS and, during the period preceding his resignation, will focus most of his efforts on structuring and effecting the spin off of MRS. "It has been my pleasure to serve as Altair`s CEO," said Dr. Long. "Our strategic focus and long-term revenue objectives are best served by this new division of labor, and I look forward to driving the success and growth of MRS."

Mentioned Last Change
ALTI 2.42 0.18dollars or (6.92%)
Upon Dr. Long`s resignation, Dr. Rudi E. Moerck, President of Altair, will become Altair`s senior executive officer and will continue to be responsible for day-to-day operations of the company and for implementing its strategic plan. "We are indebted to Dr. Long for his leadership of the company, particularly for his insight in structuring the transactions necessary for Altair to acquire its nanomaterial and titanium processing technology," said Dr. Moerck.

The company intends to commence a search for a new non-executive Chairman of the Board of Directors to work with Dr. Moerck and the board in their efforts to focus Altair`s resources on generating revenue and increasing shareholder value. Dr. Moerck noted that Altair will capitalize on the significant expertise of its board and senior management and expects them to take a hands-on approach to establishing the company`s growth strategy and goals, while closely monitoring the progress of each.

ALTAIR NANOTECHNOLOGIES INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the following: The organization of the life sciences division may not be completely or properly effected and may not prove effective in furthering marketing and development efforts in the life sciences area; the proposed MRS spin-off may not receive shareholder approval or may for other reasons not be consummated or not increase shareholder value; notwithstanding its continuing restructuring efforts, the company may not ever generate significant revenue from operations or create a significant demand for any of its products; and the company`s nanoparticle products may not be integrated into any major market groups and products, in addition to other risks identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


--------------------------------------------------------------------------------

Contacts:
Marty Tullio
McCloud Communications, LLC
949.566.9860
[e-mail]

Tracy LaFollette
Altair Nanotechnologies
307.587.8245
[e-mail]

[muhsin]

Hier eine ungefähre Übersetzung:

Altair Nanotechnologies verkündet Pläne, um Leben-Wissenschaften Abteilung zu bilden und Mineralwiederaufnahme weg zu spinnen gruppieren Systeme E-mail oder drucken diese Geschichte

März 16 2004, 07:30am UND Altair Nanotechnologies Inc. (Nasdaq: ALTI)),

eine Firma engagierte sich in sich entwickelnden nanomaterials, in der Titandioxidpigmenttechnologie und in den herstellentechnologien für einzigartige nanostructures, verkündet vier zusätzliche Schritte in seinem Umstrukturierenprogramm: 1) die Entscheidung, zum einer neuen Lebenwissenschaften Abteilung neben seiner vorhandenen nanomaterials Abteilung als Teil seiner Initiative zu bilden, um auf spezifische vertikale Märkte zu konzentrieren, 2) die Entscheidung, zum seiner Mineralwerte zu seinen Aktionären, 3) die Resignation von Altair-Generaldirektordr. William P. Long und 4) die Verabredung von Dr. Rudi E. Moerck zum älteren Executivoffizier nach Resignation des Dr. Longs weg zu spinnen. Die neue Lebenwissenschaften Abteilung konzentriert auf die anhaltende Entwicklung der pharmazeutischen Anlieferung Strukturen (TiNano Bereiche?), zahnmedizinische Materialien und neue nano-gegründete pharmazeutische Produkte einschließlich Drogeanwärter Leitung des Altairs, RenaZorb?. "wir stellten, daß mit der Verschiedenartigkeit unserer Märkte, wir direkt unsere Entwicklung verbessern, Verkäufe, Marketing und heraus-genehmigende Bemühungen durch das Organisieren dieser verschiedenen Märkte in zwei Abteilungen geführt vom Industrie-spezifischen Management," sagten Altair-Präsidenten Dr. Rudi E. Moerck fest. "Altair führt sofort eine Suche nach einem älteren Vizepräsidenten für die neue Lebenwissenschaften Abteilung." ein Die Altair nanomaterials Abteilung konzentriert auf Materialwissenschaft und auf Märkte wie Pigment TiO2, Elektroden TiO2 für Titanmetall, nano-strukturierte Materialien für Lithiumionenbatterien und Kraftstoffzellen, zusammen mit NanoCheck? für die Verhinderung des Algen Wachstums. Die Abteilung fährt unter der Richtung des älteren Vizepräsidenten Douglas K. Ellsworth fort. Altair plant, (oder weg spinnen) auf seine Aktionäre das Stammkapital einer Tochtergesellschaft zu verteilen, welche die Werte der gegenwärtigen Mineralwiederaufnahme Systeme (MRS) hält Abteilung. Altair beabsichtigt, Aktionärzustimmung für die Drehbeschleunigung weg zu erbitten und die Archivierungen durchzuführen, die notwendig sind, MRS eine berichtenfirma zu bilden. MRS hält die Rechte zur Erforschung-Stadium Mineralablagerung in Camden, Tennessee, der Besitz der zentrifugalen Spannvorrichtung des Altair und des bezogenen geistigen Eigentums für Anhäufung des Titandioxids. Dr. William P. Long findet seine Position als Generaldirektor und Mitglied der Direktion des Altairs ab Mai 1, 2004 ab. Dr. Long wird erwartet, als der Präsident von MRS und, während der Periode zu dienen, die seine Resignation vorangeht, wird die meisten seinen Bemühungen auf die Drehbeschleunigung von MRS weg strukturieren und bewirken richten. "es ist mein Vergnügen gewesen, als CEO des Altairs zu dienen," sagte Dr. Long. "unser strategischer Fokus und langfristigen Einkommen Zielsetzungen werden gut durch diese neue Arbeitsteilung gedient, und ich freue, den Erfolg und das Wachstum von MRS zu fahren." Zuletzt erwähnt ändern Sie ALTI 2.42 0.18dollars oder (6.92%) nach Resignation des Dr. Longs, Dr. Rudi E. Moerck, Präsident von Altair, wird älterer Executivoffizier des Altairs werden und fährt, für Alltagsbetriebe der Firma und für das Einführen seines strategischen Planes verantwortlich zu sein fort. "wir sind zum Dr. Long für seine Führung der Firma verschuldet, besonders für seinen Einblick, wenn, die Verhandlungen strukturierend, die für Altair notwendig sind, seine nanomaterial und Titanverfahrenstechnik zu erwerben,", sagte Dr. Moerck. Die Firma beabsichtigt, eine Suche nach neuem non-executive Vorstandsvorsitzend der Direktoren zu beginnen, um mit Dr. Moerck und das Brett in ihren Bemühungen zu arbeiten, Betriebsmittel des Altairs auf das Erzeugen des Einkommens und die Erhöhung des Aktionärwertes zu richten. Dr. Moerck merkte, daß Altair auf der bedeutenden Sachkenntnis seines Brettes und älteren Managements gross schreibt und sie erwartet, eine praktische Annäherung zum Herstellen der Wachstumstrategie und -ziele der Firma zu nehmen, bei den Fortschritt von jedem nah überwachen.

ALTAIR NANOTECHNOLOGIES INC.. Nanotechnology taucht schnell als einzigartiger Industriesektor auf. Altair Nanotechnologies bringt sich durch Produktinnovation innerhalb dieser auftauchenden Industrie in Position, um einem führenden Lieferanten der nanomaterial Technologie und der nanomaterials weltweit zu stehen. Altair besitzt eine eigene Technologie für nanocrystalline Materialien der einzigartigen Qualität und in den großen Quantitäten ökonomisch bilden. Die Firma entwickelt z.Z. spezielle Materialien mit möglichen Anwendungen im Produkt-, Titanpigment und im Metall, in den Batterien, in den Kraftstoffzellen, in den Solarzellen, in vorgerückten Energiespeichervorrichtungen, in den thermischen Sprayschichten, in den Katalysatoren, in den Kosmetik und im Klimaremediation. Zu zusätzlicher Information über Altair und seine nanoparticle Materialien, Besuch www.altairnano.com. Vorwärts-Schauen Von von Aussagen Diese Freigabe kann das Vorwärts-Schauen von von Aussagen sowie historische Informationen enthalten. das Vorwärts-Schauen der Aussagen, die in Übereinstimmung mit den Bestimmungen "des sicheren Hafens" der privaten Sicherheiten Rechtsstreit-Verbesserung-Tat von 1995 enthalten sind, kann Gefahren, Ungewißheiten und andere Faktoren mit einbeziehen, die der tatsächlichen die Resultate und Leistung Firma in den zukünftigen Perioden veranlassen können, zu jeden möglichen Zukunftresultaten oder -leistung materiell unterschiedlich zu sein, die durch die Vorwärts-schauenden Aussagen diesbezüglich Freigabe vorgeschlagen werden. Diese Gefahren und Ungewißheiten schließen, ohne Beschränkung, das folgende mit ein: Die Organisation der Lebenwissenschaften Abteilung kann möglicherweise nicht vollständig oder richtig zu bewirken und kann möglicherweise nicht wirkungsvolles prüfen, wenn man Marketing- und Entwicklungsbemühungen im Lebenwissenschaften Bereich fördert; die vorgeschlagene MRS Spin-off kann möglicherweise nicht Aktionärzustimmung empfangen oder kann aus anderen Gründen nicht durchgeführt werden oder nicht Zunahmeaktionärwert; ungeachtet seiner fortfahrenden Umstrukturierenbemühungen kann die Firma möglicherweise nicht bedeutendes Einkommen von den Betrieben überhaupt erzeugen oder eine bedeutende Nachfrage nach irgendwelchen seiner Produkte verursachen; und die Produkte nanoparticle der Firma können möglicherweise nicht in irgendwelche Hauptmarktgruppen und -produkte, zusätzlich zu anderen Gefahren integriert werden, die neuesten jährlichen Bericht der Firma im über Form 10-K gekennzeichnet werden, wie mit der sek eingeordnet. Solche Vorwärts-schauende Aussagen sprechen nur ab dem Datum dieser Freigabe. Die Firma dementiert ausdrücklich jede mögliche Verpflichtung, irgendwelche Vorwärts-schauenden Aussagen zu aktualisieren oder zu verbessern, die hierin gefunden werden, um alle mögliche Änderungen in den Firmaerwartungen oder -resultaten oder irgendeine Änderung in den Fällen zu reflektieren. -------------------------------------------------------------------------------- Kontakte: Marty Tullio McCloud Kommunikationen, LLC 949.566.9860 [e-mail] Tracy LaFollette Altair Nanotechnologies 307.587.8245 [e-mail]

[muhsin]

Altair Nanotechnologies Inc. Announces Fourth Quarter and Year-End Financial Results Conference Call
E-mail or Print this story

17 March 2004, 11:34am ET



Altair Nanotechnologies Inc. (NASDAQ: ALTI), a company engaged in developing nanomaterials, titanium dioxide pigment technology, and manufacturing technologies for unique nanostructures, announced today it will hold a quarterly conference call to discuss fourth quarter and year-end financial results for fiscal 2003 on Thursday, March 25, at 11:30 a.m. Eastern Standard Time. Shareholders and members of the investment community are invited to participate in the call.

The conference call dial-in number is 800.299.8538. As a passcode is necessary to participate in the conference call, please RSVP your participation by calling Suzanne Schnitzer at McCloud Communications, 949.566.9860. Additionally, this call is being webcast by CCBN and can be accessed at Altair`s web site, www.altairnano.com.

Mentioned Last Change
ALTI 2.33 0.08dollars or (3.31%)
Additionally, the web cast is being distributed over CCBN`s Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN`s individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN`s Individual Investor Network. Institutional investors can access the call via CCBN`s password-protected event management site, StreetEvents (www.streetevents.com).

ALTAIR NANOTECHNOLOGIES INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.


--------------------------------------------------------------------------------

Contacts:
Marty Tullio or Mark Tullio
McCloud Communications, LLC
949.566.9860
[e-mail]

Tracy LaFollette
Altair Nanotechnologies
307.587.8245
[e-mail]

E-mail this story Print this story

[muhsin]

Altair Nanotechnologies Inc. (Nasdaq: ALTI), eine Firma engagierte sich in sich entwickelnden nanomaterials, Titandioxidpigmenttechnologie, und die herstellentechnologien für einzigartige nanostructures, heute verkündet ihm halten einen vierteljährlichen Konferenzanruf, um viertes Viertel und year-end finanzielle Resultate für steuerliches 2003 am Donnerstag, März 25, um 11:30 a.m. zu besprechen. Östliche Standardzeit. Aktionäre und Mitglieder der Investitiongemeinschaft werden eingeladen, am Anruf teilzunehmen. Der Konferenzanruf Vorwahlknopf- in der Zahl ist 800.299.8538. Da ein Paßwort notwendig ist, um am Konferenzanruf teilzunehmen, bitte RSVP Ihre Teilnahme durch das Benennen von von Suzanne Schnitzer an den McCloud Kommunikationen, 949.566.9860. Zusätzlich ist dieser Anruf webcast durch CCBN und kann an der Web site des Altairs, www.altairnano.com erreicht werden. Zuletzt erwähnt worden ändern Sie ALTI 2.33 0.08dollars, oder (3.31%) zusätzlich ist die Netzform verteiltes ÜbercCBN`s Investor-Verteilungsnetz zu den Institutions- und einzelnen Investoren. Einzelne Investoren können zum Anruf hören durch CCBN`s einzelne Investormitte an www.companyboardroom.com oder indem sie irgendwelche der Investoraufstellungsorte CCBN`s im einzelnen Investor-Netz besichtigen. Institutionelle Anleger können den Anruf über CCBN`s Kennwort-geschützten Fallmanagementaufstellungsort, StreetEvents (www.streetevents.com) zugänglich machen.

ALTAIR NANOTECHNOLOGIES INC.. Nanotechnology taucht schnell als einzigartiger Industriesektor auf. Altair Nanotechnologies bringt sich durch Produktinnovation innerhalb dieser auftauchenden Industrie in Position, um einem führenden Lieferanten der nanomaterial Technologie und der nanomaterials weltweit zu stehen. Altair besitzt eine eigene Technologie für nanocrystalline Materialien der einzigartigen Qualität und in den großen Quantitäten ökonomisch bilden. Die Firma entwickelt z.Z. spezielle Materialien mit möglichen Anwendungen im Produkt-, Titanpigment und im Metall, in den Batterien, in den Kraftstoffzellen, in den Solarzellen, in vorgerückten Energiespeichervorrichtungen, in den thermischen Sprayschichten, in den Katalysatoren, in den Kosmetik und im Klimaremediation. Zu zusätzlicher Information über Altair und seine nanoparticle Materialien, Besuch www.altairnano.com.

[Albatossa]

Wenn Alti so weiter fällt dann testen wir nochmals den Boden von 30 Cent!

[Albatossa]

Also muß ich meine Ausssage unter #66 doch noch revedieren!


Besser so als anders herum!

[meikelgu]

HOPPLA-
was ist denn passiert?????????????

[rastapop]

das ist passiert:
http://www.ml.com/about/press_release/04012004-1_nanotech_in…

[meikelgu]

Danke!

[Albatossa]

[jog_]

Altair Nanotechnologies` New Thermal Spray Product Demonstrates Superior Functionality
Wednesday April 28, 8:30 am ET
TiNano Coat(TM) Outperforms Existing Commercially Available Competitive Spray Products

RENO, NV--(MARKET WIRE)--Apr 28, 2004 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) a company engaged in developing nanomaterials, titanium dioxide pigment technology, and materials science focused on nanostructures, today announced that its novel nanomaterials thermal spray grade powder, TiNano Coat(TM), demonstrated significantly superior mechanical properties in a competitive study performed by the National Research Council (NRC) of Canada. The study was performed at NRC`s state-of-the-art Industrial Materials Institute facilities in Boucherville, Quebec, from November 2003 through February 2004.
"The outstanding test results from the NRC further validate not only our TiNano Coat product itself, but provide additional proof-of-concept of our patented technology platform as the foundation from which we can drive commercialization of nanotechnology," said Dr. Rudi E. Moerck. "With testing complete, we are now focused on revenue generation, and have retained a leading international business development firm, Global Strategy, to assist us in aggressively marketing and distributing both TiNano Coat and ZNano Coat(TM) products worldwide."

Testing Methodology and Results

The competitive performance study compared two versions of TiNano Coat powders to commercially available titania products, both nano and standard powders, in air plasma spray (APS) and high velocity oxygen fuel (HVOF) coating applications. Tests included porosity (the percentage of pores that could absorb harmful fluids or gases), hardness, abrasion resistance, and bond strength. Altair`s nano-structured TiNano Coat produced the optimal mechanical properties for either HVOF or APS spray devices, compared to conventional materials. Test results also determined that HVOF is the best application process for Altair`s TiNano Coat materials, as the low bond strength problem associated with conventional coatings is completely eliminated by Altair`s materials, while simultaneously producing the low porosities typical of HVOF grade materials.

Thermal Spraying

Thermal spraying is a process in which powders (metal and non-metallic) are deposited on surfaces using either high velocity oxygen fuel or air plasma spray "guns". The powder is melted in the heated zone and forcibly ejected and splattered on the metal surface, where it provides a mechanical and chemical resistant protective barrier to safeguard against extreme conditions that the metal alone could not withstand. The process is widely used in heavy duty applications requiring abrasion and chemical resistance, and also as a thermal barrier. These include heavy industrial, chemical, petroleum, hydrometallurgical and aerospace applications to enhance the protection properties of metal alloys. Altair produces TiNano Coat products using its proprietary TiO2 ultrafine nanomaterial process. In addition, Altair produces and sells ZNano Coat(TM), a yttria stabilized zirconium oxide, for other thermal spray applications.

THE NATIONAL RESEARCH COUNCIL

The National Research Council (NRC) is the Government of Canada`s premier organization for research and development. In operation for more than 80 years, the NRC is composed of 19 different institutes and national programs, spanning a wide variety of disciplines and offering a broad array of services. The NRC is located in every province in Canada and plays a major role in stimulating community-based innovation. NRC institutes and programs are organized into three key areas: (1) Physical Sciences and Engineering, (2) Life Sciences and Information Technology, and (3) Technology and Industry Support.

GLOBAL STRATEGY, INC.

Global Strategy is an international business development consulting firm with specialized expertise in the life science, personal care, chemical, nanotechnology, and engineering industries. The firm offers services to domestic and foreign organizations in the formulation and implementation of strategic objectives, through in-license, out-license, distribution, joint venture, and acquisition and divestment programs. Related services provide world-class strategic information, via market intelligence, technology assessment, and competitive intelligence reporting, based on internal primary research capabilities. For additional information on Global Strategy, visit www.globalstrategy.biz.

ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

[meikelgu]

Was meint ihr: Sollte man aussteigen - geht ja jeden Tag ein Stück weiter runter.

[jog_]

warte mal den montag ab.
könnte sein, dass die aktie dann wieder dreht.

taipan hat z.b. als neues einstiegslimit 2,45US$ genannt; da sind wir gerade.
zusätzlich ein abstauberlimit von 2,05US$.
jetzt ist einkaufszeit.

schlecht wäre nur, wenn die märkte insgesamt weiter fallen würden, oder ein terroranschlag in usa.

grüsse jog_

[Albatossa]

Wohin geht die Reise?

[junkbuster]

Altair Nanotechnologies, Inc. to Host Open House


Market Wire - Tuesday, June 15, 2004

--------------------------------------------------------------------------------

RENO, NV -- (MARKET WIRE) -- 15-06-2004 -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI), a company engaged in developing high performance materials and life sciences products using its pigment and nanomaterials technology platforms, today announced that it will host an open house for all shareholders, customers and business partners on June 24, 2004.
Altair will hold its annual meeting of shareholders at 10 a.m. on June 24 at the Reno Hilton. The annual meeting will be followed by a light lunch and an open house at the company`s Reno, Nevada, headquarters beginning at 12 p.m. Altair is located at 204 Edison Way. After the meeting, Dr. Rudi E. Moerck, Altair`s president, in addition to Altair`s senior management team, will host a question and answer session followed by a guided tour of the company`s manufacturing facility, research labs, and corporate headquarters. During this time Altair management will also be available to speak with attendees.

"We are pleased to have this opportunity to meet with our shareholders, partners and customers from around the globe and welcome them to our headquarters in Reno, Nevada," said Dr. Rudi E. Moerck, who recently relocated to Reno.

To attend the open house and obtain directions to Altair`s corporate headquarters, please RSVP by calling Suzanne at 949.566.9860 or sending an email to [e-mail] no later than June 21, 2004.


ALTAIR NANOTECHNOLOGIES, INC.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market, that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. If the company is unable to continue to raise significant funding through such methods, it may be unable to continue as a going concern. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


klingt doch recht gut
lg junkbuster

[Albatossa]

Hallo junkbuster,

auch wenn es gut klingt so will der Markt diesen Trend noch nicht folgen!

[junkbuster]

Hi Albatossa,

ich habe mich schon eingedeckt und warte auf den run. meiner meinung nach wird der markt bald reagieren.

Geduld ist hier angesagt.

lg junkbuster

[axia]

News von Altair Nanotechnologies:

ALTAIR NANOTECHNOLOGIES, INC. RECEIVES GRANT FROM THE U.S. NATIONAL SCIENCE FOUNDATION

Company to Develop Nano-structured Electrodes for Next Generation Super Capacitors

RENO, NV – June 22, 2004 – Altair Nanotechnologies, Inc. (Nasdaq:ALTI), a company engaged in developing high performance materials and life sciences products using its pigment and nanomaterials technology platforms, today announced that it was awarded a grant from the National Science Foundation (NSF), effective July 1, 2004. Under terms of the grant award, Altair will initially receive $100,000 for work to be completed within six months of the July 1, 2004, effective date. The grant is in support of a project entitled “SBIR Phase I: Carbon-Coated Nano-Structured Electrodes for Next-Generation Lithium-Ion Ultra Capacitors.”

“We are pleased to announce Altair’s first stand-alone grant, spearheaded by our new board member, Dr. David King,” said Dr. Rudi E. Moerck, president of Altair. “The NSF’s peer review process is consistently recognized as the gold standard among government agencies and private foundations in terms of setting the bar for quality proposals and funding awards, making this grant further validation of our nanotechnology expertise and uniqueness of our technology platform. This grant builds upon the progress Altair has made in bringing nanotechnology to super capacitor and battery applications.”

Under terms of the Small Business Innovation Research (SBIR) Phase I grant award, Altair will use the proceeds to fund joint development work with Hosokawa Micron’s Nano Particle Technology Center and Rutgers University’s Energy Storage Research Group. According to Dr. Moerck, Altair’s nano-sized cathode and anode materials are perfect compliments to Hosokawa’s unique powder coating technology and equipment and Rutgers’ existing hybrid battery patents, advanced battery design and testing expertise, all of which should provide for the successful design and development of high-capacity, next generation lithium ion power sources.

Third-party studies have shown that Altair’s nano-sized lithium titanate spinel battery material exhibited charge and discharge rates up to 100 times higher than materials used in current commercially available batteries. In the third quarter of 2003, Altair announced that Telcordia Technologies (now Rutgers Energy Storage Research Group) developed a non-aqueous asymmetric hybrid prototype battery incorporating Altair’s nano-lithium titanate spinel. The Rutgers prototype battery, using Altair`s nanomaterials, met the `car of the future` power assist battery requirement as published in The Journal of Power Sources, 113 (2003) 62-71 and 115 (2003) 171-178. The Rutgers’ battery is the only prototype reported, to date, to meet these Department of Energy (DOE) standards. Altair is currently in discussions with Rutgers regarding commercialization and is providing the group with additional nanomaterials samples for further development work.

Nanomaterials are expected to provide an improvement in lithium ion battery and super capacitor performance, making it possible to use these systems in applications where immediate high power delivery is necessary. Such applications include automobile batteries, electric and hybrid vehicles. In addition to use in hybrid automobiles, nano-lithium titanate spinel-based batteries may also be incorporated into uninterrupted power supplies, military applications and specialized uses, such as notebook computers, mobile phones, and a variety of portable devices. Rapid charge/discharge times are important in all these applications.

Altair Nanotechnologies, Inc.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special materials with potential applications in pharmaceuticals, titanium pigment and metal, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

[axia]

ALTAIR NANOTECHNOLOGIES PROVIDES SHAREHOLDER UPDATE


RENO, NV – June 24, 2004 – Altair Nanotechnologies Inc. (Nasdaq:ALTI) is providing a Company update from Altair President Dr. Rudi E. Moerck, in its commitment to keep shareholders and members of the financial community current on the company’s activities.

Corporate Update
Altair has completed its reorganization and the creation of the Life Sciences and the Performance Materials Divisions. “This reorganization, and the creation of two divisions, has allowed Altair to focus on leveraging its proprietary technology to bring pioneering product technology to market,” commented Dr. Moerck. “Further, both Divisions have made significant progress in taking product concepts and developments to commercialization.”

Life Sciences Division Update
This division utilizes Altair’s patented processes in developing rare earth compounds and metal oxide technology for the development of pharmaceutical, drug delivery and biologically important ion exchange processes. Altair’s novel rare earth ion exchange processes remove specific target compounds from fluids and other process streams to almost non-detectable levels. Altair’s hollow, porous, high surface area, rigid ceramic microstructures (TiNano Spheres™) are currently made from titanium and zirconium and show promise as drug delivery and dental compounds.

• RenaZorb™ - Nanotechnology-based drug for ESRD
On May 26, 2004, Shire Pharmaceutical’s CEO announced he expects Fosrenol®, the company’s lanthanum carbonate tetra hydrate-based drug candidate for phosphate control in kidney dialysis patients with End Stage Renal Disease “ESRD” to receive approval from the FDA in June 2004. Approval of Fosrenol has already been granted in Sweden as a European Union Reference country. Shire has also announced that it had licensed Fosrenol to Bayer AG, giving them the exclusive rights to develop, market and sell Fosrenol in Japan. The total potential value of the Fosrenol deal has been reported to be in excess of $70 million, which includes up-front license fees.

Altair’s RenaZorb™ (lanthanum dioxycarbonate) represents a second-in-class lanthanum-based drug for phosphate control in patients with end-stage renal disease (ESRD). Interest in RenaZorb among potential licensees has increased significantly over the past several months. Altair has instituted additional non-clinical testing in animal models to directly compare RenaZorbTM to lanthanum carbonate tetra hydrate, (the active ingredient in Fosrenol) and sevelamer (the active ingredient in Renagel™). The results will not be available until late July, but the company is optimistic about preliminary data and the outcome of these tests.

• Drug Delivery – TiNano Spheres™ and No-Defeat™ Drug Delivery Systems
TiNano Spheres™ are hollow, porous, high surface area, rigid ceramic microstructures that are derived from Altair’s patented technology. The inside, outside or both can be coated with active pharmaceuticals to provide controlled release characteristics. The differentiating characteristic of
Altair’s TiNano SpheresTM compared with commonly available polymer-based drug delivery systems is that Altair’s system may produce a sustained drug delivery system for narcotics and other Class IV drugs that is both non-abuseable and non-defeatable.

TiNano SpheresTM are in the early stage development for drug applications. Altair plans to out-license the technology and conduct co-development work on the No-Defeat™ system for licensees and potential licensees. Discussions are ongoing with pharmaceutical companies that are interested in incorporating their active pharmaceutical ingredients into the TiNano SpheresTM and No-DefeatTM systems.

• Dental Nanomaterials
Altair continues to work with a research consortium sponsored by the National Institutes of Health to strengthen polymer-based dental fillings utilizing Altair’s nano-zirconia. While the size of the materials market for dental fillings is small, from a tonnage perspective, the dollar value is considerable. The development process is moving forward and management now expects to have a suitable product available in the fourth quarter of 2004.

Performance Materials Division Update
The Performance Materials Division is taking pioneering nanotechnology to market. This business unit uses novel chemical processes to manufacture nano-to-micron-sized ceramic materials with specific performance enhancing characteristics.

• Titanium Dioxide Pigment – Altair’s Hydrochloride Pigment Process (AHPP)
Discussions continue with several companies that have interest in producing white titanium dioxide pigment. Titanium dioxide pigment is a $9 Billion global market.

In January 2004, Altair entered into a license agreement with Western Oil Sands, Inc. for the production of titanium dioxide pigment at the Athabasca Oil Sands Project in Canada. Altair is now well into phase one of the agreement, with bulk samples of the oil sands’ tailings in the Reno plant for testing and processing into white titanium dioxide pigment.

Altair has also entered into a licensing agreement with Avireco USA to evaluate the Altair Process utilizing feedstock from Vietnam to produce titanium dioxide pigment. The government of Vietnam has approved $25 million to develop a domestic titanium dioxide pigment infrastructure. However, work under the contract has not yet been authorized.

Altair continues to work with Flowco International, Altair’s exclusive representative in the People’s Republic of China (PRC). Altair is in ongoing negotiations with a Chinese company and several Indian companies that have interest in producing white pigment for distribution in those respective countries.

• Titanium Metal
Under Altair’s January 2004 agreement with Titanium Metals Corporation (NYSE:TIE), the company has begun providing development services and selling developmental quantities of custom nano titanium dioxide and titanium alloy oxide electrode feedstock to Titanium Metals for their development program pertaining to the manufacture of titanium metal based on the patented FFC Cambridge process.

DARPA (Department of Defense), the agency funding the development program through a $12.4 million grant, has awarded Altair Nanotechnologies subcontractor status. The development program provides Altair the opportunity to supply enough TiO2 to produce 50 pounds of titanium metal per day to meet the DARPA titanium project goals as outlined by the program. Altair believes the success of the testing program could result in a licensing agreement for the production of titanium dioxide and titanium alloy oxide electrode feedstock.

• NanoCheck™
Altair’s unique nano-structured compound, NanoCheck™, has been proven to safely and effectively prevent algae growth in swimming pools in both independent and in-house laboratory testing. There are approximately eight million pools and four million existing spas and hot tubs worldwide with an additional 360,000 pools and approximately 260,000 spas and hot tubs being installed annually.

The first phase of microbiological performance testing confirmed NanoCheckTM compound’s ability to retard and prevent algae growth through absorption of phosphates from water. Field-testing focused on evaluating NanocheckTM’ compound effectiveness in providing an algae-free environment for swimming pools is currently under way. If the tests are successful, Altair or a licensee could commercially launch NanoCheck™ in the first quarter of 2005.

• United States Government Research Funds
Work between Altair, Western Michigan University (WMU) and University of Nevada is underway, under the terms of a joint development agreement funded by the Department of Energy`s Office of Science, Biological and Environmental Research. Altair and WMU are currently working on the “lab-on-a-chip” elements, which will comprise the technology being developed for detecting chemical and biological agents, a homeland defense program.

In December 2003, Altair was notified by WMU of additional grant funding for their joint development of nanosensors for detecting chemical, biological and radiological agents. The $2 million grant was included in the Omnibus Appropriations Bill and will commence August 2004. WMU and Altair will continue to jointly seek Federal support for nanotechnology research and development and will utilize the new grant funding equally.

Altair recently received at $100,000 grant from the National Science Foundation to fund the joint development work with Hosokawa Micron’s Nano Particle Technology Center and Rutgers University’s Energy Storage Research Group. The Team is working on the design and development of an advanced hybrid battery as a high capacity, next generation lithium ion power source. Altair expects to apply for additional funding for the development of Phase ll of the development program.

• Lithium Ion Battery Electrode Development
The Rutgers prototype battery, using Altair’s nanomaterials, met the ‘car of the future’ power assist battery requirement as reported in Telcordia’s (now Rutgers Energy Storage Research Group) research paper published in The Journal of Power Sources. The prototype battery, a nonaqueous asymmetric hybrid incorporating the advantages of both Li-ion batteries and super capacitors, stored energy of 11wh/kg with delivery of 800 W/kg at 95 percent efficiency. The cycle life ranged between 10,000 and 100,000 cycles. The Rutgers’ battery is the only prototype reported, to date, to meet these DOE standards. Altair is in discussions with Rutgers regarding commercialization and is providing the group with additional nanomaterials samples for further development work and prototype production.

Altair has signed a memorandum of joint development work with Hosokawa Micron International to combine the technologies of both companies to develop advanced electrode materials for electrochemical devices such as batteries, capacitors and supercapacitors from a variety of nanomaterials.


ALTAIR NANOTECHNOLOGIES INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a robust proprietary technology platform for making a wide variety of nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.


Altair Nanotechnologies, Inc.®, Altair NanomaterialsTM, TiNano®, RenaZorbTM, NanoCheckTM, TiNano SpheresTM, No DefeatTM and the Hydrochloride Pigment ProcessTM are trademarks or registered trademarks of Altair Nanotechnologies, Inc.


Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair’s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market, that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair’s operations in the short run, and that animal testing or future testing on RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. If the company is unable to continue to raise significant funding through such methods, it may be unable to continue as a going concern. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


Das ist doch eine positive Unternehmensentwicklung...

[junkbuster]

hallo,

warum fällt der kurs seit tagen, gibts anhaltspunkte?

lg junkbuster

[jog_]

liegt wohl am gesamtmarkt.

die börse macht einfach keinen spass mehr.
jog_

[axia]

Altair hat neues Board Mitglied.

Hier die Pressemitteilung dazu:

ALTAIR NANOTECHNOLOGIES ANNOUNCES NEW BOARD MEMBER APPOINTMENT

RENO, NV – July 9, 2004 – Altair Nanotechnologies, Inc. (Nasdaq:ALTI), a company engaged in developing performance materials and life science products using its metal oxide pigment and nanomaterials technology platforms, today announced the appointment of Dr. Michel Bazinet to its board of directors.

“We are pleased to announce the appointment of Dr. Michel Bazinet to our board of directors,” said Altair Board Chairman Jon Bengston. “Dr. Bazinet’s extensive medical industry expertise, coupled with his prior board of director and biotech industry experience, will add further depth to our board, especially useful for our Life Sciences Division.”

“Altair is one of the nanotechnology leaders poised to make a tremendous impact on the biotech industry,” said Dr. Bazinet. “I am honored to be appointed to its board, and am eager to provide strategic guidance and leverage industry contacts to further Altair’s mission.”

About Dr. Michel Bazinet
Dr. Bazinet brings extensive medical, biotech and health sciences experience to Altair. Dr. Bazinet is Chairman & CEO of privately held Replicor, Inc. which develop new antiviral and anticancer therapies. Prior to his involvment with Replicor, Dr. Bazinet was the founder and medical director of Mediconsult, a healthcare knowledge company. Mediconsult completed its initial public offering in 1999 and was ultimately acquired by The Cybear Group in 2001.
Dr. Bazinet, a board-certified urologist, received his MD from Sherbrooke University. He completed his residency at McGill University, Montreal, and has been a research fellow at Memorial Sloan-Kettering Cancer Center, New York. Dr. Bazinet, a former assistant professor of both urology and oncology at McGill University, is also an accomplished speaker, medical industry author and consultant.

ALTAIR NANOTECHNOLOGIES INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a robust proprietary technology platform for making a wide variety of nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.®, Altair NanomaterialsTM, TiNano®, RenaZorbTM, NanoCheckTM, TiNano SpheresTM, No DefeatTM and the Hydrochloride Pigment ProcessTM are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

[Albatossa]

Blos dem Kurs hilft diese Meldung noch nicht!

Die Frage ist nun wohl wann muß man jetzt einsteigen oder nachkaufen! Gilt die 2 Dollargrenze als Wiederstand oder geht es abwärts bis 1 Dollar?

[hooray1]

Was zum Teufel ist eigentlich bei ALTI los?
Die Aktie bewegt sich im Schweinsgalopp Richtung Süden.

Ist da fundamental etwas nicht in Ordnung oder liegts am Gesamtmarkt?
Aussitzen oder "rette sich wer kann"?!!
Danke für eure Meinung.

[Guru-Schreck]

For the three months ended 3/31/04, revenues totaled $140 thousand, up from $20 thousand. Net loss increased 30% to $1.7 million. Results reflect revenues generated from contract research work and other contracted services, offset by higher salaries and related overheads and increased stock options and warrants expense.


Immer noch hoch bewertet dieses Unternehmen, wenn man den Umsatz und Gewinn zugrunde legt.

[hooray1]

Das dürfte die Höchststrafe sein:

Wollte heute aus ALTI raus, hab erst in Frankfurt zu 1,35 limitiert, Kurs erreichte nur 1,34.
Hab den Auftrag dann zu 1,65 an die Wallstreet gelegt; dieser Kurs wurde auch erreicht, allerdings 10 Minuten bevor ich ihn eingegeben habe.
Hab dann frustriert den intraday weiter und weiter bröckelnden Kursen hinterhergeschaut, bis ich entnervt aufgegeben habe und das Limit auf mittlerweile 1,50 US Dollar herunterreduziert habe.
Und als "Krönung" bekomme ich jetzt eine Teilausführung in 8(!) Tranchen, für die ich jedesmal bei Consors die volle Grundgebühr bezahlen muss.
Habe dort bereits nachgefragt, keinerlei Kulanz - das wäre eben Pech..
Dankeschön, so macht traden richtig Spass!!

[Guru-Schreck]

#87

Warum kaufst du auch solche marktengen Werte in Deutschland.
USA wäre wohl besser gewesen, da kann man auch diese Teilausführungen verhindern.

[hooray1]

Das ist ja das Schlimme.
Ich HAB ja in den USA verkauft, dort wurden mir die 8 Teilausführungen aufs Auge gedrückt..
Ich hab jetzt auch nochmal ans Beschwerdemanagement bei Consors geschrieben; wenn die mir da nicht entgegen kommen, bin ich weg.
Bei der DAB z.B. werden solche Orders anstandslos zusammengefasst!!
Kennt jemand hier noch nen Broker, der nicht nur drauf ist, seine Kunden auf Teufel komm raus zu melken?

[Guru-Schreck]

#89

Normalerweise kann man in den USA angeben, dass man eine "Alles oder Nichts" Ausführung will. Oder bieten das nicht alle an ?

[jog_]

#87-90

mit meinem Sohn haben die das ebenso veranstaltet.

Nach massiver Beschwerdeführung hat man dann aber nachgegeben, und die Kosten für die geteilten Order
erstattet.

Im übrigen habe ich selbst den Eindruck, dass sich Consors vom "besten Broker" eher weit entfernt, als diese Stellung zu halten.

MfG. jog_

[jog_]

#91
kleine Korrektur: die Teilausführung fand bei einem Kauf statt.

[meikelgu]

Was tradest auch bei Consors.
Nur um ein paar Kröten zu sparen??

[rastapop]

Altair meldet neue Patente
27.07.2004 - Bei Technologiefirmen ist das Patentportfolio enorm wichtig. Neue Patentanmeldungen sorgen häufiger für Kurssprünge. Auch bei Altair? Das Unternehmen hat zwei neue Patente bezüglich der Drug-Delivery-Technologie „TiNano Spheres“ angemeldet. Am Montag schloss das Papier des Unternehmens bei 1,53 Dollar, ein Minus von rund 5 Prozent. Die Aktie notiert damit im Bereich einer wichtigen Support-Zone.

Quelle: http://www.4investors.de/php_fe/index.php?sektion=stock&ID=2…

[Guru-Schreck]

Wenn ich mir den 2Jahres-Chart anschaue würde ich vermuten, dass alti noch bis unter 1Dollar fällt, falls nicht bald etwas grundsätzlich postives passiert.

[rastapop]

wenn mal die 1,33 Dollar fallen, gehts abwärts

http://members.vectorvest.com/newstockanalysis/directanalysi…

[Albatossa]

Hallo rastapop,

was nützen einen die viele gute Patente wenn sich damit kein Geld verdienen läßt!

Der Kurs hat leider in der Zwischenzeit Brechpotenzial wenn da bald nicht gute Nachrichten kommen geht Altair mit seine ganzen tollen Patente sang und klanglos unter! Dann gibt es Patente für die Gläubiger das Stück für 1 US$

[rastapop]

Servus Albatossa,
ich hab eh immer noch nicht durgeblickt, was die mit ihren patenten anfangen wollen in 10+ jahren vielleicht mal lukrativ
So ein patent für 1€ wär dekorativ auf dem Lokulus

[CompanyInfo]

Aktuelle Pressemitteilung von Altair Nanotechnologies:

ALTAIR NANOTECHNOLOGIES INC. ANNOUNCES SECOND QUARTER FINANCIAL RESULTS CONFERENCE CALL


RENO, NV – August 4, 2004 – Altair Nanotechnologies Inc. (Nasdaq: ALTI), today announced that it will hold a conference call to discuss financial results for its second quarter of fiscal 2004, ended June 30, 2004. The call will be held Thursday, August 12, at 11:00 a.m. Eastern (EDT). Shareholders and members of the investment community are invited to participate in the call.

The conference call dial-in number is 800.361-0912. As a passcode is necessary to participate in the conference call, please RSVP your participation by calling Suzanne Schnitzer at McCloud Communications, 949.566.9860. Additionally, this call is being webcast by Premier Conferencing and can be accessed by visiting www.visualwebcaster.com.or Altair’s web site at www.altairnano.com.

Könnte interessant sein, das webcast aufzurufen.

[Albatossa]

Bald sehen wir den Konkurs!

[Albatossa]

Hallo rastapop,

ich gehe davon aus das die Patente nur ein Trick der Firmenleitung ist! Die Patente sind praktisch ein unnützer Stück Papier und in ein paar Jahren wissen wir alle das es nur reines Blendwerk war!

Machen wir uns nichts vor! Die Firma hat vielleicht einen Gesamwert von villeicht 0,5 Millione Dollar und keinen Cent mehr! Dies würde einen Kurs von genau einen Eurocent bedeuten oder 0,008 $! Alles andere ist und wäre reine Spekulation.


Strong sell!

[jog_]

#100
rede nicht so einen dünnsch....
schau dir den gesamtmarkt an und denke darüber nach.

alti kann bis ins vierte quartal, wenn der markt diese tendenz beibehält, durchaus bei etwa 0,70usd oder tiefer landen.

[Albatossa]

Hallo jog_,

da wahr leider noch niemals Substands! Gibt da überhaupt einen vernüftigen Umsatz! Natürlich nicht!

Gibt es irgend was positives! Natürlich nicht!


Sind die Patente was wert! Natürlich nichts!


Man sollte sich nur die Sprüche vom Vorstand und ehemaligen Autoverkäufer aus dem Jahre 2002 ansehen und man lacht sich kaputt!


Fazit´: Mega Strong Sell

[Albatossa]

Der Kurs kennt nur eine Richtung!

[gustav71]

ha,
vielleicht hat von Euch noch niemand sich wirklich um Agli gekümmert und sich die Fa. mal genau angesehen.
Die Fa. hat nur einen Zweck: Investoren abzuzocken, und das mehr oder weniger erfolgreich seit mehreren Jahren.
Nanotechnologie, alles Quatsch bei Agli International.
Hat jemals jemand die quartalsberichte gelesen?? Wohl niemand, ansonsten kann man die Fa. doch wohl nicht empfehlen. Seit Jahren wird da irgendwas versprochen, und nicht eingehalten. Ominöse Press Releases gegeben, mit Multimillionenaufträgen, die natürlich nie kommen, und in den letzten 5 Jahren auch nicht kamen kokettiert. Jedem Hype wird nachgegangen, jetzt eben nano...
TiSpheres - da lacht doch jeder chemiker nur darüber. Die patente absolut wertlos, doch das scheint leichtgläubigen investoren nichts zu machen. Agli hat nur einen umsatzpunkt: die zahlungen an Beratungsfirmen, die gefakte Empfehlungsschreiben für Investoren rausgeben. Wers nicht glaubt: Bitte die letzten SEC Berichte nachlesen, da steht das drin, was in den Press Releases so nicht drin steht.

Und wetten: der nächste Quartalsbericht, wieder voll mit ankündigungen, aber kein wirklicher Umsatz, nur Umsatz von StockBroker Firmen - alles getarnt.

Agli international, wie wir "langzeitinvestoren" die Fa. kennen...

[meikelgu]

Der Aktie scheint es nicht gut zu tun - sie bricht heute leider ein.

[jog_]

#105
wer oder was, bitteschön, ist "Agli"????

[Albatossa]

Firmen: ALTAIR: Umsatzwachstum im 2. Quartal 2004

ALTAIR (Nasdaq:ALTI) hat im 2. Quartal 2004 einen Umsatz von 154.233 U.S.-Dollar erzielt. Der Netto-Verlust liegt noch bei 2,154 Mio. U.S.-Dollar bzw. 0,04 U.S.-Dollar pro Aktie.

Nach Aussage des Geschäftsführers Rudi E. Moerck hat das Unternehmen Aufträge im Wert von ca. 1,1 Mio. U.S.-Dollar in den Büchern stehen.
Die erhöhten operativen Kosten sind durch wachsende Forschungs- und Entwicklungsausgaben sowie Marketing- und Verkaufsaufwendungen begründet.

Die Barmittel betragen jetzt 10,2 Mio. U.S.-Dollar (Ende 2003: 3,9 Mio. U.S.-Dollar). Finanzchef Edward Dickinson beziffert die monatlichen operativen Ausgaben mit ca. 425.000 U.S.-Dollar im ersten Halbjahr 2004. Im dritten und vierten Quartal sollen diese Ausgaben aufgrund zunehmender Ausgaben für die Produktentwicklung leicht ansteigen.


http://nano.ivcon.org/modules.php?name=News&file=article&sid…

[junkbuster]

"Stocks to Watch:

Altair erholt sich deutlich

17.08.2004 - Auch Altair gehöre am Montag zu den großen Gewinnern der Erholungsrallye, die weite Teile des Nanotech-Sektors erfasste. Knapp 19 Prozent ging es mit der Aktie aufwärts, womit allerdings der kurzfristige Abwärtstrend noch nicht überwunden ist. Die psychologisch wichtige Marke von einem Dollar wurde damit aber erst einmal gehalten. News von Unternehmensseite gibt es nur im Personalbereich, wo Alan J. Gotcher den CEO-Posten übernommen hat."

zitiert von 4investors http://www.4investors.de/php_fe/index.php?sektion=stock&ID=2… verifiziert am 17.08.04

[junkbuster]

ALTAIR (Nasdaq:ALTI) hat im 2. Quartal 2004 einen Umsatz von 154.233 U.S.-Dollar erzielt. Der Netto-Verlust liegt noch bei 2,154 Mio. U.S.-Dollar bzw. 0,04 U.S.-Dollar pro Aktie.

Nach Aussage des Geschäftsführers Rudi E. Moerck hat das Unternehmen Aufträge im Wert von ca. 1,1 Mio. U.S.-Dollar in den Büchern stehen.
Die erhöhten operativen Kosten sind durch wachsende Forschungs- und Entwicklungsausgaben sowie Marketing- und Verkaufsaufwendungen begründet.
------------------

Stocks to Watch:

Altair meldet neue Patente

27.07.2004 - Bei Technologiefirmen ist das Patentportfolio enorm wichtig. Neue Patentanmeldungen sorgen häufiger für Kurssprünge. Auch bei Altair? Das Unternehmen hat zwei neue Patente bezüglich der Drug-Delivery-Technologie „TiNano Spheres“ angemeldet. Am Montag schloss das Papier des Unternehmens bei 1,53 Dollar, ein Minus von rund 5 Prozent. Die Aktie notiert damit im Bereich einer wichtigen Support-Zone.

Unser Tipp: Aktuelle Nanotech-News direkt in Ihr Mail-Postfach:

-------------------

Die Barmittel betragen jetzt 10,2 Mio. U.S.-Dollar (Ende 2003: 3,9 Mio. U.S.-Dollar). Finanzchef Edward Dickinson beziffert die monatlichen operativen Ausgaben mit ca. 425.000 U.S.-Dollar im ersten Halbjahr 2004. Im dritten und vierten Quartal sollen diese Ausgaben aufgrund zunehmender Ausgaben für die Produktentwicklung leicht ansteigen.

Angaben in U.S.-Dollar 2. Quartal 2004 2. Quartal 2003 6 Monate 2004 6 Monate 2003
Umsatz 154.233 4.434 293.982 24.711
Netto-Verlust 2.154.032 1.334.591 3.864.789 2.651.585
Verlust pro Aktie 0,04 0,04 0,08 0,09

Zeit: 12.08.2004.
Quellen: Altair Nanotechnologies: www.altairnano.com

--------------------

Bei ALTAIR NANOTECHNOLOGIES (Nasdaq:ALTI) übernimmt Alan J. Gotcher den Posten des Vorstandsvorsitzenden. Gotcher ist schon seit Mai 2004 im Unternehmen und war zuvor bei INDELIBLE TECHNOLOGIES und AVERY DENNISON. Sein Spezialgebiet ist Chemie (Ph.D. und B.S. in Chemie von der "University of California").
Zeit: 16.08.2004.
Quelle: Altair Nanotechnologies: www.altairnano.com


it works lg junkbuster

[Albatossa]

So sieht eine klassische technische Reaktion einer Aktie im fallen aus!

[gustav71]

agli international wie es lebt und leibt....

agli, nur zur Info: alias altair, alias ugli international...so hiess die firma früher, als noch keine Welt von Nano sprach. und genau gesehen, ist Agli kar kein Nano-Stock, ma mache nur folgendes:
Analysiere bitte jeder für sich selbst die Einkommensquellen von Agli - don`t believe the PR!!!

neuer chef - ha da lacht die börse...der herr Alan J. Gotcher, Ph.D. war übrigens schon vorher bei dem Geldverdienerconsultingverein Agli International as Consultan t tätig. Also quasi auch ein Mitglied des Abzockvereins. Hat keine weitreichenden Verdienste an den Tag gelegt bisher...
Eigentlich wirds Zeit, dass die SEC mal ne Durchsicht der Agli Unterlagen macht - man sollte mal wirklich die K10 Berichte lesen - die haben leider mit den Press Releases nicht das geringste zu tun.
Apropos PR: TiN-Anus Sphers. Das macht Merck KG (Darmstadt, Germany) schon seit Jahren. Das Patent ist damit völlig wertlos von Agli International. Ähnliches gilt für alle anderen Produkte und Patente. Apropos, letztes Quartal hatte Agli ganze $1,200 in Aufträge. Ich würde mal sagen, meine Miete war letztes Quartal höher...
Und diese $1,200 waren sowieso für mehrere $100k via ominöse Consulting Firmen erkauft. Da kommt dann wieder unser Alan J. Gotcha yeaa ins Spiel. War ja eben Consultant bei Agli International vorher.
We are all a big fat AGLI renAbsurb family...

[Wunram]

jedenfalls hat CEO Alan J Gotcher schonmal 50.000 Optionen zu $2,09 und sein Stiefsohn -wer ist das?- hat 100 ALTI Anteile!
http://www.edgar-online.com/bin/cobrand/finSys_main.asp?nad=…

und ALTI Aktien eingekauft hat er auch schon brav für rund $12.000,-
http://www.edgar-online.com/bin/cobrand/finSys_main.asp?nad=…

und besitzt damit schon 7640 Aktien (direkt und indirekt)

Gute N8

Wunram

[jog_]

warscheinlich hast du ein "agli"-syndrom.

jedenfalls habe ich mit ALTAIR ("ALTI")!!! mehrfach gutes geld verdient; nicht zuletzt, weil ich an die firma glaube.

einige bleiben halt immer mal wieder auf der strecke, egal ob bei ALTI, dcgn, enmd..... oder wie auch immer.

Ist nur ziemlich unnötig, gift und galle zu speien.
es gibt ja auch noch das gute alte SPARBUCH!

MfG.

[Wunram]

und er kauft weiter:

http://www.edgar-online.com/bin/cobrand/finSys_main.asp?nad=…

jetzt sinds schon 31.700 Anteile und der Stiefsohn hat sich auch nochmal 400 (boah ey) zugelegt.

Schönes WE
Wunram

[Wunram]

Altair Nanotechnologies Begins Work on Nano-Structured Electrode Materials With U.S. National Science Foundation Small Business Innovation Research Grant

24 August 2004, 11:07am ET

Technology From Altair Nanotechnologies, Hosokawa Micron and Rutgers University Targets $1.5 Billion Battery Materials Market

Altair Nanotechnologies Inc. (NASDAQ: ALTI) today announced that it has begun work on a development project entitled "SBIR Phase l: Carbon-Coated Nano-Structured Electrodes for Next-Generation Lithium-Ion Ultra Capacitors." The Small Business Innovation Research (SBIR) Phase l grant, initially for $100,000, provides the opportunity to receive an additional $500,000 Phase ll grant which, if the development program is successful, leads to a Phase lll commercialization.

Altair and Hosokawa Micron`s Nano Particle Technology Center produced the first advanced carbon coated materials for this program, which were tested under a contract with the Energy Storage Research Group at Rutgers, the State University of New Jersey. Based on that work the final research testing protocol was determined. The Phase l grant work is scheduled for completion in December 2004.

This program, with the ultimate objective of commercialization of a high-power, fast-charge battery within the automotive industry, is the product of successive inventions and development agreements that have been published and announced over a period of several years. A summary of these technology advances provides insight into opportunities created by Altair`s unique, functional nanomaterials.

Nano-structured electrodes, using Altair`s proprietary materials, combine the high-speed capabilities of capacitors with the energy storage features associated with batteries. The work is expected to lead to significant commercialization opportunities within the automotive industry for batteries using hybrid Ultra Capacitor/Battery concepts and Altair`s electrode materials. The potential for commercializing these technologies was first reported by Altair in its November 2001 news release in which Dr. K.M. Abraham, an independent consultant, confirmed that Altair`s new nano-sized lithium titanate spinel could achieve lithium ion charging and discharging rates 10 to 100 times higher than with materials commercially available at that time.

This superior performance of Altair`s lithium titanate spinel in a prototype battery was first reported by Telcordia (now Rutgers University`s Energy Storage Research Group) in the Journal of Power Sources, published in March 2003. Telcordia`s new thin film hybrid battery / Ultra Capacitor technology used Altair`s advanced materials. This hybrid battery met the performance standards established by the U.S. Department of Energy (DOE) for the power assist batteries required for cars of the future using fuel cells or hybrid internal combustion engines/battery drives.

The advancement in charging and discharging capabilities of Altair`s materials were published in the July 2003 issue of Journal of Electrochemistry through a joint collaboration with Altair, Switzerland-based Xoliox and Czechoslovakia-based J. Heyrovsky Institute. The report demonstrated that Altair`s nanomaterials could be fully charged in only a few seconds and that Dr. Abraham`s assessment proved to be correct. The Rutgers team utilized the technology in their unique prototype battery and is now participating in the current test work. Based upon the results of Rutgers` prototype battery, Altair has taken the necessary steps to improve both its technology and its ability to supply commercial quantities of its nanomaterials to the marketplace.

Using information available from the Telcordia/Rutgers` publications, Altair and Hosokawa Micron International joined forces to overcome the limitation of electrical transport and lithium ion availability in electrodes made of high performance nano-materials, and to provide the battery industry with a sufficient supply of the advanced materials. The agreement between the companies was jointly announced in February 2004 and stated that the two companies would undertake to achieve the following goals:

1. Establish a development program using both companies` combined technologies to develop advanced electrode materials for electrochemical devices, including batteries, capacitors and supercapacitors, using a variety of nanomaterials;

2. Strengthen the technical and market position of the companies by combining technological and financial assets, including existing manufacturing capabilities.

3. Apply for U.S. government grants for the development and funding of commercialization activities.

Altair and Hosokawa agreed that if testing and commercialization prove to be successful, additional funding would be committed and sought to provide dedicated facilities for the production of the advanced materials. Both Altair and Hosokawa are currently seeking battery manufacturers that can utilize the advanced materials for participation in the next development stages and potential commercialization.

Altair is committed to participating in advanced/alternative energy industries and uses a similar approach for developing projects related to hydrogen generation and fuel cells. Each program offers the potential for advanced materials, but must overcome the limitations imposed by existing products or markets that were not initially structured to use these new materials. Altair is building upon its experience in the advancement of its battery materials as a basis for the development of its fuel cell, solar cell and hydrogen production materials.

ALTAIR NANOTECHNOLOGIES INC.

Although an emerging field, nanotechnology is already having a unique impact on several industry sectors. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Industrial Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.®, Altair Nanomaterials?, TiNano®, RenaZorb?, NanoCheck?, TiNano Spheres?, No Defeat? and the Hydrochloride Pigment Process? are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

HOSOKAWA MICRON GROUP (Hosokawa Micron Corporation is listed in Tokyo Stocks Exchange: 6277)

The Hosokawa Micron Group is a world leader in providing process solutions for powder and particle processing, blown film processing, and in Japan, environmental business. The company is continuing to advance its 88 years of market leadership with the application, development and commercialization of ultra fine composite particles in the rapidly expanding field of nanotechnology. Hosokawa Micron`s three Nano Particle Technology Centers (located in Japan and the USA) are dedicated solely to the development of new functional and value added materials for next generation. For additional information on the Nano Particle Technology Centers, visit our website at www.hosokawanano.com or our corporate website at www.hosokawamicron.com for more information about the Hosokawa Micron Group.

Forward-Looking Statements
......


For Additional Information:
Marty Tullio or Mark Tullio
McCloud Communications, LLC
949.566.9860
[e-mail]
[e-mail]

Gruss Wunram

[jog_]

...und noch einmal in deutscher kurzform:


ALTAIR: Start von SBIR Phase I

ALTAIR NANOTECHNOLOGIES (Nasdaq:ALTI) hat bekanntgegeben, daß das Unternehmen sein Entwicklungsprojekt "SBIR Phase l: Carbon-Coated Nano-Structured Electrodes for Next-Generation Lithium-Ion Ultra Capacitors" begonnen hat.
Zeit: 24.08.2004.
Quelle: Altair Nanotechnologies: www.altairnano.com
Siehe auch 22.06.2004: ALTAIR NANOTECHNOLOGIES: Förderung von der NSF

[lars23]

http://www.azom.com/news.asp?newsID=1880

Neuerer Artikel zum gleichen Thema. Klingt ganz interessant, Batterien mit 10 bis 100 mal kürzerer Aufladezeit als herkömmliche Lithium-Ionen-Akkus...

[jog_]

und noch ein Beitrag:

ALTAIR NANOTECHNOLOGIES REPORTS RESULTS OF TESTING AND LIKELY PATIENT DOSING FOR PHOSPHATE BINDING DIALYSIS DRUG




RenaZorb™ Outperforms RenagelTM and the Active Ingredient in Fosrenol(TM) for Phosphate Binding


RENO, NV – September 1, 2004 – Altair Nanotechnologies, Inc. (Nasdaq: ALTI), reports the results of a pre-clinical animal study performed by an independent laboratory for Altair’s lead drug candidate, RenaZorbTM. The study was conducted to determine the phosphate binding efficiency of existing and proposed non-calcium containing phosphate binding drugs for phosphate control in kidney dialysis patients with end stage renal disease (ESRD).

Animal studies indicate the measurement of phosphate concentration in urine from rats fed a diet of predetermined phosphate levels demonstrated that gram-for-gram RenaZorb administered to the test rats bound more phosphate than Renagel, Genzyme’s drug for ESRD, and significantly more phosphate than lanthanum carbonate tetrahydrate, the active ingredient in Fosrenol, Shire’s proposed drug for ESRD.

Renagel, an approved FDA drug for ESRD, is forecast to have sales of approximately $350 million in 2004. The Fosrenol product, already approved in the European Union reference country of Sweden, is expected to receive FDA approval for use in the U.S. in October 2004. The studies indicate that RenaZorb may offer a better solution for patients with ESRD.

”The testing confirms previous Altair laboratory results that compared RenaZorb to competing phosphate binding drugs and confirms the results of previous independent testing in dogs and 5/6 nephrectomized rats,” said Altair President Dr. Rudi E. Moerck. “RenaZorb may control serum phosphate levels with only one small tablet per meal compared to two or three large tablets per meal required by competing drugs. We believe that this reduction in the number of tablets taken each day will improve patient compliance and reduce phosphate levels more reliably. Our goal is to improve patient compliance and quality of life.”

According to an article in Dialysis and Transplantation Journal Volume 33, Number 5, Page 236-240, phosphate binder therapies currently approved by the FDA required an average of 8-plus tablets per day. Overall patient compliance was only 37.8 percent in this study. The National Kidney Foundation Kidney Disease Outcome Quality Initiative (K/DOQI) suggests that more effective binders (i.e. fewer pills to achieve a similar effect) may aid in achieving the K/DOQI guidelines’ therapeutic goals for serum phosphate levels.

Altair’s RenaZorb (lanthanum dioxycarbonate) represents a second-in-class lanthanum-based drug candidate for phosphate control in patients with ESRD. Altair is seeking to partner with a pharmaceutical company to further advance RenaZorb as a drug candidate and to conduct necessary clinical development programs for worldwide regulatory approval. Preparations for out-licensing are advancing with the assistance of RBC Capital Markets Corporation.

ALTAIR NANOTECHNOLOGIES INC.
Although an emerging field, nanotechnology is already having a unique impact on several industry sectors. Altair Nanotechnologies is positioning itself through product innovation to become a leading supplier of nano-material technology and nano-materials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Industrial Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.®, Altair NanomaterialsTM, TiNano®, RenaZorbTM, NanoCheckTM, TiNano SpheresTM, No DefeatTM and the Hydrochloride Pigment ProcessTM are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Renagel® (sevelamer hydrochloride), is a trademark of Genzyme Corporation. Fosrenol® (lanthanum carbonate tetrahydrate) is a trademark of Shire Pharmaceuticals.

[jog_]

Firmen: ALTAIR: Michael Grätzel im Wissenschaftlichen Beirat

ALTAIR NANOTECHNOLOGIES (Nasdaq:ALTI) hat bekanntgegeben, daß Michael Grätzel in den Wissenschaftlichen Beirat des Unternehmens aufgenommen wurde. (1)

Prof. Dr. Dr. h.c. Michael Grätzel lehrt an der ETH Lausanne. "Seit seinem USA Aufenthalt interessiert er sich für die Eigenschaften kolloidaler Systeme, vor allem von Mizellen, Liposomen und nanokristallinen Metallen und Halbleitern, die auf ihre physikalisch-chemischen Eigenschaften untersucht wurden. Im Mittelpunkt seiner Forschung steht dabei die Ausnutzung solcher Systeme zur Steuerung von Redoxprozessen und zur Lichtenergiekonversion. So entwickelte Prof. Grätzel in den letzten Jahren die nanokristalline Injektions-Solarzelle, welche auf der Sensibilisierung von mesoskopischen Oxidschichten mit Übergangsmetallkomplexen beruht und in ihrem Wirkungsprinzip der natürlichen Photosynthese nahesteht." (2)
Zeit: 17.09.2004.
Quellen:
(1) Altair.
(2) Walter Christen-Marchal, In: c+b - Fachzeitschrift des VSN, 3/1996, EducETH.

[Albatossa]

Warum sollte man gerade in Altair investiernen! Hier werden die Kurse manipuliert das einem übel wird.

[tomhead]

Information vom 30 September 2004

ALTAIR NANOTECHNOLOGIES, WESTERN MICHIGAN UNIVERSITY, AND UNIVERSITY OF NEVADA RECEIVE SECOND AWARD FROM U.S. DEPARTMENT OF ENERGY



DOE Awards Additional $2 Million Contract to WMU, Altair to Receive $672,000 as Subcontractor for Joint Development of Nanosensors

RENO, NV – September 30, 2004 – Altair Nanotechnologies, Inc. (NASDAQ:ALTI), in collaboration with Western Michigan University (WMU) and the University of Nevada, Reno today announced the consortium has received a Notice of Financial Assistance Award from the U.S. Department of Energy (DOE) for the joint development of nanosensors for detecting chemical and biological weapons. Under terms of the Stage 2, two-year contract, Altair will receive $672,000 for collaborative research and development efforts through its subcontractor agreement with WMU.

“Altair is pleased to receive additional support and funds from the Department of Energy,” said Altair chief executive officer Dr. Alan J. Gotcher. “This new contract builds upon the Stage 1 grant funding that Altair announced in 2003 and the progress our company has made thus far in developing nanosensors and related nanotechnology applications for the DOE. We look forward to working closely with these leading educational centers to advance nanotechnology solutions for our homeland security.”

“This kind of private/public collaboration is paramount to society’s ability to tackle emerging global threats to public health and safety,” said Tom Bell, professor of chemistry at the University of Nevada, Reno. Professor Bell and a team of fellow researchers are spearheading the project to develop methods that detect potential agents of terrorism, including radioactive materials that can be released into the air by a “dirty bomb” or the deadly nerve toxins such as sarin and tabun.

Under terms of the award agreement, the project comprises joint development work for the design, synthesis and characterization of nanosensors for chemical, biological and radiological agents. The resulting nanosensors will be designed to detect chemical, nuclear and biological agents, and for related national defense applications and homeland security programs. Altair received $356,000 for subcontract work, which has one year remaining on the initial research and development effort. Both of these ongoing awards were the result of the teaming agreement between Altair and WMU announced in January 2003.

“We would also like to extend our thanks to Senator Reid and Representative Upton for their continued support of Altair and our research efforts,” added Dr. Gotcher.

UNIVERSITY OF NEVADA, RENO
Founded in 1864 as Nevada’s land-grant institution, the University of Nevada, Reno is a component of the University and Community College System of Nevada. The Carnegie Classification of Institutions of Higher Education lists Nevada as a “Doctoral / Research Universities-Extensive” institution, its highest rating. UNR offers more than 65 undergraduate degree programs, 60 master`s degree programs, and 30 doctoral degree programs. For more information, visit www.unr.edu.

WESTERN MICHIGAN UNIVERSITY
WMU is a Carnegie-designated Doctoral/Research-Extensive university and one of only 102 public research universities to be included in this top classification. WMU is a national leader in nanobioenvironmental chemistry research and has established the Nanotechnology Research and Computation Center to further this research. For more information, visit www.wmich.edu.

ALTAIR NANOTECHNOLOGIES, INC.
Altair Nanotechnologies pioneers the discovery and development of nano-materials of unique structure, performance, quality and cost. The company is positioning itself through product innovation to become a leading supplier of nano-materials technology and nano-materials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nano-materials of unique structure, performance, quality and cost. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nano-materials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings (titanium pigments and thermal spray coatings), Advanced Materials for Improving Industrial Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nano-materials, visit www.altairnano.com.


Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair expenses will rise during the following quarters as a result of unexpected cash or non-cash expenses; Altair’s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market, the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb, its TiNano Sphere or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair’s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. These risks and uncertainties also include, without limitation Altair, UNR, and WMU’s ability to receive DOE funding for the projects and the commercial success of these projects. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

[jog_]

Tuesday, October 5, 2004

.........auch gut:

Private investor earmarks $30M to help rebuild Altair Inc.


By Nick Bunkley / The Detroit News

Comment on this story
Send this story to a friend
Get Home Delivery


TROY - For 19 years, Altair Engineering Inc. has helped other companies build stronger products.

Now, a venture-capital firm has agreed to become the first outside investor to help Altair build a stronger company.

Troy-based Altair, which uses a process called virtual prototyping to build and test potential products, will announce today it has secured $30 million in funding from General Atlantic Partners LLC, the world`s leading information-technology investment firm.

Altair President and CEO James Scapa said the investment means his company can grow faster and be more aggressive. Since Scapa founded Altair with two friends in 1985, it has grown to 700 employees in 11 countries. About half of its workers are in Michigan.

"Until now, we`ve just been reinvesting our own capital," Scapa said. "That`s a challenging way to get this big. It has limited us to the types of things that we can do."

Scapa said Altair has always been profitable and the company was not under pressure to secure outside investors. Altair will use the investment to expand by growing its own business and through acquisitions, he said, although there are no specific plans for the latter.

Marc McMorris, a partner at Greenwich, Conn.-based General Atlantic who will join Altair`s board of directors, said Altair is well-positioned to take advantage of the growing global demand for its design, optimization and testing software.

"The company`s seasoned organization and strong management team have developed unparalleled expertise in engineering services and product development, resulting in a blue-chip client base with long-term relationships," McMorris said.

Altair`s clients include Ford Motor Co., Procter & Gamble, Nokia and the federal government. It has aided in the development of many transportation-related products, including a bike-rack system for public buses across the Midwest and a faster hull for the AmericaOne yacht racing team`s entry in the America`s Cup race.

You can reach Nick Bunkley at [phone] or [e-mail].

[lars23]

in welchem verhältnis steht denn die Altair Engineering Inc. zur Altair Nanotechnologies Inc.?
haben die eine gemeinsame holding? die altair nanotechnologies sitzt doch in reno, die engineerung in troy?

[tomhead]

DR. RAVI I. THADHANI JOINS ALTAIR NANOTECHNOLOGIES SCIENTIFIC ADVISORY BOARD

Award-winning Harvard Medical School Professor and Kidney Dialysis Research Specialist Brings Focused Expertise to Advisory Board
RENO, NV – October 7, 2004 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today announced that Dr. Ravi I. Thadhani has joined the company’s Scientific Advisory Board. Dr. Thadhani, an award-winning clinical instructor, researcher, and medical practitioner, will lend his expertise to the company’s life sciences division, in particular the ongoing development of nano-based pharmaceutical and biotechnology applications.

“I am enthusiastic to be joining Altair’s Scientific Advisory Board at this particular juncture in their business strategy,” said Dr. Thadhani. “Nanotechnology-based research has already shown tremendous promise for applications in traditional medicine and I anticipate nanotechnology to truly change the future of all aspects of life sciences. I look forward to working closely with the Altair team and board as they continue development of their drug candidate for end stage renal disease as well as their advanced drug delivery systems.”

“The appointment of Dr. Thadhani to our Scientific Advisory Board will prove invaluable to our life sciences efforts,” said Altair Chief Executive Officer Dr. Alan J. Gotcher. “Ravi is an established clinician, with widely regarded expertise in researching and developing new therapeutic techniques for kidney-related ailments including chronic and acute renal failure. We are honored to have him join our board.”

The Scientific Advisory Board provides a wealth of scientific and industrial technology expertise that Altair’s management, research and product development teams can draw upon as the company drives toward commercialization of nanotechnology products.


About Dr. Ravi I. Thadhani

Dr. Ravi I. Thadhani is currently an active practioner, medical researcher, and an Assistant Director of the Massachusetts Institute of Technology (MIT) Clinical Research Center. He has pioneered research in both pregnancy and dialysis outcomes, having recently received several grants from the NIH and foundations for this work. Dr. Thadhani spends a significant amount of time teaching at some of the world’s leading medical institutions. In addition to his role at MIT, he also currently acts as Director for Harvard Medical School’s Core Medicine rotation at Massachusetts General Hospital and Assistant Director of the Pasteur Program at Harvard Medical School, where he received Harvard’s highest award in clinical teaching.

A board-certified physician, Dr. Thadhani is a member and Vice Chair, Clinical Research Committee of the National Kidney Foundation, a member of the International Society of Hypertension in Pregnancy, and a member of the American Society of Nephrology. He is also a published author of more than 35 original publications, including several publications in the New England Journal of Medicine, and he is a recipient of numerous awards and honors from both the University of Pennsylvania and Harvard Medical School.

Dr. Thadhani holds a medical degree from the University of Pennsylvania, a master’s degree in public health from Harvard School of Public Health, and a Bachelor of Science degree, summa cum laude, from the University of Notre Dame.

[jog_]

ALTI: immer besser!!!!!!!!!!!!!

NEWS!!!! ALTI -- Altair Nanotechnologies Inc.
Com (No Par)

COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:

Altair Nanotechnologies, Inc. Announces European Patent Award Notification


Latest Patent protects Manufacturing Process for Lithium Titanate Spinel Materials Used in High Power Battery Applications

RENO, NV, Oct. 14, 2004 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today announced that the European Patent Office has notified Altair that it has approved Altair`s patent application for a "Process For Making Lithium Titanate." This European patent application describes the process and underlying technology for producing lithium titanate spinel materials of high purity and tightly controlled particle size over a range of 5 to 2,000 nanometers.
The processes protected by the patent were used to make materials that have been formed into electrodes which exhibit high charge and discharge rates in lithium ion batteries and in super capacitors being used in the National Science Foundation`s SBIR grant announced in June 2004. The SBIR grant is funding a joint program under which Altair, Hosokawa Micron`s Nano Particle Technology Center and Rutgers, The State University of New Jersey`s Energy Storage Research Group are using their combined technologies with the objective to develop and commercialize high-power, long life, fast-charge lithium ion batteries.

"Over the past five years, Altair has expended significant resources to pioneer and develop metal oxide nanotechnology and as of today, Altair owns four issued U.S. Patents, 12 issued foreign patents and 45 additional pending U.S. and foreign patent applications," said Dr. Alan J. Gotcher, Chief Executive Officer of Altair Nanotechnologies. "This European patent is significant to the company, as the European and Asia-Pacific regions are a crucial part of our global business strategy," continued Dr. Gotcher. "We are aggressively pursuing licensing and business development programs with our technology, nanomaterials and products in European countries and in India, China, Japan and Vietnam."

"Our Performance Materials Division, in conjunction with various industry partners, is involved with alternative energy development programs that include lithium ion batteries, super capacitors, fuel cell development and a solar hydrogen generator using Tandem Cell(TM) technology," commented Gotcher. "We believe nanomaterials, in the near future, can significantly improve lithium ion battery and super capacitor performance, making it possible to use these systems in applications where immediate high power delivery is necessary. Such applications include automobile batteries, electric and hybrid vehicles, as well as military applications and specialized uses such as notebook computers, mobile phones, and a variety of portable devices."

ALTAIR NANOTECHNOLOGIES, INC.

Altair Nanotechnologies pioneers the discovery and development of low cost nanomaterials of unique structure, performance and quality. The company is positioning itself through product innovation to become a leading supplier of nanomaterials technology and nanomaterials worldwide. Altair owns robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nanomaterials. Altair has installed semi-works capability with a capacity to produce hundreds of tons of nanomaterials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for Paints, Coatings and Sensors (titanium pigments, thermal spray coatings and nano-sensors), Advanced Materials for Improving Industrial Process Technologies (titanium metal manufacturing, catalysts and water treatment), Advanced Materials for Alternative Energy (high performance batteries, fuel cell and photovoltaics) and other high performance material applications. For additional information on Altair and its nanomaterials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market, that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb(TM) or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the long run, and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. If the company is unable to continue to raise significant funding through such methods, it may be unable to continue as a going concern. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.



For Additional Information:
Marty Tullio or Mark Tullio
McCloud Communications, LLC
949.566.9860
[e-mail] [e-mail]

SOURCE: Altair Nanotechnologies, Inc.




Copyright 2004 Market Wire, All rights reserved.

-0-

SUBJECT CODE: Chemicals:Specialty Chemicals
Energy and Utilities:Oil and Gas
Environment:Waste Management
Government:International
Manufacturing and Production:Mining and Metals

[tomhead]

Das hoert sich auch sehr nett an
Speculative BUY rating

New York, New York – October 21, 2004 – Westrock Advisors, Inc. today announced it has initiated coverage on Altair Nanotechnologies, Inc. (NASDAQ: ALTI) and, after conducting in-depth research on the company, its patented technology, and strategic plans for commercial success, gives the company a speculative BUY rating.

“Nanotechnology holds the potential for significant change in the marketplace, and we believe the first investment opportunities will be among nanotech developers such as Altair,” said Debra Fiakas, research consultant for Westrock Advisors. “The company has reached an inflection point with its new management, a business restructuring, and a refocused priority list, bringing commercial viability within its grasp. Should any one of its processes or products prove viable and reach volume production, Altair offers significant return potential to investors.”

Westrock Advisors, Inc. is a full service broker-dealer, offering a broad range of institutional and retail investments and services. To request a copy of the full report, please contact either Don Hunter at 212-922-1995, or McCloud Communications at 949.566.9860.

The information in this report is provided for general information purposes only and should not be considered an individualized recommendation. All investors are encouraged to use multiple sources of investment information and to actively monitor their holdings. Altair Nanotechnologies or the industry sector discussed may not be a suitable investment for everyone. This report is based on information from a variety of sources and the statistical data is believed to be reliable but in no way are warranted as to accuracy, timeliness, completeness or reliability.

The report and rating are the final opinion of Westrock Advisors, Inc. and does not guarantee that any target price will be met or that the predicted business results will occur. Any and all revenue and earnings estimates and projections assume certain conditions and industry developments, which are subject to change and no guarantee is made as to the suitability or potential value of any investment.

This report is published for informational purposes only and is not to be construed as a solicitation or an offer to buy or sell any security. Opinions expressed are subject to change without notice and Westrock Advisors does not undertake to advise the public, nor is Westrock under any obligation to advise the public as to any changes in its projections or views of the industry or Altair Nanotechnologies. Past information is no guarantee or indication of future results.

WESTROCK ADVISORS, INC.
Westrock Advisors is a New York based Full Service Broker-Dealer offering a comprehensive range of high quality financial services for individuals as well as institutional investors. For more information, please visit www.westrockadvisors.com.

Tomhead

[meikelgu]

Echt irre. Wenn ich mir die Umsätze in der Aktie anschaue und das mal mit vor einigen Monaten (kann auch 2 Jahre sein), wo ich die Aktie gekauft habe. Wahnsinn.
Das sieht alles sehr gut aus und bleibt für mich ein Dauerinvestment.

[tomhead]

ALTAIR NANOTECHNOLOGIES, INC. ANNOUNCES THIRD QUARTER FINANCIAL RESULTS CONFERENCE CALL
RENO, NV – October 27, 2004 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI) announced today it will hold a quarterly conference call to discuss third quarter financial results for fiscal 2004 on Friday, November 12, at 11:00 a.m. Eastern (EST). Shareholders and members of the investment community are invited to participate in the call.

The conference call dial-in number for U.S. callers is 800.967.7141. The conference call dial-in number for international callers is 719.457.2630. As a passcode is necessary to participate in the conference call, please RSVP your participation by calling Suzanne Schnitzer at McCloud Communications, 949.566.9860. Additionally, this call is being webcast by Premier Conferencing and can be accessed by visiting www.visualwebcaster.com or Altair`s web site, www.altairnano.com.

[jog_]

Analysen - Ausland

02.11.2004
Altair nicht aus der Hand geben
Hot Stocks Investor

Die Aktienexperten von "Hot Stocks Investor" raten kein Stück der Aktien von Altair Nanotechnologies (ISIN CA0213731056/ WKN 902675) aus der Hand zu geben.

Die Empfehlung der Experten habe sich bereits mit positiven Meldungen am Markt empfehlen können. So habe das Unternehmen eine potenziell sehr wichtige Patenterteilung durch die europäischen Patentbehörden vermelden können. Hierbei handele es sich um eine Patentzuerkennung für ein Herstellungsverfahren von Lithium-Titanat für den Einsatz in hochleistungsfähigen Lithium-Akkus. Mit dieser Technologie werde es möglich, das Material in Partikelgrößen von wenigen Nanometern herzustellen, wodurch die Eigenschaften von Lithium-Akkus nochmals erheblich verbessert würden. Somit sei das Interesse am Markt für Altair kaum verwunderlich.

Die Experten von "Hot Stocks Investor" empfehlen investierten Anlegern kein Stück der Altair-Aktien aus der Hand zu geben

[tomhead]

Denke ich auch
Tomhead
ALTAIR NANOTECHNOLOGIES REPORTS FINANCIAL RESULTS FOR
THIRD QUARTER OF FISCAL 2004

Company Reports Third Consecutive Quarter of Revenue Growth with
Significant Improvement in Gross Profit Margins


RENO, NV – November 12, 2004 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today reported financial results for its third quarter ended September 30, 2004.

The company reported that revenue for the third quarter of fiscal 2004 increased to approximately $347,000 compared to revenue of approximately $17,000 for the third quarter of fiscal 2003. The net loss for the third quarter 2004 was $1.4 million, or a loss per share of $0.03, versus a net loss of $1.7 million, or a net loss per share of $0.05 for the comparable quarter in 2003. The gross margin for the third quarter was approximately $53,000, a considerable improvement when compared to a gross margin of approximately ($46,000) on sales of approximately $154,000 for its second quarter ended June 30, 2004.

For the nine-month period ended September 30, 2004, revenue increased to approximately $641,000, with a net loss of $5.3 million, or a net loss per share of $0.11, compared to revenue for the nine-month period ended September 30, 2003 of approximately $42,000, with a net loss of $4.6 million, or a net loss per share of $0.13.

“This has been a solid year of improved performance for the company,” commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. “We are on track to successfully transition from a research and development company into a nanotechnology company with commercial products and a variety of development services. We believe that we can announce one or two new commercial contracts by the end of fiscal 2004. Currently we have booked orders of $1.5 million and, depending upon our market partners, we expect to invoice more than twenty-five percent of these orders by the end of fiscal 2004.”

Operating expenses for the third quarter, which ended September 30, 2004, were approximately $1.5 million, versus operating expenses for the comparable quarter in 2003 of approximately $1.2 million. The increase in operating expenses over the comparable period in 2003 is a result of expansions in research, development, marketing, and sales.

Altair CFO Edward Dickinson noted, “Our net cash used in operations has averaged around $460,000 per month for the first three quarters, and we expect a modest increase in net cash used in operations for the fourth quarter as we add additional personnel and increase investments in product development.” As of September 30, 2004, Altair’s balance sheet was strong, with a cash position of approximately $9.0 million compared to $3.9 million at December 31, 2003.

“When comparing Altair to other nanotechnology companies,” continued Dickinson, “it is important to note that Altair’s long-term debt consists only of a promissory note of $3.0 million to purchase the building that houses Altair’s 80,000 square foot corporate headquarters, research laboratories and production facilities in Reno, Nevada.” Under the terms of the promissory note, interest begins accruing in August 2005 with the first payment due February 2006.



Altair Nanotechnologies Corporate Update

§ Dr. Alan J. Gotcher joins Altair as Chief Executive Officer and a Director.
§ Dr. Ravi I. Thadhani, a professor at Harvard Medical School and kidney dialysis research specialist, joins Altair’s Scientific Advisory Board.
§ Dr. Michael Graetzel, a professor at the Swiss Federal Institute of Technology in Lausanne, Switzerland and nanomaterials research pioneer, joins Altair’s Scientific Advisory Board.
§ Westrock Advisors, Inc. initiates coverage on Altair Nanotechnologies, Inc. with a BUY rating.
§ Altair CEO, Dr. Alan J. Gotcher presents at the 15th annual New York City Analyst Pharmaceutical Conference.

Life Sciences Division Update

· Pharmaceutical Products
RenaZorb™ Products - Nanotechnology-based Drug Candidate for Phosphate Binding in End Stage Renal Disease
Altair’s RenaZorb (lanthanum dioxycarbonate) represents a second-in-class lanthanum-based drug candidate for phosphate control in patients with end-stage renal disease (ESRD).

§ October 26, 2004, Shire Pharmaceutical’s CEO announced that the FDA had approved Fosrenol®, Shire’s lanthanum carbonate tetra hydrate-based drug for phosphate control in kidney dialysis patients with ESRD. FDA approval of the first lanthanum-based drug candidate is likely to facilitate the development of RenaZorb.
§ Preparations for the out-licensing of RenaZorb are underway. Altair, with the assistance of RBC Capital Markets, has sent the license marketing package for RenaZorb to over forty pharmaceutical and biotechnology companies. Several of these companies have expressed interest.

· Drug Delivery Products
TiNano® Spheres™ Drug Delivery Systems
TiNano Spheres are rigid, hollow, porous, high surface area, ceramic microstructures proposed for use in drug delivery systems, including systems to mitigate diversion and abuse of drugs.
§ Two patent applications have been filed for the TiNano Sphere drug delivery technology platform.

· Dental Nano-materials
§ Altair continues to work with a research consortium sponsored by the National Institutes of Health to strengthen polymer-based dental fillings utilizing Altair’s nano-zirconia.

Performance Materials Division Update

· Advanced Materials for Paints, Coatings and Sensors
Titanium Dioxide Pigment – Altair’s Hydrochloride Pigment Process (AHPP)
§ Altair has now completed approximately 50 percent of Phase l of the Western Oil Sands Project.
§ Altair was awarded a third contract from a (confidential) Fortune 100 company to supply testing quantities of customized nano-sized coating material.

Nanosensors
§ Western Michigan University and Altair received a $2 million contract from DOE for joint development of nanosensors for detecting chemical and biological weapons. Under terms of the Stage ll contract scheduled to commence this quarter, Altair will receive $672,000 over a two-year period for collaborative research and development as a subcontractor.

· Advanced Materials for Improving Process Technologies
Titanium Metal Manufacturing via Electrolysis Processing
§ Altair’s development agreement with Titanium Metals Corporation (NYSE:TIE), provides Altair the opportunity to supply enough TiO2 micro porous electrodes to produce 50 pounds of titanium metal per day to meet the DARPA titanium project goals as outlined by the program. Altair has met its goals and work plan and the project continues to successfully move forward.


NanoCheck™ Products for Binding Phosphate in Water
§ Independent and in-house laboratory testing has proven that Altair’s unique nano-structured compound, NanoCheck, safely and effectively removes phosphate from water preventing algae growth in swimming pools and reduces the quantity of chemicals currently required for algae prevention.
§ Field testing, focused on evaluating Nanocheck’s effectiveness in providing an algae-free environment for
swimming pools, was delayed due primarily to hurricanes in the field testing areas. Testing has been reinitiated and results will be made public when available. Negotiations with major pool chemical companies for licensing of the product are underway.

· High Performance Materials for Alternative Energy
Lithium Ion Battery Electrode Development
§ Altair is completing research work scope under a $100,000 SBIR Phase I grant and intends on applying for a $500,000 SBIR Phase ll grant from the U.S. National Science Foundation to continue work on carbon-coated nano-structured electrodes for next-generation lithium-ion ultra capacitors with partners Hosokawa Micron and Rutgers University.
§ Altair was awarded a European patent for its “Process for Making Lithium Titanate” a product used in the development of lithium ion batteries and super capacitors.

[tomhead]

News
ALTAIR NANOTECHNOLOGIES, UNIVERSITY OF NEVADA RESEARCH FOUNDATION AND HYDROGEN SOLAR LLC LEAD ALTERNATIVE ENERGY CONSORTIUM WITH $3 MILLION GRANT FROM U.S. DEPARTMENT OF ENERGY



Altair to Receive $400,000 as Subcontractor to Perform Research Activities to Enhance the Capabilities of Hydrogen Refilling Stations

RENO, NV – November 23, 2004 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI), in collaboration with the University of Nevada, Las Vegas, Research Foundation (UNLVRF) and Hydrogen Solar LLC, today announced the consortium has received a $3 million grant award from the U.S. Department of Energy (DOE). The fund is for joint research activities related to solar hydrogen production at a refilling station that is under development in Las Vegas. Vehicle integration testing and demonstration will also be included in the project.

Under the terms of the multi-year grant Altair will receive $400,000 for collaborative research and development efforts through its subcontractor agreement with UNLVRF. Additional project partners include University of Nevada Center for Energy Research (UNLVCER), Proton Energy Systems (PES), and the Las Vegas Valley Water District.

“This grant award marks a groundbreaking event for the development of alternative energy sources,” said Dr. Alan J. Gotcher, chief executive officer of Altair Nanotechnologies. “The consortium’s two-pronged approach – that of developing new Tandem Cells™ for power, along with related vehicle refilling stations—should serve to rapidly commercialize alternative energy vehicles throughout Nevada and ultimately the entire U.S. We are proud to be part of a project supporting the National Hydrogen Fuel Initiative.”

“The hydrogen refilling station project is a positive step toward achieving the national goal of energy independence,” said Thomas Williams, Executive Director of the UNLV Research Foundation. “We are pleased to work with such prestigious companies in advancing the hydrogen economy. We are also addressing related factors, such as how to achieve higher efficiency for electrolysers, and the development of new and expanding technologies that will alleviate our dependence on fossil fuels.”

Hydrogen Solar’s CEO, Dr. David Auty, added, “This project is the first step to commercializing our Tandem Cell technology in the American arena. We believe we have a highly efficient and world leading product for producing inexpensive, carbon-free hydrogen. We expect this to be a key technology as we move towards a future hydrogen economy, and are delighted to be working with such high caliber partners.”

“Hydrogen is the fuel of the future and solar applications to produce hydrogen are a good way to become energy independent,” said Senator Harry Reid, Senate Minority Leader and a long-time supporter of hydrogen research and development at UNLV. “We have the capabilities in Nevada to bring these cutting-edge technologies to the market. The research performed by this grant will bring us a step closer to achieving our goals.”

Under the terms of the grant, UNLVRF, a non-profit affiliate of UNLV, and UNLVCER will lead a team of industrial and technology partners to spearhead multiple research and development projects that will lead, in the future, to production and commercialization of solar-based hydrogen technologies. UNLVCER serves as the technical lead, with PES as the electrolyser developer, supplier and subcontractor. Hydrogen Solar LLC and Altair will act as research and product development partners in utilizing nanotechnology processes. The Las Vegas Valley Water District will provide vehicles for conversion, as well as continuing site support and coordination.

Phase I of the project, entails the development of a hydrogen refilling station, and work is already underway on this by the UNLVRF.

Phase II comprises the expanding of capabilities of the existing station by developing a high pressure, more efficient electrolyser. Phase II also includes the use of the Tandem Cell™, which converts light and water directly into hydrogen fuel in a highly efficient, renewable and carbon-free process.
Hydrogen Solar LLC believes the Tandem Cell will provide hydrogen at a significantly lower cost than the current photovoltaic / electrolyser routes being developed.

Central to the Tandem Cell technology is the very high performance of the photo-catalytic nano-crystalline thin films developed by Hydrogen Solar LLC. These are used to gather photons of incident light and convert them into electrons to directly split water into its constituent elements. Altair Nanotechnologies, Inc. will use their nanomaterials synthesis technology to develop low cost processing for and further improve the performance of the thin film electrode in the front section of the Tandem Cell. Altair’s efforts will focus on iron oxide-based materials and include development of film deposition methods and synthesis routes for the optimized metal oxide nanomaterials.

The Tandem Cell concept was co-invented by the Swiss Federal University of Technology in Lausanne (EPFL) and the University of Geneva (UoG), and was made possible thanks to research and development support by the Swiss Federal Office of Energy over a considerable period of time. The Tandem Cell ™ concept is the subject of a patent by Prof. Michael Graetzel (EPFL) and Jan Augustynski (UoG). Hydrogen Solar LLC is a wholly owned subsidiary of Hydrogen Solar Ltd UK, which holds the world-wide exclusive rights to the Tandem Cell™. Prof. Graetzel is a scientific advisor to both Hydrogen Solar Ltd and Altair.

tomhead

[junkbuster]

Altair Nanotechnologies, Inc. Announces US Patent Award Notification


Latest Patent Protects Manufacturing Process for Lithium Titanate Spinel Materials Used in High Power Battery Applications


RENO, NV -- (MARKET WIRE) -- 01/07/05 -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today announced that the US Patent Office has notified Altair that it has allowed Altair`s patent application for a "Process For Making Lithium Titanate." This US patent application describes the process and underlying technology for producing lithium titanate spinel materials of high purity and tightly controlled particle size over a range of 5 to 2,000 nanometers.

The processes protected by the patent were used to make materials that have been formed into electrodes which exhibit high charge and discharge rates in lithium ion batteries and in super capacitors being used in the National Science Foundation`s SBIR grant announced in June 2004. The SBIR grant is funding a joint program under which Altair, Hosokawa Micron`s Nano Particle Technology Center and Rutgers, The State University of New Jersey`s Energy Storage Research Group are using their combined technologies with the objective to develop and commercialize high-power, long life, fast-charge lithium ion batteries.

"Over the past five years, Altair has expended significant resources to pioneer and develop advanced ceramic nanotechnology and as of today, in addition to this patent award, Altair owns four issued U.S. Patents, 12 issued foreign patents and 46 additional pending U.S. and foreign patent applications," said Dr. Alan J. Gotcher, Chief Executive Officer of Altair Nanotechnologies. "We are aggressively pursuing licensing and business development programs with our technology, nanomaterials and products worldwide.

"Our Performance Materials Division, in conjunction with various industry partners, is involved with alternative energy development programs that include lithium ion batteries, super capacitors, fuel cell development and solar hydrogen generation," continued Dr. Gotcher. "We believe nanomaterials can significantly improve lithium ion battery and super capacitor performance, making it possible to use these systems in applications where immediate high power delivery is necessary. Such applications include automobile batteries, electric and hybrid vehicles, as well as military applications and specialized uses such as notebook computers, mobile phones, and a variety of portable devices."

ALTAIR NANOTECHNOLOGIES INC.

Altair Nanotechnologies, through product innovation, is a leading supplier of advanced ceramic nanomaterial technology worldwide. Altair Nanotechnologies has assembled a unique team of material scientists who, coupled with collaborative ventures with industry partners and leading academic centers, has pioneered an impressive array of intellectual property and product achievements.

Altair Nanotechnologies has developed robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has a scalable manufacturing capability to meet emerging nanomaterials demands, with capacity today to produce hundreds of tons of nanomaterials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for paints and coatings; titanium metal manufacturing, catalysts and water treatment; and alternative energy. For additional information on Altair and its nanomaterials, visit www.altairnano.com.

Altair Nanotechnologies, Inc.®, Altair Nanomaterials™, TiNano®, RenaZorb™, NanoCheck™, TiNano Spheres™ and the Hydrochloride Pigment Process™ are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair expenses will rise during the following quarters as a result of unexpected cash or non-cash expenses; Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market: the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb, its TiNano Sphere or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

For Additional Information:
Marty Tullio or Mark Tullio
949.553.9748
McCloud Communications, LLC
[e-mail]@mccloudcommunications.com

[junkbuster]

Hier in deutsch - mittels Internetübersetzung!


RENO, Nanovolt -- (MARKT-LEITUNG) -- 01/07/05 -- Altair Nanotechnologies, Inc. (Nasdaq: ALTI), heute verkündet, daß das US Patentamt Altair mitgeteilt hat, daß es Altair`s Patentanfrage für ein " erlaubt hat; Prozeß Für Das Bilden Des Lithiums Titanate." Diese US Patentanfrage beschreibt die Prozeß- und zugrundeliegende Technologie für das Produzieren der spinel Materialien des Lithiumtitanats des hohen Reinheitsgrades und der fest gesteuerten Teilchengröße über einer Strecke 5 bis 2.000 Nanometer. Die Prozesse, die durch das Patent geschützt wurden, wurden verwendet, um Materialien zu bilden, die in Elektroden gebildet worden sind, die hohe Aufladung ausstellen und Rate in den Lithiumionenbatterien und in den Superkondensatoren entladen, die in der nationalen Wissenschaft Foundation`s SBIR Bewilligung verwendet werden, die im Juni 2004 verkündet wird. Die SBIR Bewilligung finanziert ein gemeinsames Programm, unter dem Altair, Hosokawa Micron`s Nano Partikel-Technologie Mitte und Rutgers, die Landesuniversität der neuen Jersey`s Energie-Speicher-Forschungsgruppe ihre kombinierten Technologien mit der Zielsetzung verwenden, um starkes, langes Leben zu entwickeln und in den Handel zu bringen, schnell-aufladen Lithiumionenbatterien. " Über den letzten fünf Jahren hat Altair bedeutende Betriebsmittel verbraucht, um voranzugehen und vorgerücktes keramisches nanotechnology und ab heutigem Tag, zusätzlich zu diesem Patentpreis, Altair zu entwickeln besitzt vier herausgegebene VEREINIGTE STAATEN Patente, 12 herausgab fremde Patente und 46 zusätzlich während VEREINIGTE STAATEN und fremde Patentanfragen, " besagter Dr. Alan J. Gotcher, Generaldirektor von Altair Nanotechnologies. " Wir üben konkurrenzfähig mit unserer Technologie, nanomaterials und Produkten genehmigen und geschäftliche Entwicklung Programme weltweit aus. " Unsere Leistung Material-Abteilung, in Verbindung mit verschiedenen Industriepartnern, wird in Entwicklungsprogramme der alternativen Energie, die Lithiumionenbatterien, Superkondensatoren, Kraftstoffzelle Entwicklung und Solarwasserstofferzeugung einschließen, " miteinbezogen; anhaltender Dr. Gotcher. " Wir glauben, daß nanomaterials die Lithiumionenbatterie und Superkondensatorleistung erheblich verbessern können und es möglich machen, diese Systeme in den Anwendungen zu benutzen, in denen sofortig hohe Energie Anlieferung notwendig ist. Solche Anwendungen schließen die Automobilbatterie-, elektrische und hybrideträger, sowie militärische Anwendungen und fachkundiger Gebrauch wie Notizbuchcomputer, bewegliche Telefone und eine Vielzahl beweglichen devices." mit ein; ALTAIR NANOTECHNOLOGIES INC.. Altair Nanotechnologies, durch Produktinnovation, ist ein führender Lieferant der vorgerückten keramischen nanomaterial Technologie weltweit. Altair Nanotechnologies hat eine einzigartige Mannschaft der materiellen Wissenschaftler zusammengebaut die, verbunden mit gemeinschaftlichen Wagnissen mit Industriepartnern und führenden akademischen Mitten, einer eindrucksvollen Reihe mit Ausführungen des geistigen Eigentums und des Produktes vorangegangen hat. Altair Nanotechnologies hat robuste eigene Technologieplattformen für die Produktion einer Vielzahl der kristallenen und nichtkristallinen nanomaterials von einzigartiger Struktur, von Leistung, von Qualität und von Kosten entwickelt. Die Firma hat eine scalable Herstellung Fähigkeit, zum der auftauchenden nanomaterials Nachfragen, mit der Kapazität zu befriedigen, Hunderte Tonnen nanomaterials heute zu produzieren. Die Firma wird in zwei Abteilungen organisiert: Leben-Wissenschaften und Leistung Materialien. Die Leben-Wissenschaften Abteilung übt Marktanwendungen in den pharmazeutischen Produkten, in der Drogeanlieferung, in den zahnmedizinischen Materialien, in den Kosmetik und in anderen medizinischen Märkten aus. Die Leistung Material-Abteilung übt Marktanwendungen in vorgerückten Materialien für Farben und Schichten aus; Titanmetallherstellung, Katalysatoren und Wasserbehandlung; und alternative Energie. Zu zusätzlicher Information über Altair und seine nanomaterials, Besuch www.altairnano.com. Altair Nanotechnologies, Inc.®, Altair Nanomaterials?, TiNano®, RenaZorb?, NanoCheck?, TiNano Bereiche? und der Hydrochlorid-Pigment-Prozeß? sind eingetragene Warenzeichen oder eingetragene Warenzeichen von Altair Nanotechnologies, Inc.. Vorwärts-Schauen Von von Aussagen Diese Freigabe kann das Vorwärts-Schauen von von Aussagen sowie historische Informationen enthalten. Aussagen Vorwärts-schauen, die in Übereinstimmung mit dem " enthalten sind; sicheres harbor" Bestimmungen der privaten Sicherheiten Rechtsstreit-Verbesserung-Tat von 1995, können Gefahren, Ungewißheiten und andere Faktoren mit einbeziehen, die dem company`s tatsächliche Resultate und Leistung in den zukünftigen Perioden veranlassen können, zu jeden möglichen Zukunftresultaten oder -leistung materiell unterschiedlich zu sein, die durch die Vorwärts-schauenden Aussagen diesbezüglich Freigabe vorgeschlagen werden. Diese Gefahren und Ungewißheiten schließen, ohne Beschränkung, die Gefahren ein, daß Altairunkosten während der folgenden Viertel resultierend aus unerwartetem Bargeld oder bargeldlosen Unkosten steigen; Altair`s werden zahlreiche Entwicklung Stadium Produkte nicht zum Punkt der Kommerzialisierung entwickelt, oder das, selbst wenn in den Handel gebracht, kein Markt, besteht für solche Produkte, oder Altair kann zu den Kunden in einem Markt effektiv vermarkten nicht: die Gefahren, daß Altair nicht imstande ist, an den Lizenzvereinbarungen betreffend sind seinen Pigmentprozeß (AHPP), RenaZorb, sein TiNano Bereich teilzunehmen, oder andere sich entwickelnde Produkte, die, selbst wenn Altair an solchen Lizenzvereinbarungen teilnimmt, kurze Bezeichnung Einkommen von solchen Vereinbarungen sind nicht genügend, Altair`s Betriebe langfristig zu finanzieren, und die die Tierprüfung oder die zukünftige Prüfung von RenaZorb oder andere Produkte der Firma nicht erfolgreich sind und das Entwicklung beendet werden muß. Im allgemeinen ist Altair und erwartet, in der sofortigen Zukunft zu sein, die nach den Kapitaln abhängig ist, die von den Verkäufen von Sicherheiten, Bewilligungen, Prüfung von Vereinbarungen und von Lizenzvereinbarungen, seine Prüfung, Entwicklung und fortwährenden Betriebe zu finanzieren erzeugt werden. Zusätzlich werden andere Gefahren im company`s der meiste neue jährliche Bericht über Form 10-K gekennzeichnet, wie mit der sek eingeordnet. Solche Vorwärts-schauende Aussagen sprechen nur ab dem Datum dieser Freigabe. Die Firma dementiert ausdrücklich jede mögliche Verpflichtung, irgendwelche Vorwärts-schauenden Aussagen zu aktualisieren oder zu verbessern, die hierin gefunden werden, um alle mögliche Änderungen in den Firmaerwartungen oder -resultaten oder irgendeine Änderung in den Fällen zu reflektieren. Zu Zusätzlicher Information: Marty Tullio oder Markierung Tullio 949.553.9748 McCloud Kommunikationen, LLC [e-mail]@mccloudcommunications.com


hoffe es get bald wieder steil nach oben!

lg junkbuster

[junkbuster]

Altair: Break muss sich stabilisieren

10.01.2005 - Top-Aktientipps von www.4investors.de – jede Woche kostenlos per Mail: hier klicken!!!

Die Aktie von Altair Nanotechnologies gehörte am Freitag zu den Nanotech-Tagesgewinnern an der Nasdaq. Hintergrund des Anstiegs von mehr als 14 Prozent sind positive Entwicklungen um ein angemeldetes Patent des Unternehmens. Durch den Anstieg, der die Aktie auf 2,57 Dollar führte, wurde der Widerstand bei 2,50 Dollar wieder überwunden. Allerdings muss sich am Montag zeigen, ob dieser Break von bestand ist, nachdem die Aktie zuvor in einen tertiären Abwärtstrend gefallen war.
( mic )

[tomhead]

@all
Neuer Mann an Board:
ALTAIR NANOTECHNOLOGIES APPOINTS SENIOR VICE PRESIDENT OF SALES AND MARKETING

Company Taps Technology Industry Veteran to Drive Revenue and Forge
Strategic Global Relationships

RENO, NV – January 12, 2005 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI), announced today that it has appointed Roy Graham to the position of Senior Vice President, Sales and Marketing.

“We are pleased to have Roy join our executive team,” said Altair Nanotechnologies CEO Dr. Alan J. Gotcher. “We have aggressive revenue growth objectives and commercialization milestones projected for 2005 and believe it is crucial to begin the year with a seasoned sales and marketing executive of Roy’s caliber. He has an extensive emerging technology background and proven track record in driving revenue, building brand, securing strategic partnerships, and building sales and customer support teams which will serve us well as we launch into commercialization during 2005.”

In this role, Graham is tasked with driving worldwide revenue, increasing market awareness and securing collaborative partnerships. The position is also responsible for functional areas including sales, marketing, customer support, business development and corporate development.

“This is an opportune time to join the Altair team,” commented Graham. “We are seeing the nanotechnology sector moving rapidly toward commercialization, and Altair is uniquely positioned to capitalize on this burgeoning industry and secure a leadership position in its target markets. I look forward to working with Altair’s management team, as we build an outstanding sales, marketing and customer support team.”

About Roy Graham
Roy Graham brings to Altair more than 30 years of industry experience in senior management roles with startup and publicly-traded companies. His industry experience includes the high-tech, telecommunications, financial services and healthcare markets.

Graham comes to Altair from modeMD, Inc., a developer of wireless application software and systems for the healthcare industry, where he held the position of President and CEO. Prior to modeMD, Graham held several senior roles including Executive Vice President of Sales for RetailOne, and Executive Vice President of Sales, Marketing and Customer Service for Be, Inc., a digital media operating system company which successfully completed a $200 million IPO. He has also held senior vice president and director-level sales and marketing roles with Wyse Technology, Tandem Computers, and Digital Equipment Corporation. Graham received a Bachelor of Science degree with honors from Sussex University in the United Kingdom.


tomhead

[junkbuster]

Altair Nanotechnologies Announces U.S. Patent Award Notification


Patent Protects Manufacturing Process for Ceramic Nanoparticles


RENO, NV -- (MARKET WIRE) -- 01/14/05 -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today announced that the U.S. Patent Office has notified Altair that it has allowed Altair`s patent application for a "Process For Making Nano-sized and Sub-micron-sized Lithium-Transition Metal Oxides." The patent application describes the process and underlying technology for producing nano-sized and sub-micron sized oxides of lithium and a transition metal with particle size over a range of 10 to 1,000 nanometers and with narrow size dispersion.

The patent was derived from developing cathode materials for next-generation lithium ion batteries and is complementary to the patent announced by Altair on January 7, which related to materials for anodes. The processes protected by the new patent are used to make materials that have been formed into electrodes and have been successfully tested by several battery and battery technology companies. The patents are an important cornerstone in Altair`s program to develop mated pairs of high performance anode and cathode materials for advanced high power, fast recharge, long cycle life in safe, high capacity lithium ion batteries.

Over the past five years, Altair has expended significant resources to pioneer and develop advanced ceramic nanotechnology and currently owns six U.S. Patents and 12 foreign patents with 46 additional pending U.S. and foreign patent applications. Altair is aggressively pursuing licensing and business development programs utilizing it technology, nanomaterials and nano-based products worldwide.

"Our Performance Materials Division, in conjunction with industry partners, is involved with alternative energy development programs that include lithium ion batteries, super capacitors, fuel cell development and solar hydrogen generation," said Altair Nanotechnologies CEO Dr. Alan J. Gotcher. "We believe our nanomaterials can significantly improve lithium ion battery and super capacitor performance, making their use possible in applications where immediate high power delivery is necessary. Such applications include automobile batteries, electric and hybrid vehicles, as well as military applications and specialized uses such as notebook computers, mobile phones, and a variety of other portable devices."

ALTAIR NANOTECHNOLOGIES INC.

Altair Nanotechnologies, through product innovation, is a leading supplier of advanced ceramic nanomaterial technology worldwide. Altair Nanotechnologies has assembled a unique team of material scientists who, coupled with collaborative ventures with industry partners and leading academic centers, has pioneered an impressive array of intellectual property and product achievements.

Altair Nanotechnologies has developed robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has a scalable manufacturing capability to meet emerging nanomaterials demands, with capacity today to produce hundreds of tons of nanomaterials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for paints and coatings; titanium metal manufacturing, catalysts and water treatment; and alternative energy. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altairnano™, Altair Nanotechnologies, Inc.®, Altair Nanomaterials™, TiNano®, RenaZorb™, NanoCheck™, TiNano Spheres™ and the Hydrochloride Pigment Process™ are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair expenses will rise during the following quarters as a result of unexpected cash or non-cash expenses; Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market; the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb, its TiNano Sphere or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

For Additional Information:
Marty Tullio or Mark Tullio
McCloud Communications, LLC
949.553.9748
[e-mail]@mccloudcommunications.com


junkbuster

[tomhead]

@all
neues Patent:
ALTAIR NANOTECHNOLOGIES ANNOUNCES NEW PATENT AWARD NOTIFICATION



Patent protects basic technologies for commercial development Programs of nano-sized and pigment-sized Ti02

RENO, NV. – January 25, 2004 – Altair Nanotechnologies, Inc. (NASDAQ:ALTI) announced today that it was awarded a new Australian patent covering “Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment” by the Australian Patent Office.

The new patent describes the fundamental technology for a hydrometallurgical process for producing pigment-grade titanium dioxide (‘Ti02” containing solutions. The process includes hydrolyzing the solution via complete evaporation in controlled conditions of temperature to form titania oxide of defined characteristics. After hydrolyzing, the titanium oxide is calcined to form either anatase or rutile pigment of the desired particle size. It is then milled for final processing.

“Our patented process provides significant economies of scale and considerable environmental advantages over the existing chloride and sulfate processes,” commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. “Further, our manufacturing process provides for an environmentally-friendly method for pigment companies to streamline operations and reduce costs.”

The new patent follows the award of two other patents covering the environmentally friendly process for TiO2 pigment production, an $8 billion industry. Altair’s patent portfolio includes: 1) Processing Titaniferous Ore to Titanium Dioxide Pigment; 2) Processing Aqueous Titanium Chloride Solutions to Ultrafine Titanium Dioxide, and 3) Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment.

Over the past five years, Altair has expended significant resources to pioneer and develop advanced ceramic nanotechnology and currently owns six U.S. Patents and 12 foreign patents with 46 additional pending U.S. and foreign patent applications. Altair is aggressively pursuing licensing and business development programs utilizing its technology, nanomaterials and nano-based products worldwide.


tomhead

[junkbuster]

Altair Nanotechnologies Announces New Patent Award Notification


Patent Protects Basic Technologies for Commercial Development Programs of Nano-Sized and Pigment-Sized Ti02


RENO, NV -- (MARKET WIRE) -- 01/25/05 -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI) announced today that it was awarded a new Australian patent covering "Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment" by the Australian Patent Office.

The new patent describes the fundamental technology for a hydrometallurgical process for producing pigment-grade titanium dioxide ("Ti02") containing solutions. The process includes hydrolyzing the solution via complete evaporation in controlled conditions of temperature to form titania oxide of defined characteristics. After hydrolyzing, the titanium oxide is calcined to form either anatase or rutile pigment of the desired particle size. It is then milled for final processing.

"Our patented process provides significant economies of scale and considerable environmental advantages over the existing chloride and sulfate processes," commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. "Further, our manufacturing process provides for an environmentally friendly method for pigment companies to streamline operations and reduce costs."

The new patent follows the award of two other patents covering the environmentally friendly process for TiO2 pigment production, an $8 billion industry. Altair`s patent portfolio includes: 1) Processing Titaniferous Ore to Titanium Dioxide Pigment; 2) Processing Aqueous Titanium Chloride Solutions to Ultrafine Titanium Dioxide, and 3) Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment.

Over the past five years, Altair has expended significant resources to pioneer and develop advanced ceramic nanotechnology and currently owns six U.S. Patents and 12 foreign patents with 46 additional pending U.S. and foreign patent applications. Altair is aggressively pursuing licensing and business development programs utilizing its technology, nanomaterials and nano-based products worldwide.

ALTAIR NANOTECHNOLOGIES INC.

Altair Nanotechnologies, through product innovation, is a leading supplier of advanced ceramic nanomaterial technology worldwide. Altair Nanotechnologies has assembled a unique team of material scientists who, coupled with collaborative ventures with industry partners and leading academic centers, has pioneered an impressive array of intellectual property and product achievements.

Altair Nanotechnologies has developed robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has a scalable manufacturing capability to meet emerging nanomaterials demands, with capacity today to produce hundreds of tons of nanomaterials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for paints and coatings; titanium metal manufacturing, catalysts and water treatment; and alternative energy. For additional information on Altair and its nano-materials, visit www.altairnano.com.

Altairnano™, Altair Nanotechnologies, Inc.®, Altair Nanomaterials™, TiNano®, RenaZorb™, NanoCheck™, TiNano Spheres™ and the Hydrochloride Pigment Process™ are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair expenses will rise during the following quarters as a result of unexpected cash or non-cash expenses; Altair`s numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market: the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb, its TiNano Sphere or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair`s operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

For Additional Information:
Marty Tullio or Mark Tullio
McCloud Communications, LLC
949.553.9748
[e-mail]@mccloudcommunications.com

[tomhead]

ALTAIR NANOTECHNOLOGIES LICENSES RENAZORB™ TO SPECTRUM PHARMACEUTICALS



RenaZorb targets potential multi-billion dollar chronic kidney disease market

RENO, NV – January 31, 2005 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI), announced today that a licensing agreement has been signed with California-based Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), giving Spectrum the exclusive worldwide rights for human therapeutic and diagnostic applications to develop, market and sell its RenaZorb™ product line. Altair’s RenaZorbTM products, which target an emerging billion dollar plus market, are for phosphate control in patients with Chronic Kidney Disease (CKD) and hyperphosphatemia, high phosphate levels in blood, associated with End Stage Renal Disease (ESRD). These products are non-aluminum, non-calcium-based phosphate binders, which utilize Altair’s proprietary lanthanum nanomaterial technology.

Under the terms of the licensing agreement, an initial payment will be made consisting of restricted shares of Spectrum’s common stock and a cash purchase by Spectrum of Altair common stock at a 100 percent premium to market price. Upon the successful completion of animal studies later this year confirming specified results, Spectrum will make an additional payment of restricted shares of Spectrum’s common stock, for a projected total first year value of approximately $1.3 million. Although no further financial details have been disclosed, the terms of the licensing agreement follows industry norms for drug candidate licensing, with most of the potential consideration coming in the form of milestone payments and royalty rate payments over time. A multi-year collaborative research and development program between Altair and Spectrum is a component of the licensing agreement. Assuming a drug containing Renazorb receives timely FDA approval, the market for phosphate controlling drugs continues to grow at projected rates, and the product becomes a leader in the market place, the total revenues to Altair over the life of this agreement could exceed $100 million.

It is estimated that 340,000 people in the U.S. have ESRD and are on kidney dialysis. Worldwide sales of phosphate binders are estimated at $600 million to $750 million per year. This market is anticipated to grow significantly with the recommendation by the National Kidney Foundation’s K/DOQI guideline which states that patients with Chronic Kidney Disease could benefit from beginning the use of phosphate binders during earlier stages of the disease. With the implementation of the K/DOQI guidelines by the healthcare industry, there would be the potential for an additional 8.4 million patients that many of which could benefit from phosphate binding therapy, driving the potential market to over one billion sales per year within the U.S. alone.

“Spectrum is known for its ability to rapidly assess preclinical research, clinical data, and the commercialization potential of drugs such as RenaZorb,” commented Altair Nanotechnologies CEO Dr. Alan J. Gotcher. “Our team is pleased to be working with Spectrum and its people, who have a solid reputation and expertise in taking promising products through the complex development and regulatory approval process to successful commercialization. We are delighted to see RenaZorb, the first of our Life Sciences initiatives, attract an excellent commercial partner.”

“This in-licensing of RenaZorb is an important step in our continued effort to build an extensive and well-diversified portfolio of product candidates that span all stages of development and address significant unmet medical needs,” stated Rajesh Shrotriya, M.D., Chairman of the Board, Chief Executive Officer and President of Spectrum Pharmaceuticals, Inc. “We are extremely pleased to establish this alliance with Altair. We look forward to advancing RenaZorb™ into clinical trials, and pursuing the appropriate regulatory strategy to maximize its potential.”

“RenaZorb represents a new generation of high performance phosphate binding drugs that have promise of lowest dose in class and excellent patient compliance”, stated Dr. Ravi Thadhani, M.D., Ph.D. Department of Medicine and Renal Unit, Massachusetts General Hospital, Boston MA, “The partnership between Altair and Spectrum is an excellent complementary marriage of leaders in their respective fields.”


tomhead

[jog_]

und was ist nun los???????????????????

warum geht die Aktie in den Sturzflug über??

kann ich einfach nicht nachvollziehen.

[junkbuster]

Altair: Millionen-Deal

Altair: Millionen-Deal
Spectrum Pharmaceuticals Licenses RenaZorb(TM) From Altair Nanotechnologies

IRVINE, Calif., Jan. 31 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc. announced today that it has acquired worldwide exclusive rights to RenaZorb(TM) (two second-generation lanthanum-based phosphate binding agents) from Altair Nanotechnologies (Nachrichten) . These novel non-aluminum, non-calcium phosphate binders which utilize Altair`s proprietary lanthanum nanomaterial technology have the potential to treat hyperphosphatemia, i.e., high phosphorus levels in blood, in patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD), with potentially as little as one tablet per meal while currently approved therapies require as many as several tablets per meal. There are an estimated 340,000 ESRD patients in the U.S. who are on kidney dialysis, and the market for phosphate binding agents was in excess of $600 million in 2004. According to the National Kidney Foundation, the number of ESRD patients in the U.S. is expected to double over the next decade. In addition, there are an estimated 8.4 million CKD patients, representing a potential multi-billion dollar market opportunity, who are candidates for phosphate binder therapy under the National Kidney Foundation`s Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines, issued in 2003.

Under the terms of the agreement, Spectrum acquired an exclusive worldwide license to develop and commercialize RenaZorb(TM) for all human therapeutic and diagnostic uses. Spectrum will pay to Altair an upfront payment of 100,000 shares of restricted Spectrum common stock and will make an equity investment of $200,000 for 38,314 shares of Altair common stock. In addition, Altair is eligible to receive payments upon achievement of a clinical development and certain regulatory and sales milestones, in addition to royalties on potential net sales. Additional financial details were not disclosed.

"This in-licensing of RenaZorb is an important step in our continued effort to build an extensive and well-diversified portfolio of drug product candidates that span all stages of development and address significant unmet medical needs," stated Rajesh Shrotriya, M.D., Chairman of the Board, Chief Executive Officer and President of Spectrum Pharmaceuticals, Inc. "We are extremely pleased to establish this alliance with Altair. We look forward to advancing RenaZorb(TM) clinical trials, and pursuing the appropriate regulatory strategy to maximize its potential."

"We are delighted to have the opportunity to work with the Altair team and look forward to developing and commercializing RenaZorb," stated Luigi Lenaz, M.D., of Spectrum Pharmaceuticals, Inc. "We believe there is a significant unmet medical need for the treatment of hyperphosphatemia, a condition that leads to significant bone disorders and cardiovascular disease, and is associated with a significantly higher death risk in patients with chronic and end-stage kidney disease. According to K/DOQI Guidelines, fewer than 30 percent of dialysis patients are able to achieve and maintain serum phosphorus levels in the optimal range, despite dietary phosphorus restriction and treatment with currently marketed phosphate binders. As a non-aluminum, non-calcium phosphate binder, RenaZorb has the potential to become one of the preferred first-line treatment options for hyperphosphatemia under the new K/DOQI Guidelines because it has the potential to significantly improve patient compliance by lowering the daily pill burden to the lowest-in-class dosage, namely one tablet per meal, and smaller-sized tablets, in addition to a potentially more favorable safety and efficacy profile."

"We are delighted to have a collaborator for the first of our Life Sciences initiatives, RenaZorb, with the drug development, regulatory and commercialization expertise of Spectrum`s management," stated Alan J. Gotcher, Ph. D., Chief Executive Officer of Altair Nanotechnologies, Inc. "We look forward to working with Spectrum to enhance and expedite the development of this promising compound."

"RenaZorb represents a new generation of high performance phosphate binding drugs that have significant promise in terms of dose and compliance," stated Dr. Ravi Thadhani, M.D., M.P.H. Department of Medicine and Renal Unit, Massachusetts General Hospital, Boston, MA. "The partnership between Altair and Spectrum is an excellent complementary marriage of leaders in their respective fields."

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is a specialty pharmaceutical company engaged in the business of acquiring, developing and commercializing proprietary and generic drug products for various indications. The Company`s current proprietary drug products are primarily focused on the treatment of cancer and related disorders. The Company`s lead drug, satraplatin, is a phase 3 oral, anti-cancer drug being co-developed with GPC Biotech AG, and has been granted fast-track status by the United States Food and Drug Administration (FDA) for its initial indication, second-line chemotherapy for hormone-refractory prostate cancer. Elsamitrucin, a phase 2 drug, is being studied for its initial indication, refractory non-Hodgkin`s lymphoma. EOquin(TM), a phase 2 drug, is being studied in the treatment of superficial bladder cancer. SPI-153 (formerly, D-63153), a phase 2 drug, is a 4th generation LHRH antagonist with the potential to treat hormone-dependent cancers as well as benign proliferative disorders, such as benign prostatic hyperplasia and endometriosis. The Company`s Abbreviated New Drug Application for ciprofloxacin, a broad-spectrum antibiotic and the generic version of Bayer Corporation`s Cipro(R) tablets, received approval from the FDA in September 2004. In addition, the Company has six Abbreviated New Drug Applications pending at the FDA. For additional information, including SEC filings, visit the Company`s web site at http://www.spectrumpharm.com/.

Spectrum Pharmaceuticals, Inc. forward-looking statements

This press release may contain forward-looking statements regarding future events and the future performance of Spectrum Pharmaceuticals that involve risks and uncertainties that could cause actual results to differ materially. These statements include but are not limited to statements that relate to our business and its future, the success of our oncology drug candidates in their initial indications and future indications, sales of ciprofloxacin, RenaZorb`s potential to treat hyperphosphatemia and be the preferred therapy, the size of the market opportunity, the number of ESRD and CKD patients in the future, the size of the tablet, the daily bill burden, the Company`s efforts to build an extensive and well-diversified portfolio, advancing RenaZorb into clinical trials, developing and commercializing RenaZorb, the experience of the Company`s management, the safety and efficacy profile of RenaZorb, patient compliance and any statements that relate to the intent, belief, plans or expectations of Spectrum or its management, or that are not a statement of historical fact. Risks that could cause actual results to differ include the possibility that our existing and new drug candidates may not prove safe or effective, the possibility that our existing and new drug candidates may not receive approval from the FDA in a timely manner or at all, the possibility that our existing and new drug candidates, if approved, may not be more effective, safer or more cost efficient than competing drugs, the early stage of the development of RenaZorb, the possibility that RenaZorb may not be able to effectively treat hyperphosphatemia, the possibility that an effective dose of RenaZorb may require more than one pill, the possibility that the National Kidney Foundation may modify their guidelines, the possibility that price and other competitive pressures may make the marketing and sale of our proprietary and generic drugs not commercially feasible, the possibility that our efforts to acquire or in-license and develop additional oncology drug candidates may fail, our lack of revenues, our limited experience in establishing strategic alliances, our limited marketing experience, our limited experience with the generic drug industry, our dependence on third parties for clinical trials and other risks that are described in further detail in the Company`s reports filed with the Securities and Exchange Commission.

Contacts: Rajesh C. Shrotriya, M.D., CEO and President Spectrum Pharmaceuticals, Inc. [phone] Anna Kazanchyan, M.D. Spectrum Pharmaceuticals, Inc. [phone]

Spectrum Pharmaceuticals, Inc.

[junkbuster]

Altair: Millionen-Deal

31.01.2005 - Unser Tipp: Aktuelle Nanotech-News von www.4investors.de direkt in Ihr Mail-Postfach: hier klicken!!!

Das Nanotechnologie-Unternehmen Altair hat an Spectrum Pharmaceuticals die weltweiten Exklusivrechte für Renazorb vergeben. Spectrum kann die Rechte für die Weiterentwicklung und den Verkauf im humantherapeutischen und diagnostischen bereich nutzen. Spectrum wird im Gegenzug Altair-Aktien zeichnen, deren Bezugspreis 100 Prozent über dem Altair-Kurs liegt. Zusätzlich erhält Altair Aktien von Spectrum Pharmaceuticals. Bei Weiterentwicklung des Produktes erhält Altair zusätzliche Meilensteinzahlungen und Royalties, wenn der Wirkstoff an den Markt kommt. Alles in allem könnte Altair im besten Fall mehr als 100 Mio. Dollar erhalten.
( mic )

[junkbuster]

wurde aber auch zeit *gg

lg junkbuster

[junkbuster]

Altair: To Make Improved Rechargable Batteries



RENO, Nev. (Dow Jones)--After receiving two new patents and a National Science Foundation grant, Altair Nanotechnologies Inc. (ALTI) said it achieved a breakthrough in Lithium Ion battery electrode materials enabling it to introduce a new generation of rechargeable batteries.

Shares of Altair were trading up 119.7%, or $2.49, at $4.57, in composite activity Thursday afternoon, on volume of 47.8 million shares. Average daily trading volume is 871,659 shares.

Altair`s announced its first patent award on Jan. 7 and the other on Jan. 14; the National Science Foundation grant was successfully completed in January.

In a press release Thursday, the company said its new materials will enable the manufacturing of rechargeable batteries with three times the power of existing Lithium Ion batteries at the same price.

The company also noted the batteries will be able to recharge much quicker than current products.

The fast-charging battery will be marketed to consumers in areas such as handheld power tools, hybrid electric vehicles, portable electronics and medical surgery tools.

Altair said it already has confidentiality agreements in place with some battery development companies to commercialize the battery electrode materials.

Company Web site: http://www.altairnano.com.

-Geoffrey Rogow; Dow Jones Newswires; 201-938-5400; [e-mail]

Corrected Feb. 10, 200515:53 ET (20:53 GMT)

Shares of Altair were trading up 119.7%, or $2.49, at $4.57, in composite activity Thursday afternoon, on volume of 47.8 million shares. Average daily trading volume is 871,659 shares.

(An item published at 3:14 p.m. EST misstated Thursday`s trading volume.)


Dow Jones Newswires
02-10-051514ET

[opelmanta3]

ALTI wieder abgegangen....

XDSL ist billiger

[mirox]

und nochmal für die englischfaulen, weil es so geil ist:
-------
10.02.2005 - 19:34
Nanotech-Firma meldet Durchbruch

Altair Nanotechnologies hat heute gemeldet, mit neuen Elektroden-Materialien einen Durchbruch im Bereich Lithium-Batterien erzielt zu haben. Laut Unternehmensangaben könne dadurch eine neue Generation wiederaufladbarer Batterien entstehen, die die dreifache Speicherkapazität herkömmlicher Batterien aufweisen würden. Auch die Auflade-Dauern ließen sich dadurch von mehreren Stunden auf einige Minuten verkürzen.
Wie das Unternehmen weiter berichtete, hätten einige Batterienhersteller die Neuerungen als „bemerkenswert“ bezeichnet. Man habe auch mit einigen führenden Produzenten bereits verbindliche Abkommen zur Vermarktung der neuen Materialien geschlossen.

An der Nasdaq springt die Aktie von Altair Nanotechnologies aktuell um 43,27 Prozent nach oben auf 2,98 Dollar.
-------------
mein Depot zeigt heute +126%, ist das nicht geil?

[junkbuster]

meins auch *ggg*

[junkbuster]

halten oder verkaufen, was meint ihr?

[mirox]

wenn das aufgeht: halten
wenn ente: verkaufen

ich denke jedoch, daß Milliarden!!! von Menschen über schwache Akkus klagen.
Ich halte, da keine bessere Storys vorliegen!

[junkbuster]

da muss ich dir voll und ganz zustimmen. ich werde mir morgen den krusverlauf anschauen und mich dan spontan entscheiden.

ich liebe das spiel

lg junkbuster

[telltom]

Bekanntlich ist ja an einer Gewinnmitnahme noch niemand gestorben!!!

Allerdings hat ALTAIR eine bahnbrechende Entwicklung gemacht und Batterien findet man überall, in Autos (Hybridautos wird der nächste große Renner in Europa), in Notebooks, in allen tragbaren Elektrogeräten wie zB der IPOD.

Da ALTAIR ein Basisplayer ist, werde ich ALTAIR im Depot belassen.

Mich würde interessieren, ob Morgen der große Absturz einsetzt???

Euere Meinung???

[junkbuster]

Ich glaube der große Absturz wird morgen noch nicht kommen.

da die leute morgen noch wie verrückt kaufen werden, denke ich dass am Montag oder dienstag die hype vorbei sein wird.

aber ich will mich gerne eines besseren belehren lassen.

lg junkbuster

[Chlorophyll]

Bin auch gespannt wies weiter geht. Bei 99% solcher Anstiege erfolgt normalerweise ein grösserer Rückgang.
Bei dieser Aktie allerdings vermute ich, hoffe ich auch etwas, wirds weitergehen.

[telltom]

Wichtig ist, welche fundamentalen Meldungen kommen, die diesen Kurs unterstützen.

Würde mich freuen, wenn ALTI auch eine Kursbewegung machen würde wie RIMM, TASR oder TZOO, d.h. im dreistelligen Bereich......

Man sollte auch beachten, ob weitere Institutionelle einsteigen. Sieht man bei http://www.nasdaq.com unter Institutional Holdings!!!!

Überlege mir, shortterm noch mal 1000 ins Depot zu legen
und Sie freitags wieder abzustoßen.....

Mal sehen, ob man Morgen welche ergattern kann!!!!

[roger11]

im Yahoo-Board rasten die Amis völlig aus. " God bless A......."......und son Zeugs...

nachbörslich bei inet bereits 5.10 $, wie man liest.
Kurse um 10 $ werden da gehandelt...

nun ja...

[[KERN]Codex]

huhu leute, das sind die besten news die ich dieses jahr gehört habe

[opelmanta3]

ALTI auf 5 jahreshoch (zubesten bubble zeiten)

XDSL (nanograss batteries mphasetech.com ) hat noch 500% spiel nach oben

[Bauernpizza]

warum sollte xdsl davon profitieren wie hoch sind deren Schulden?Gewinn?Verlust Umsatz?....


Gruß Bauernpizza

[telltom]

Man muß bedenken, das XDSL im OTB-Board notiert wird. Institutionelle kaufen XDSL noch nicht da sie nicht an der Amex oder direkt an der Nasdaq notieren.

XDSL ist eine Zockeraktie.....

[opelmanta3]

XDSL: wenn mann dann noch auf ein NASDAQ relisting spekuliert spechen wir sovieso von ganz anderen preisen...

wenn erstmal die $1 geknackt ist...



aufjedenfall ist NANOTECH die nächste ganz dicke sache....

hier noch mehr player:

EMFP (nanomasken / filtration ---> für army etc)
ARWR "allround nano" optionsschein auf diverse nanosparten
FEIC "TOOLS for NANOtech" (quasi die CSCO für nanotech)
NANX nanomaterials
HGCP ----> venture capital (wie TINY)

CBMX
TGAL

lecker NANOs

[borti]

ein bekannter Börsenbrief hat soeben altair zum Kauf empfohlen. Mal schauen, wie lange der Kurs noch steigen wird!

[opelmanta3]

www.donpenny.com

[Casson]

Hallo Jungs und Mädels,

Vor dem Hintergrund, daß die neu entwickelten Lithium-Titanium-Akkus insbesondere für den weltweit immer noch wachsenden Mobile Phone Markt (sog. Handys) wie gerufen kommen (3 mal längere Sprechzeit, Wiederaufladung in Minutenschnelle), dürfte die begründete Annahme einer raschen Kurskonsolidierung fürs erste wohl nicht auf der Tagesordnung stehen.
Das wirtschaftliche Potential und die damit ausgelöste Kursphantasie erscheint mir momentan dafür einfach zu gigantisch!
Ich denke, daß diese Akkumulatoren in naher Zukunft, und die auf Innovation getrimmte Technologiebranche wandelt sich ja bekanntlich rasend schnell, bereits den Standard in diesem Nano-Technologiezweig bilden werden.
Ich sehe deshalb für dieses Produkt eine wahre Umsatzlawine losbrechen!

Casson

[[KERN]Codex]

De USA rüstet sich mit Staub.. erm Nanosaugern
ALTI zieht durch bis 20$ (!)

[[KERN]Codex]

5,6$

[borti]

Habe mir nicht gedacht, das ich so schnell 20% machen werde, aber auch schön. Ich hoffe es geht so weiter heute. Wird auf jeden Fall ein schönes Eröffnungsgap heute

[ZpunktOcker]

holla

[opelmanta3]

XDSL wilrd grade entdeckt .70

mPhase Researcher will report on Nanobattery at the Nano Science and Technology Institute
Friday February 11, 9:41 am ET


NORWALK, Conn.--(BUSINESS WIRE)--Feb. 11, 2005--mPhase Technologies Inc. (OTC: XDSL - News) today announced that its lead researcher, Victor Lifton, will present a paper, "Atoms to products - a nanostructured novel battery," at the Nano Science and Technology Institute Conference and Trade Show in Anaheim, California.
Dr. Lifton will report on the progress of the mPhase plan to fabricate nanotech-based batteries, which can generate electric current. The project is based on a joint program with Bell Labs, the R&D arm of Lucent Technologies.

The novel battery is based on a Bell Labs discovery that liquid droplets of electrolyte will stay in a dormant state atop microscopic structures called "nanograss" until stimulated to flow, thereby triggering a reaction producing electric current.

"We are especially excited about the ability to use various battery chemistries and take advantage of the special characteristics of Nanograss," Lifton said.

Future batteries based on this technology have the potential to deliver far longer shelf life and better storage capacity than existing battery technology. Potential initial applications for this technology may include defense, industrial, healthcare, and consumer electronics. mPhase is also targeting the nanobattery for use in a technically-improved, lighter

[opelmanta3]

http://biz.yahoo.com/bw/050211/115250_1.html


XDSL .75

[Klardoch]

@casson,
Keine Frage ,das Marktpotential der Lithium-Titanium-Akkus ist durchaus beachtlich.Überdies scheint es ja bereits verbindliche Abkommen mit einigen "führenden Produzenten" zu geben,wenn man den Ausführungen von ALTI vertrauen darf.Aber was hälst du denn von XDSL?Scheinen doch auch kurz vorm Durchbruch zu stehen und sind zudem nur mit einem Fünftel der MK von ALTI bewertet.Also warum diese Versteifung auf ALTI?
Für eine Einschätzung wäre ich dankbar...

[opelmanta3]

VIDEO:

http://www.sciencentral.com/articles/view.php3?type=article&…

[MrRipley]

für welche Anwendungen sind die Akkus gedacht?

[[KERN]Codex]

Alle nur erdenklichen AKKUS

[balboa]

@mrripley:
für anwendungen jeder art.
jedes handy, notebook wird sich in zukunft mit den dingern von altair schmücken. die akkus sollen sogar für den selben preis zu haben sein wie die jetzigen akkus.
also? welcher handy bzw. notebook-hersteller wird so einen herkömmlichen akku in sein gerät reinstecken wenns auch besser geht???...undzwar mit den akkus von altair.
also wenn das kein selbstläufer wird dann weiss ichs auch nicht. dann glaube ich habe ich an der börse nichts verloren! aber...
abwarten und die show genießen und auf keinenfall ein einziges stück von altair abgeben!
da wird richtig kohle in die kassen fließen!
wird eines der highflyer 2005!
werdets alle sehen!

[Ozonloch]

Für wie unwahrscheilich haltet ihr es, dass das bestehende Gap noch geschlossen wird?

güße

[[KERN]Codex]

Das GAP wurde doch geschlossen!

[[KERN]Codex]

balboa,


stellt sich nur die frage wann die kohle fließt

[Ozonloch]

Das Werkeln an meiner Diplomarbeit scheint meine Hirnzellen völlig zu benebeln....Verzeihung.

[[KERN]Codex]

@ozonloch,

macht doch nix


Altair Nanotechnologies Inc.(WKN: 902 675),

ist ein Unternehmen der Nanotechnologie. Es werden Nanomaterialien und Beschichtungen hergestellt, Nanoröhrchen her in denen sich Wasserstoff speichern lässt (Brennstoffzellentanks). Auf der Web-Site des Unternehmens wurde gestern eine Pressemitteilung veröffentlicht. Das Unternehmen, so schreibt es, habe einen Durchbruch bei Materialien für Lithium Ion Batterien erzielt, der eine neue Generation von wiederaufladbaren Batterien ermöglicht, die in den Markt eingeführt werden können. Die neuen Materalien erlauben wiederaufladbare Batterien zu produzieren, die drei mal die Kraft von existierenden Lithium Ion Batterien hätten und dies zum gleichen Preis, so das Unternehmen. Nach 14 Preisfeststellungen konnten die Aktien der Firma ein Plus von über 61 Prozent erzielen.

financial.de


..also warten wir auf verträge und sonstiges

Altair ist mit Sanyo und co. schon im Gespräch, denke ich


gruß codex

[opelmanta3]

[opelmanta3]

NEUE NEWS bei XDSL:



Februar 11, 2005

Firm Says Nanobattery For Mobile Devices Coming Soon



By Jim Nash Courtesy of InformationWeek

A telecom technology provider says it`s 12 to 18 months away from having a commercially available battery based on nanotechnology. Such a nanobattery could conceivably power anything that uses ordinary batteries, such as cell phones and PDAs.
The company, mPhase Technologies Inc., is using a discovery by Lucent Technologies to design batteries that can sit in their packages for decades, be activated instantaneously, and outlast conventional batteries. MPhase foresees using the batteries in everything from battlefield equipment to consumer electronics.

Lucent`s R&D unit, Bell Labs, found that liquid droplets of an electrolyte--a variety of nonmetallic electric conductor--and microscopic material called nanograss can be used to produce an electric current.

Last March, Lucent licensed the technology to mPhase, which is developing it into a commercial product. The company hasn`t said how much a nanobattery would cost or if such a battery would come in the familiar forms of conventional batteries.

Among mPhase`s other products is the TV+ platform, which distributes digital TV, high-speed Internet access, and phone service over existing copper phone wires.


http://informationweek.mobilepipeline.com/news/60400300

[opelmanta3]

strong buy:
http://quote.barchart.com/texadv.asp?sym=XDSL


sell:
http://quote.barchart.com/texadv.asp?sym=alti

[[KERN]Codex]

Auf w:0 können die wenigsten LESEN

Genesis Air Introduces Innovative System Employing Nano-Titanium Dioxide Produced Using Altair`s Patented Manufacturing Process

RENO, NV. – February 8, 2005 – Altair Nanotechnologies, Inc. (NASDAQ:ALTI) [profile] announced today that it is partnering with Texas-based Genesis Air to produce specialized surface activated, nano-sized titanium dioxide compounds for use in an innovative HVAC air cleaning system. The system, based on Genesis Air Photocatalysis (GAP™) technology, is marketed by Genesis Air domestically and internationally.

[balboa]

@codex:
die firmen werden versuchen so schnell wie möglich mit altair verträge abzuschließen.
spätestens nach dem 1Q-bericht 2005 gehen wir ab. kurzfristig könnte es noch ein wenig runter gehen.
aber mittel bis langfristig ist dies ne goldgrube.

@opelmanta:
mag schon sein dass altair in dem link was du reingestellt hast zum verkauf angeboten wird.
Ist ja auch normal nach einem solchen kursanstieg.
nichtsdestotrotz sehe ich in altair mehr potenzial als bei xdsl.
das wird ein tenbagger!
mir sich bin.
gruß
balboa

[[KERN]Codex]

könnte auch weiter aufwärts gehen, denke nicht dass wir noch großartig konsolidieren, aber wir werden sehen

[[KERN]Codex]

Scheiss auf XDSL, wenn die kommen haben alle schon die Batterien von ALTI XDSL spricht von 2006, ALTI von Anfang 2005


1. In July, officials at Altair said that 1-3 batteries will be released around February, according to Reno Gazzette-Journal.

2. In January, two US patents for battery materials are just awarded. Now the technologies are protected.

3. National Science Foundation sponsored an August-January Research on the battery materials. It is just concluded very positively. An additional $500,000 NSF fund is now under consideration. The main goal is to provide batteries for automobile industry.

3. Dr. Michael Graetzel joined the company. He is a top top 50 most cited scientists in the world. A published author of more than 500 publications, two books and over 40 patents. Dr. Michael Graetzel is currently a Professor at the Swiss Federal Institute of Technology in Lausanne, where he directs the laboratory of Photonics and Interfaces. He has pioneered research in nano-materials, in particular the field of semiconductor nanocrystallites and mesoscopic oxide films and their energy and display-related applications. His extensive research and development track record includes the development of new ionic liquids, used as "green" electrolytes, and high power lithium ion batteries based on mesoporous films. He has also discovered a new type of solar cell based on dye sensitized nanocrystalline oxide particles, which could ultimately prove a new and viable alternative energy source.

A published author of more than 500 publications, two books and over 40 patents, Dr. Graetzel counts amongst the top 50 most cited scientists in the world. He has been an invited professor and lecturer at the University of California at Berkeley, the University of Tokyo, the Ecole National Supérieur de Paris, the Delft University of Technology, and more than one dozen other leading institutions. He has received numerous awards including the Millennium 2000 European Price of Innovation, the 2001 Faraday Medal of the British Royal Society, the 2001 Dutch Havinga Award, two McKinsey Venture awards in 1998 and 2002, the 2002 IBC award in Supramolecular Science and Technology.

4. Department of Energy granted a $672,000 fund to Altair in September, in addition to $356,000 granted before.

5. Dr. Ravi I. Thadhani, now working both at MIT and Harvard, joined the company.

6. Another European patent was awarded.

7. Department of Energy awarded another $400,000 grant to Altair in November.

8. Altair received an Australian patent in January.

9. Two companies licensed a Altair drug valued at about $2 million this year, and $15+ millions over 5-7 years. The potential is over $100M+.

10. Company just announced that battery matterials and other Altair technologies are "now coming to the commercilization stage".

11. The price of the battery is now estimated no more expensive than conventional batteries. This is a great competitive index!

12. Company, upon getting the first new US patent in January, immediately hired a senoir VP for SALES And MARKETING, to jump start its sales and marketing force. This is a great takeoff.

[opelmanta3]

tach zusammen...mir ist es egal wer zuert kommt....

ALTI oder XDSL#

habe beide aktien fett gebunkert...

nur ALTI ist bereits mächtig abgegangen...

XDSL hat 500% potential


aber hauptsache kohle...womit ist ja egal....

[Ozonloch]

4,40$ Schlußkurs
Dollar um 1 cent gestiegen im Vergleich zu Freitag

entspräche ungefähr einem Kurs von 3,39 €

Frankfurt ist ganz schön mutig.

[[KERN]Codex]

ozonloch, du musst das ganze nicht so subjetiv betrachten, guck mal auf singapur und in den ami boards geht auch die post ab, obwohl die eigentlich schlafen sollten

[Canadian2000]

Bin bei 3,76(mit kleinem Verlust:-( raus und geh heute nicht über 3,50 wieder rein!

[borti]

Heute verkaufte der Börsenbrief dei Aktie Altair wieder. Managemnet soll ein wenig dubios sein. Ähnliche Meldungen wurden schon des öfteren gebracht. Vorsicht ist geboten.

[balboa]

@borti:
sogar wenn hitler im management drin wär...
du, die aktie wird ein selbstläufer.
von welcher vorsicht sprichst du eigentlich.

[Dream]

welch seriöser Börsenbrief
Altair hat bis jetzt noch nie eine ihrer Versprechungen erfüllt.
Verkauft den Laden, bevor es zu spät ist...
gutgemeinter Ratschlag

[balboa]

welche versprechung???
das sind fakten!verstehe euch alle nicht!
da entgeht euch was.

[Ozonloch]

Hab selten so ein wahnwitziges Kursfeuerwerk gesehen.

[balboa]

aktuell ein +von 4,8% in us

[balboa]

das sind noch einstiegskurse!
aber mir egal. verpassen tut ihr was.
nicht ich.

[Casson]

@borti

Managemnet soll ein wenig dubios sein

Was sollen denn diese nebulösen Andeutungen???

@Dream

Altair hat bis jetzt noch nie eine ihrer Versprechungen erfüllt.

Und auch hier hätte ich gerne mal "Futter bei die Fische"!!!

Casson

[[KERN]Codex]

casson,


der hat einfach kein plan welche leute da mitwirken, die sitzen an einem ganz großen hebel und wenn borti stress macht bekommt er keine baterien mehr

Bin ich der einzige der auf INFOS scharf ist???

Altair Nanotechnologies, Inc. Announces Fourth Quarter Financial Results Conference Call
Monday February 14, 8:30 am ET


RENO, NV--(MARKET WIRE)--Feb 14, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) announced today that it will hold a quarterly conference call to discuss fourth quarter and year-end financial results for fiscal 2004 on Thursday, February 24, at 11:00 a.m. Eastern (EST). Shareholders and members of the investment community are invited to participate in the call.
The conference call dial-in number for U.S. callers is 888.245.7013 and the dial-in number for international callers is 973.582.2732. Please dial into the conference 10 minutes before the call is scheduled to begin. As lines are limited, please RSVP your participation by calling Suzanne Schnitzer at McCloud Communications, 949.553.9748. A replay of the conference call will be available until March 3, 2005, and can be accessed by dialing 877.519.4471 and entering conference number 5721762.

Additionally, the conference call is being webcast by ViaVid Communications and can be accessed by visiting www.viavid.net/detailpage.aspx?sid=00002296 or Altair`s web site.

http://www.altairnano.com

[[KERN]Codex]

10:43:25.597

[[KERN]Codex]

hab ich ja fast richtig getimed, die Zeit (0,6sekunden, ladezeiten bei w:o sind laenger deswegen)



4,49$

[[KERN]Codex]

Warten wir bis Donnerstag, dann gibt neue News

[[KERN]Codex]

ALTI hat sein meinem Post um über 10% zugelegt

[Dream]

@casson

man achte auf das Datum

Altair Announces Battery Material Breakthrough
CODY, Wyo., Oct 16, 2001 /PRNewswire via COMTEX/ -- Altair Nanotechnologies Inc. (Nasdaq: ALTI) today announced results from the cooperative work program it conducted with the J. Heyrovsky Institute, Prague, Czech Republic and Ecole Polytechnique Federal de Lausanne (EPFL), Switzerland. Early evaluation of the report indicated that the results achieved in energy storage far exceededexpectations, and verified the potential of Altair`s nanosized lithiated titania to charge and discharge at rates that are orders of magnitude higher than more conventional material.

This ability to deliver energy at such high rates and to recharge in such a short time offers a new and revolutionary tool to battery manufacturers seeking solutions to battery requirements for solar cars, fuel cell drives, hybrid vehicles, and other growing markets for portable power.

In his comments, the Principal Investigator, Dr. Ladislav Kavan, noted, "The strong point of our work is, that we are dealing with a broad array of materials of varying surface area (particle size) but with identical chemical composition." He goes on to say, "Our conclusions about the dependence ofelectrochemical parameters on the surface area are well supported, and of general validity." Tim Spitler, Director of Research for Altair and author of the research design in conjunction with Dr. Kavan said, "Dr. Kavan`s work is a marvelous verification of the value of the ability to control particle size andquality afforded by the Altair process. We are currently reviewing the report carefully for patentable and publishable discoveries."

"The cooperation and teamwork between Tim Spitler and his research team and Dr. Kavan was remarkable," said Ken Lyon, president of Altair Nanomaterials Inc. Both Dr. Kavan and Mr. Lyon credited the EPFL and its staff for providing the necessary infrastructure, stimulating work environment, and assistance. The research program was done under the overall direction of Professor Michael Graetzel of the EPFL, Switzerland. Dr. Graetzel is one of the world`s most honored scientists in the fields of photoelectronics and electrochemistry.

The study was partially funded by Xoliox, SA. Switzerland, a battery technology company which has several ongoing research programs with both EPFL and the J. Heyrovsky Institute. In an October 5th, 2001 press release, Xoliox stated, "Xoliox`s recent research of these new nanomaterials, which was conducted in conjunction with Professor Michael Graetzel (Lausanne, Switzerland), revealedcharge and discharge rates that are more than 100 times faster than conventional lithium ion battery technologies, enabling the battery to be fully recharged in under one minute." A meeting has been scheduled in the near future between Altair and Xoliox to review the findings of the report and chart a path for future development activities between the two companies.

This is an example of nanoparticles as an enabling technology in a potentially very large market. Altair is positioned to supply commercial quantities of unique nano lithium titanate materials to this developing worldwide market.

Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies` corporate goal is to become the leading supplier of nanomaterials worldwide through product innovation in a new science. Altair owns a proprietary technology for making nanocrystalline materials of unique quality,economically in large quantities. The company is currently developing special nanomaterials with potential applications in fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. Altair holds mineral leases on a "world class" titanium mineral sand deposit in Tennessee where the recently constructed pilot plant is operational.

This press release may be deemed to contain certain forward-looking statements with respect to Altair that are subject to risks and uncertainties that include, but are not limited to, Altair`s ability to obtain necessary capital, performance and reliability of technology, market acceptance of products usingAltair technology, variance in anticipated production costs and unanticipated effects of regulatory requirements related to the technology, as well as those identified in the Company`s press releases or discussed from time to time in the Company`s Securities and Exchange Commission filings. Actual results may vary materially.

[balboa]

@dream:
und dann?

[Casson]

@Dream

Danke!

Aber das ist doch auch schon fast 3 1/2 Jahre her, also sozusagen "alte Kamellen"!!!

Casson

[dickson]

HIER IST WAS OBERFAUL !!!

VORSICHT vor Altair,dem Verfasser dieses Thrads sei die isonics Aktie ans Herz gelegt ....

[balboa]

@dickson:
was soll denn da bitte oberfaul sein?
ich denke du bist einer von denen die es immer noch nicht gecheckt haben worum es hier geht was?
dass ding is +17% in den usa nach einem anstieg von über 115% am donnerstag.
also?
das wars noch lange nicht!
wirst dich noch grün ärgern wenn du jetzt nicht einsteigst bei altair!

[cripplecreek]

http://finance.yahoo.com/q/mh?s=ALTI

falls es noch keinem aufgefallen sein sollte...es haben sich bereits einige große fonds fett in den wert eingekauft. das beste zeichen, dass das weit mehr als eine fluffy-news war. also go long!

[Dream]

@balboa,
eine Firma kritisch zu hinterfragen hat noch nie geschadet.
Und wenn Du die rosa Brille abnimmst, kommst Du zum gleichen Ergebnis. Manche Kommentarte von Altair waren in der Vergangenheit sehr optimistisch ums mal freundlich auszudrücken und mussten wieder relativiert werden.
Ich wünsche denjenigen, die nicht davon lassen können, sich nicht die Finger zu verbrennen.

Das war mein letzter Kommentar zu diesem Wert.

P.S.
Man sollte sich an der Börse niemals von Emotionen leiten lassen.
gecheckt?
:-)

[[KERN]Codex]

[balboa]

@dream:
ich freu mich dass dies dein letzer beitrag war in diesem tread.
da bahnt sich was ganz großes an.
würd mich mal interessieren welche misstaktien du in deinem depot hast.
aber naja...

altair? yes! but long. no short.

[[KERN]Codex]

Bei ALTI sind diese Woche Kurse um 10$ möglich

[[KERN]Codex]

Conference Call ist am 24. (Donnerstag) 1100 am.. nicht diese Woche

[Ozonloch]

Ich dachte immer ich bin des Englischen einigermaßen mächtig, aber mit diesem Abschnitt komm ich nicht ganz klar. Vielleicht kann jemand helfen...

Re: Registration Statement on Form S-3

We have acted as Ontario counsel to Altair Nanotechnologies Inc., a corporation incorporated under the Canada Business Corporations Act (the "Corporation"), in connection with the preparation of the Corporation`s Registration Statement on Form S-3, File No. 333-111416, (the "Registration Statement") for the registration under the Securities Act of 1933, as amended, of up to 5,000,000 common shares (the "Common Shares") of the Corporation for sale from time to time by the Corporation. In connection with the opinions hereinafter expressed, we have conducted or caused to be conducted such searches as we have considered necessary, advisable or relevant.

[Ozonloch]

...für den Kurs gibt es jedenfalls bessere news, als die, dass demnächst 5.000.000 neue Aktien auf den Markt kommen...hmmm. Andereseits würde diese bei der momentanen Liquidität überhaupt nicht ins Gewicht fallen.

[[KERN]Codex]

Altair Nanotechnologies, Inc. Announces Shelf Registration Closing
Tuesday February 15, 9:29 am ET


RENO, NV--(MARKET WIRE)--Feb 15, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) announced today that it has entered into definitive agreements with respect to the sale of five million shares of its common stock to institutional investors at a price of $4.05 per share, for gross proceeds of approximately $20,250,000. Following closing of the financing, which is expected to occur today, Altair expects to receive approximately $19,237,500 after deducting all fees and expenses. With the completion of the placement, Altair will have 56,794,724 shares of common stock issued and outstanding. Maxim Group LLC is acting as placement agent for the transaction. As consideration, Maxim Group LLC is entitled to receive a cash fee equal to 5% of the gross proceeds from the offering and a warrant to purchase 250,000 shares of common stock at an exercise price of $5.265 during a four year term, and is subject to one demand registration right and unlimited incidental registration rights.
ADVERTISEMENT


The proceeds will be used for general corporate purposes, including, but not limited to, working capital, capital expenditures, research and development activities and the acquisition of other technologies.

[Ozonloch]

....dann hält sich der Kurs ja noch ganz gut. Fragt sich nur wie lange. für 4.05$ hätte ich auch gern welche..

[roger11]

sagen wir mal so: es gibt schönere Nachrichten..

but what shalls:
mag es den Shorties als kurzfristige Steilvorlage willkommen sein, eines jedoch ist ab jetzt auch offensichtlich geworden: der momentan schwer einzuschätzende Fair Value.

wenn ein Käufer die $ 4.05 hinblättert....

capiche ?!?..

[balboa]

wenn ihr mich fragt war des ein fond der da fett eingekauft hat.
morgen gehts steil rauf!
fakt ist: wir haben geile news bekommen! die ersten lizenze sind unter dach und fach, kein akku bzw. batteriehersteller kann es sichs leisten nicht bei altair anzuklopfen.
oder seid ihr da anderer meinung?
am donnerstag und nächste woche gibts statements von altair.
danach werden wir weitersehen.
die steigen schon wieder!

[balboa]

@roger11:
hast ne Bordmail!

[dickson]

Diese Aktie ist die vielleicht am meisten unterbewertete am Nasdaq NMN. Hier ist die Luft noch lange nicht raus und es wird auch keine Blase platzen. Das Chance-Risiko-Verhältnis ist extrem günstig. Tiefer kann es bei dem KGV eigentlich gar nicht mehr gehen. Es hat sich inzwischen ein Boden ausgebildet. Wenn der Widerstand durchbrochen wird, dürfte die Aktie explodieren. Das sind absolute Einstiegskurse.

Günstiger wird die Aktie nicht mehr zu haben sein. Die 10.000%-Chance. Wer jetzt nicht kauft, ist selber Schuld. Morgen kommt möglicherweise eine Ad-Hoc-Mitteilung. Ein Branchenkenner hat mir erzählt, dass bald weitere Hammernews zu erwarten sind. Die Infos sind aus absolut zuverlässiger Quelle. Die Aktie ist ein klarer Kauf. Ein kommender Highflyer, der zur Zeit fundamental stark unterbewertet und charttechnisch sehr interessant ist.

Die Aktie wird vielleicht sogar die neue General Electric. Man sollte kaufen, bevor der Zug abfährt. So billig wird es den Wert vielleicht nie wieder geben. Am besten sofort einsteigen. Es handelt sich um eine absolute und bisher noch unentdeckte Perle. Die Zocker sind längst raus. Auch die zittrigen Hände sind draußen, jetzt kann es nur noch aufwärts gehen. Der Kurs wird derzeit noch künstlich niedrig gehalten. Da kaufen zur Zeit offenbar Fonds. Es werden große Stückzahlen eingesammelt. Ich habe heute noch einmal nachgekauft.

Die Entwicklung verläuft genauso, wie ich es vorhergesehen habe. Wenn der Kurs aufgrund von Gewinnmitnahmen noch einmal fällt, werde ich weiter kaufen. Die Aktie wird garantiert steigen. Dem Vernehmen nach sollen derzeit mehrere Kaufstudien in Arbeit sein, u.a. von verschiedenen internationalen Investmentbanken, die in Kürze veröffentlicht werden. Fast alle Analysten haben den Wert inzwischen auf aggressiv kaufen gestellt. Sehr wahrscheinlich dürfte die Aktie am Freitag auch in verschiedene 3sat-Depots aufgenommen werden sowie in zahlreiche Musterdepots von Börsenbriefen.

Es gibt zudem im Markt Gerüchte, dass mehrere Akquisitionen anstehen und ein Listing am S&P 500 erwogen wird. Zudem sollen die Planzahlen für die Jahre 2005 und 2006 bald drastisch angehoben werden.Übrigens hat mir jemand aus Kulmbach erzählt, dass in der nächsten Ausgabe von „Der Aktionär" wahrscheinlich ein mehrseitiger, sehr euphorischer Bericht erscheinen soll. Mal sehen, ob auch n-tv heute noch was bringen wird.

Mein Kursziel: konservativ geschätzt, 1000 US-$

Fazit: Unbedingt sofort kaufen !!!!!!!!!! Die Rakete wird in Kürze zünden !!!!!!!!!!!!!!!!!!!!!! Der Kurs geht dann durch die Decke !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

[[KERN]Codex]

dickson = dummpusher

[Klardoch]

Aber sonst geht´s dir gut?!Von welchem KGV spricht´s du bitte,und wie kommst du auf so ein vermessenes Kursziel?
Mein Tip:Mach ne Hotline auf

[balboa]

hallo dickson!
ich hoffe wir können noch freunde werden!
sorry für den beitrag vorhin!wollt ich nich.

endlich haben wir mal dieselbe meinung über altair!

aber 1000$...na na na! reichen 100$ nicht?

mfg
balboa

[[KERN]Codex]

Merckt ihr denn gaarnix?

[balboa]

@kerni:
merke nur dass bald ein rießen feuerwerk stattfindet...
unr ich merke dass ich das auch spüren werde...
was soll ich noch merken?

[Casson]

Ich bin eigentlich recht optimistisch zu Altair eingestellt, und bewerte die erfolgreiche Kapitalerhöhung positiv!

Aber das, was der User "dickson" in seinem Posting #223 von sich gegeben hat, läßt mich stark annehmen, dass er seine Verkaufsorder inzwischen beim Makler schon platziert hat - vermutlich um die 3,50 Euro je Aktie, und daß er aus dem Papier nur noch so schnell wie möglich rrraaauuusss will!

Liebe Grüsse an alle Altairaner von

Casson

[jog_]

3004 Form 8-K dtd Feb 15th---

[[KERN]Codex]

huhu balboa

naa dicksons sein sarkasmus, der meint das doch garnicht so todernst wie er es schreibt

1 QQQQ NM 29,765,339 38.2470 13:09:02.3 1,147 +0.3780 +1.00
2 INTC NM 15,642,897 24.5200 13:09:08.8 1,252 +0.2100 +0.86
3 JDSU NM 11,436,448 2.0330 13:09:02.9 855 +0.0630 +3.20
4 MSFT NM 10,870,797 25.9600 13:08:55.9 1,435 -0.0500 -0.19
5 CSCO NM 10,375,249 17.9900 13:09:07.6 1,512 +0.0200 +0.11
6 AMAT NM 9,940,269 17.4000 13:09:09.0 720 +0.2700 +1.58
7 AAPL NM 9,326,698 87.4700 13:09:08.9 474 +2.8400 +3.36
8 SPY AM 9,194,743 121.1900 13:09:06.3 1,098 +0.5100 +0.42
9 ALTI SC 8,037,985 4.3500 13:08:53.2 399 -0.6000 -12.12


=> Ich sehe die Kapitalerhöhung auch Positiv, es kauft ja keiner mal eben für 20 MIO $ Aktien wenn da nix weiteres im Anmarsch ist (!)

[jog_]

Form 8-K dtd Feb 15th---
http://ir.10kwizard.com/filing.php?repo=tenk&ipage=3273046&a…

[dickson]

Hallo liebe WO-Gemeinde,

zunächst möchte ich dickson gratulieren, der diese geniale Aktie entdeckt hat. Ich werde sie selbstverständlich in mein Musterdepot aufnehmen. Ich kann allerdings das Kursziel von dickson und das meines Kollegen Förtsch absolut nicht nachvollziehen. Deshalb halte ich dagegen: 5.000 Euro!

Euer Egbert Prior

[balboa]

wer um gotteswillen ist dieser mann?
Egbert Prior? kenn ich nicht!
wer bist du?

[balboa]

ausserdem ist es mir saccomancetti was andere hier schreiben!
wichtig für mich ist das altair sagt und offiziell bekannt gibt.
nach der nächsten news werden wir wieder nen fetten kurssprung sehen!
wichtig ist, dass diese entdeckung bzw. forschung gemacht wurde und auch patente bzw. verträge schon unter dach und fach gebracht worden seien!
alles andere, mir saccomancetti.

auf steigende kurse morgen!!!

gruß an alle die an altair glauben und setzen!
balboa!

[cripplecreek]

Geduld, geduld...Rom wurde auch nicht an einem Tag erbaut. Der Umsatz war weitaus niedriger, als die letzten Tage. Dass vielleicht einige Investoren enttäuscht sind über die News heute, kann ich verstehen. Schließlich haben ein paar Große weniger bezahlt. Aber...gerade das sollte dem seriösen Investor zeigen, dass mehr als nur ein wenig Dynamik in dem Unternehmen steckt. Allein die tatsache, dass Barclays seit 14.02. mit über 500K an Aktien dabei ist, sollte jeden auf den Kaufen-Knopf drücken lassen. Bei einem geschätzten Marktpotenzial von 17Mrd Dollar für LI-Batterien, ist bei einem frühen Markteintritt der Nanobatterie von Altair die Marktkapitalisierung von 200Mio ein witz.

[[KERN]Codex]

Sehr konstruktives Posting cripplecreek

Ein paar AMIS sind enttäuscht, dass die 5 MIO so billig verkauft wurden, aber der Kurs hält sich über 4$ und ich denke das wird auch so bleiben, da alle gespannt auf nächste Woche warten und zunehmend mehr Leute das enorme Potenzial in ALTI entdecken

[roger11]

Dickson untertreibt masslos in seinem posting #223.

er wollte eigentlich " Kursziel 2006 = 10.000 $ " schreiben, dann pfiff ihn doch seine Alte zurück und meinte:

" Schatz, lass uns zu Bett gehen. Ausserdem hattest Du mir versprochen,
in Zukunft nicht mehr all die Idioten da draussen von der unendlichen Weisheit
Deiner Glaskugel teilhaben zu lassen. Es reicht, wenn ich.....ähhhhh, wir verdienen. Komm jetzt. "
Dickson hackte seufzend das Kursziel 1.000 $ in sein Powerbook, ging offline
und anschliessend in die Gemächer seiner Frau - nicht, ohne vorher einen Blick auf die Kugel zu werfen,
in welcher ein angeblasster Goldfisch in trübem Wasser mehr oder weniger opportun seine Runden drehte.

[[KERN]Codex]

Nun hakkkkt doch nicht alle auf dem Armen rum

[[KERN]Codex]

huhu,

guckt mal hier:


Top Institutional Holders:

Barclays Bank Plc 580,872 1.17 $2,875,316 14-Feb-05
Hussman Econometrics Advisors, Inc. 565,800 1.13 $2,800,710 14-Feb-05
Vanguard Group, Inc. (The) 272,347 0.55 $1,348,117 14-Feb-05
Condor Capital Management 125,900 0.25 $623,205 14-Feb-05
Northern Trust Corporation 55,622 0.11 $275,328 14-Feb-05
Reynolds Capital Management 51,000 0.1 $252,450 14-Feb-05
Mellon Bank, N.A. 50,800 0.1 $251,460 14-Feb-05
Merrill Lynch & Co., Inc. 46,720 0.09 $231,264 14-Feb-05
Calpers (California-Public Employees Retirement System) 28,250 0.06 $139,837 14-Feb-05
State Street Corporation 27,400 0.05 $135,630 14-Feb-05

Top Mutual Fund Holders:

Hussman Investment Trust-Hussman Strategic Growth Fund 565,800 1.13 $2,800,710 14-Feb-05
Reynolds Fund 35,000 0.07 $173,250 14-Feb-05
Reynolds Opportunity Fund 16,000 0.03 $79,200 14-Feb-05
Spartan Extended Market Index Fund 15,064 0.03 $74,566 14-Feb-05
Quantitative Master Series Tr-Extended Market Index Seri 8,900 0.02 $44,055 14-Feb-05

[roger11]

CODEXKERN !

ich hacke nicht auf dem Kerl herum, ganz im Gegenteil !

wenn er sich selbst als Alter Ego benutzt, ist es wohl erlaubt, die Sache noch auf die Spitze zu treiben.

seinen Sarkasmus bzgl. hypender Lemminge, die im Geiste bereits jetzt auf den Bahamas leben, kann ich nur unterstreichen.

[balboa]

@roger:
das über dickson und seiner frau...
ja, is ja cool...

sachliches:
wieviel mrd $ marktkapazität haben die akkus?
und für alle hat altair die patente und lizenzen in der tasche???
is das richtig?


mir hauts gleich die augen raus!!!
mir schwindlig werd

die 4$ halten morgen! sehen morgen die 5 wieder!
aus amen!

[roger11]

verdammt, Balboa

wie lange biste schon im Geschäft ?!? weisst Du, wie viele Companies ich schon hab´ nach unten abrauschen gesehen ?? und never seen again ??

also, der Ball darf die Grashalme nicht verlassen im Kopf eines Anlegers.
nicht alles cash auf ein Fohlen setzen, capiche ?

wenn´s gut geht - und das wird man im Laufe der Zeit schon mitkriegen -
kann man immer noch was nachlegen.

keep man

Gruss
R.

[[KERN]Codex]

Hab ich ihm auch schon gesagt, lieber das Geld streuen (!)

Altair’s Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. Altair`s Performance Materials Division is pursuing market applications in Advanced Materials for Paints and Coatings, Advanced Materials for Improving Process Technologies, Advanced Materials for Alternative Energy, and other high performance material applications.

The company also boasts a proprietary, leading technological platform for the commercial manufacture of a wide variety of ceramic oxides, including metal oxides, metal titanates and combination crystals, all of which can range in structure from hollow to porous.

This patented platform, scaleable across all industries, is UNIQUE in the marketplace, providing precision control of composition, chemical purity, and particle size.

More on:

http://www.altairnano.com/framesets/devlpmt_unique_frmset.ht…


..ja der dickson, purer sarkasmus, kann man ihm ja nicht verübeln!

[[KERN]Codex]

balboa,


lese dir das erstmal durch bevor du alles auf grün setzt

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3276…

Hier ein Auszug (Seite 2)

Advancements in these nanomaterials may ultimately be paired with
advancements in the electrolyte`s ability to carry high current density and
result in batteries that can yield high power and recharge in a shorter time
than currently available batteries. In laboratory experiments, nano-sized
specialty materials have accepted a full charge within less than one minute;
however, further development with a strategic partner in the battery industry
will be necessary before a marketable product could be developed.

=> Anwendungen in folgenden Bereichen:

We believe
that this technology has the potential to become a key component of rapidly
recharging high energy batteries that would be used in standard automobiles,
electric vehicles, and hybrid automobiles; battery-powered power tools; fuel
cells; and solar generation systems.


Recent Developments

In August 2004, we began work under a $100,000 Small Business Innovative
Research grant awarded by the National Science Foundation to fund joint
development work on next generation lithium ion power sources with Hosokawa
Micron`s Nanoparticle Technology Center and Rutgers University`s Energy Storage
Research Group. The work was completed in December 2004 and a report issued on
it in January 2005. Our research indicated that our materials provide a
significant improvement over conventional materials in lithium ion batteries. As
a result, we have submitted a proposal for a second phase project totaling
$500,000 to continue and expand the work of phase 1 by making cathode materials
for use with anode materials already produced. We have also submitted a proposal
for another project in the amount of $100,000 to improve the manufacturing
method for the materials to make it more scalable and efficient. We expect
decisions on these proposals in July 2005. (!)

We have completed a series of tests in collaboration with the EPFL
Switzerland, Heyrovsky Institute in Prague, Czech Republic and the Xoliox
subsidiary of Ntera, a display and battery technology development company.
A joint patent was filed with Xoliox related to electrode performance of
nanomaterials made by Altair. We have extended a marketing agreement with
Nissho Iwai Americas Corporation for marketing this technology in Japan to
leading lithium ion battery manufacturers.

[balboa]

hi roger, hi kerni,

1. mal angenommen ich habe all meine kohle in altair investiert. oder mit all meiner kohle ein stopbuy für altair gesetzt.
frage: was wäre dabei so falsch bei diesen aussichten???
wollt ihr mich verarschen....???

warum seid ihr jetzt so confused???

[dickson]

Wenn ihr noch was zum streuen braucht ,dann hier:

http://www.nuclearsolutions.com

Aktie: NSOL.OB
Marktkapitalisierung: 30 Mio.US-$

Nsol arbeitet ebenfalls an der Nanobatterie,aber auch
daran,nuklearen Abfall zu neutralisieren !

Potential ohne Ende ....

[roger11]

um es auf den Punkt zu bringen:

ich hab in der BILD noch nie von nem Typen gelesen, dessen Lotto-Spiel selbst nach 30 Jahren gamblen erbärmlichstes Nothing hervorbrachte.

Sehr wohl prangert das Konterfei eines " Lucky Pencel Punchers " an allen Ecken der Republik, wenn´s einschlägt.

aber all die anderen Loser ?......kennt keiner


think about...

[balboa]

@dickson.
geh bis die soweit sind, sind wir mit altair schon über alle berge.

[roger11]

och Dickson,

ich dachte, Du pennst schon bei Deiner Ollen...

na gut, wenn Du schon mal auf bist, gib wenigstens dem armen Fisch was frisches Wasser...
oder soll er Dir die Kurse im Dilirium erzählen ?!?

nicht im Sinne der Hausherrin, schätze ich.
Das Neutralisieren nuklearen Abfall´s im atomaren Beziehungsbereich sollte aber in Deinem ureigensten Interesse sein !!!

[dickson]

Balboa ...

Wenn du schon Egbert Prior nicht kennst,bist du wirklich neu
am Aktienmarkt, was ? Keiner will dich verarschen,nur wir
haben mehr Erfahrung! Und Altair ? Gut,wenn ich noch Kohle
überhätt würde ich mich mir sicher eine kleine Position
gönnen,aber niemals alles,dazu ist es noch viel zu früh,du
weisst noch gar nicht was aus Altair wird,erst die Zeit wird zeigen .....

MFG

[[KERN]Codex]

danke für die info dickson

[roger11]

hat hier eben jemand Prior gesagt ???

wie wo was ? ist der aus England abgerauscht oder wie ?!?

wo ist der Kerl ? unter uns ?

wo ist meine Knarre...

[balboa]

wer sagt denn dass ich alles auf altair gesetzt habe oder setzen werde.
ist ein sehr sehr geiler titel der bei diesen gegebenheiten einfach laufen muss.
habe noch:
zur info jungs:dass ihr mal nen horizont bekommt:
1. sinovac
2. stopbuy nanogen
3. stopbuy altair
4. stoploss biophan

aber da habt ihr einerseits schon recht mit dem abwarten und tee trinken.
aber leute, überlegt dochmal, da steckt potenzial ohne ende drin. wie seht ihr denn die chancen von
top oder flop???
ich sage 90:10!!!

[roger11]

lieber Balboa,

bring reichlich Anlagehorizont mit für Dein überpacestes Nano-Basket,

und bete, dass Dickson´s Fisch lange lebt.

dann könnt´s was werden...

[[KERN]Codex]

1 Jahr minimum.. nur gucken und nicht traden

[junkbuster]

Altair erhöht das Kapital

16.02.2005 - Unser Tipp: Aktuelle Nanotech-News von www.4investors.de direkt in Ihr Mail-Postfach: hier klicken!!!

Altair Nanotechnologies hat 5 Mio. junge Aktien an institutionelle Investoren ausgegeben. Die Papiere wurden zum Emissionspreis von 4,05 Dollar platziert. Weitere 250.000 Aktien sind als Greenshoe platzierbar. Mit den Geldern soll der Kapitalbedarf des Unternehmens gedeckt und evtl. Akquisitionen vorgenommen werden.
( mic )

[[KERN]Codex]

Die Top 11 auf island.com

1 QQQQ NM 15,162,183 38.0930 11:22:27.2 1,179 -0.0470 -0.12
2 INTC NM 8,250,636 24.3200 11:22:22.9 1,168 -0.1500 -0.61
3 SPY AM 8,035,770 120.9900 11:22:24.4 992 -0.1400 -0.12
4 AMAT NM 6,953,399 17.6100 11:22:26.2 676 +0.1200 +0.69
5 JDSU NM 5,608,479 1.9630 11:22:08.9 884 -0.0570 -2.82
6 CSCO NM 5,047,499 17.8500 11:22:16.3 1,330 -0.0700 -0.39
7 NTAP NM 4,390,405 31.3400 11:22:27.1 209 -3.0200 -8.79
8 MSFT NM 4,322,576 25.8500 11:22:08.9 1,259 -0.0800 -0.31
9 AAPL NM 3,950,018 88.4500 11:22:27.1 458 +0.0400 +0.05
10 SMH AM 3,807,700 34.1950 11:22:23.2 364 +0.0950 +0.28
11 ALTI SC 3,540,961 4.6200 11:22:25.3 346 +0.4110 +9.76

[opelmanta3]

XDSL +20%
MIVT +40%

EMFP einstiegspunkt
HGCP einstiegspunkt ( www.icurie.com )

ARWR
CBMX
TGAL

nanunano

[opelmanta3]

nicht zuvergessen ein besonderes schätzchen:

CRII cellrobotics

.14 zu haben heute....chart ist sehr vielsagen....

CRII immer für nen 100% run zuhaben

einzuorden bei FEIC und NVEC

[[KERN]Codex]

Heute Morgen waren wieder Institutionelle am Werk denke ich, so wie die shortis da verhauen wurden hats mir richtig spaß gemacht in den AMI boards zu lauschen

Wäre ein gutes Zeichen wenns jetzt zu Handlsende nochmal weiter hochgeht

Aktuell bei 4,34$

[opelmanta3]

und für nanobiologen:

NNBP

GMED (gestern news zu cancer)

[balboa]

hi leute!
man braucht wirklich gute nerven für altair.
von +10 bis +1,5%!!! ZEFIX!
aber gut.

mal was anderes:
kennt einer die story von berkshire hathaway???
da kostet ein papier 69000€!!!
was ist denn da los???
kann mich einer aufklären???
Boardmail geht auch.

grüße
ps:morgen geht nanogen durch die decke!
hab mich schon positioniert.

[dickson]

Es ist ja nicht mal klar ,ob die Batterieindustie die neue Nanobatterie überhaupt gutheisst oder produzieren will !
Wenn die Altair-Batterie 3x solange hält,bei gleichem Preis,dann gehen doch wohl die Umsätze nach Adam Riese auf 1/3 zurück,oder wie ? Welcher Batterieproduzent verzichtet schon freiwillig auf 2/3 seiner Umsätze ??! Ausserdem würde ich erst mal eine "Confirmation" der Batterie-news seitens Altair abwarten ....

[balboa]

verdammt, dickson, was ist denn das für ne logik bitte???
warum soll denn der umsatz zurückgehen!!!
anstatt den bisherigen akkus/batterien kommen die dinger von atlair rein! aus amen!
nur weil die batterien länger halten geht doch der umsatz nicht zurück???
oder kaufst du gleich ein neues laptop wenn dein akku leer ist???
nicht bös gemeint, aber das ist jetzt von weit hergeholt.
warten wir ab was altair nächsten donnerstag zu sagen hat.
gruß
balboa

[brokersvenja007]

was ist nächsten donnerstag?

sorry --- habe keinen zeit mir jeden thread durchzulesen...
vielen dank für die antwort

grüße
svenja

[Cyberworker]

So Svenja, das dürfte Dir weiterhelfen.

Die Infos bekommt man sehr gut unter www.bigcharts.com
mit den amerikanischen Kürzeln in dem Fall: alti


Altair Nanotechnologies, Inc. Announces Fourth Quarter Financial Results Conference Call

MONDAY, FEBRUARY 14, 2005 8:34 AM

RENO, NV, Feb. 14, 2005 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (ALTI) announced today that it will hold a quarterly conference call to discuss fourth quarter and year-end financial results for fiscal 2004 on Thursday, February 24, at 11:00 a.m. Eastern (EST). Shareholders and members of the investment community are invited to participate in the call.


Grüße Cyberworker

[brokersvenja007]

vielen dank

[Casson]

@dickson
#264

Was sind denn das für Texte???

"Wenn die Altair-Batterie 3x solange hält,bei gleichem Preis,dann gehen doch wohl die Umsätze nach Adam Riese auf 1/3 zurück,oder wie?"

Wenn die Wissenschaft einen Treibstoff erfindet, mit dem Flugzeuge dreimal so weit fliegen und Autos dreimal so weit fahren können wie bisher, warum sollten dann die Flugzeugbau- und Automobilindustrie ein Drittel weniger Umsatz machen???

Fällt der Groschen???

@all

In den USA wird noch mit dem Kurs gespielt und gezockt, aber wenn sich der Pulverrauch der Schlacht so langsam mal verzogen hat, und die letzten Unternehmensmeldungen tatsächlich der Wahrheit entsprechen, werden für alle Aktionäre von Altair rosige Kurszeiten anbrechen.

Dies wird nicht "über Nacht" geschehen, aber ein langsamer, und dafür kontinuierlicher Anstieg der Aktie über einen längeren Zeitraum, hat ja auch was Schönes!

Jedenfalls spricht die jüngst erfolgte Kapitalerhöhung nahe dem aktuellen Kurs über immerhin 20 Mio. US-Dollar von kapitalkräftiger Investorenseite her eine deutliche Indiziensprache, denn diesen Kreisen werden vor ihrer Investmententscheidung immer etwas bessere und tiefere Einblicke in ein Unternehmen gewährt, als dem sog. Durchschnittsanleger!

Casson

[balboa]

hi casson!
schön mal was zu hören von dir!
das habe ich dickson auch schon geschrieben.
aber gut, der bringt paar bsp die wir dann ausschließen können. ist auch nicht schlecht.
da gebe ich dir recht mit dem kursverlauf.
lieber langsam und kontinuierlich als so 150% am tag!

[balboa]

scheint so, als hätten wir denn boden gefunden.
jetzt kommts auf die meldungen von altair an.
aber da bin ich zuversichtlich.

[nosabotas]

ja nach dem gezocke die letzten paar tage durch die erfreulichen news hat sich der kurs nun beruhigt was auch an den Umsätzen zu sehen ist. Bin bei 4.16 erstmal raus was sich ja als richtig herausgestellt hat und steige wohl demnächst wieder ein sobald sich was tut. Jetzt heisst es warten. Auf jedenfall eine Aktie mit grossem Potenzial für die Zukunft

[balboa]

. Auf jedenfall eine Aktie mit grossem Potenzial für die Zukunft

so ist es und so wird es immer sein!
was meint ihr wenn ich bis 31.12.2006 investiert bleibe, was wir dann für nen kurs sehen werden???
bis ende des jahres minimum 10€!!!
mehr sag i net.

[weltklasse]

ist denn bereits was von der konferenz bekannt????

[balboa]

hallo weltklasse!
denke du meinst die konferenz die erst nächsten donnerstag stattfindet.


Altair Nanotechnologies, Inc. Announces Fourth Quarter Financial Results Conference Call

MONDAY, FEBRUARY 14, 2005 8:34 AM

RENO, NV, Feb. 14, 2005 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (ALTI) announced today that it will hold a quarterly conference call to discuss fourth quarter and year-end financial results for fiscal 2004 on Thursday, February 24, at 11:00 a.m. Eastern (EST). Shareholders and members of the investment community are invited to participate in the call.

gruß
balboa

[Paepstin]

Es könnte wohl sein, dass vor dem Conference-Call am Donnerstag noch eine Pressmitteilung kommt!
Oder was denkt ihr?

Päpstin



21.02.2005 13:40 Uhr
Börse Frankfurt-News: Nanotech fürs Depot

FRANKFURT (DEUTSCHE-BOERSE AG) - 21. Februar. Einige Anleger setzen heute auf Nanotechnologie. Sie kaufen nach Angaben der Marktmacher auf dem Frankfurter Parkett ein Basket-Zertifikat von Merril Lynch (WKN A0DG92). Das Papier ist erst Mitte Dezember zu 100 Euro ausgegeben worden und hat sich seitdem sehr volatil entwickelt, und zwar bis zu gut 110 Euro. Derzeit notiert es bei knapp 103 Euro. Der Basket, dessen Zusammensetzung sich während der Laufzeit nicht verändert, besteht aus 12 Unternehmen: Accelrys, Altair, AMCOL, Flamel, Harris&Harris, Headwaters, MTS Systems, Nanogen, Nanometrics, Nanophase, NVE Corporation, Symyx.



Die Nanotechnologie wird seit einigen Jahren als DIE Zukunftstechnologie und damit potentieller Börsenmotor beschworen, inkl. IPO-Welle versteht sich. Hinter dem Begriff verbirgt sich die Wissenschaft der kleinsten Teilchen. Ein Nanometer ist ein millionstel Millimeter. Er ist verglichen mit einem Meter so groß wie eine Haselnuss zur Erde. Die Produkte der Nanotechnologie sind sehr unterschiedlich. Dazu gehören kleinste Werkzeuge ebenso wie die Beschichtung von Plastikbierflaschen.

Marco Beckmann, Sub-Berater des DAC Nanotech-Fonds von Hauck & Aufhäuser und Vorstand der Nanostart AG ist sehr optimistisch für die Branche: "Nanotech-Unternehmen kommen weltweit jährlich auf einen Umsatz von einer Milliarde US-Dollar. Dies soll sich neuesten Studien in den nächsten fünf Jahren verzehnfachen, also auf eine Billion US-Dollar Umsatz in 2010". Dennoch würde das Thema bisher von Anlegern kaum wahrgenommen. Den Grund dafür sieht Beckmann in der geplatzten Internet- und Biotechnologie-Blase. Die hätte Anleger in den vergangenen Jahren sehr skeptisch gemacht gegenüber neuen Technologien. Also eine Art Sippenhaft für die Nanotechnologie?

Einige Experten warnen vor einem "Nano-Virus". So zum Beispiel Finanzprofessor Max Otte. Er bemerkt, dass Finanzmedien immer wieder versuchten, eine Nanotech-Welle zu starten. Er sei sich zwar sicher, dass in diesem Bereich ein großer technischer Fortschritt möglich wäre. "Allerdings gibt es "die Nanotechnologie" nicht. Zudem profitieren von den Anwendungen zunächst die großen Konzerne." Aus seiner Sicht entstünden wenige neue Unternehmen mit Massenappeal. Und so mancher Branchenanalyst befürchtet, inzwischen stünde der wachsenden Nachfrage nach Nanotech-Werten kaum solides Angebot gegenüber.

Auch Marco Beckmann weist darauf hin, dass sich hinter dem Begriff `Nanotechnologie` eine Vielzahl unterschiedlichster Unternehmen befinde. Er kommt nur zu einer anderen Schlussfolgerung: "Es gibt international über 180 kleine und mittelgroße börsennotierte Unternehmen, die der Nanotechnologie zuzuordnen sind. Davon nehmen Anleger höchstens 30 als solche war. "Diese Unternehmen tragen `Nano` im Namen und sind alle deutlich überbewertet." Ein Phänomen, das typisch für die Frühphase einer Technologie sei.

Neben dem Basket-Zertifikat hat Merill Lynch übrigens im vergangenen April einen Branchenindex zur Nanotechnologie aufgelegt. Der Index enthält 25 Werte und ist an der American Stock Exchange, kurz Amex, gelistet (Kürzel NNZ).

Möchten Sie sich über neue Themen an der Börse Frankfurt informieren lassen? Abonnieren Sie einfach unseren 14-tägigen Newsletter. Senden Sie uns dazu eine E-Mail an [e-mail].

Quelle: Deutsche Börse AG. Beachten Sie bitte weitere Informationen und unseren Disclaimer unter http://deutsche-boerse.com/privatanleger.

(Für den Inhalt der Kolumne ist allein Deutsche Börse AG verantwortlich. Die Beiträge sind keine Aufforderung zum Kauf und Verkauf von Wertpapieren oder anderen Vermögenswerten.)

[Cyberworker]

Solange die Nachricht positiv ist es mir natürlich recht... Bleibt eben abzuwarten. Also ich glaube, dass sich Altair nach der Konferenz ein wenig nach unten korrigiert, da noch rote Zahlen geschrieben werden. Langfristig mit Sicherheit ein super Investment. Demnach geh ich am Donnerstag Mittag sicherheitshalber mal raus.


Gruß Cyberworker

[opelmanta3]

XDSL endlich abgekoppelt von ALTI...

XDSL wird ALTI wohl outperformen....




XDSL www.mphasetech.com

[[KERN]Codex]

Achja guckt mal auf ALTI

[brokersvenja007]

ALTI schießt gerade in amiland durch die decke,...da istr ichtig was los,..aktuell 4,60$

grüße
svenja

[Cyberworker]

Genau wie der Euro!

Das is echt bitter:O

Cyberworker

[Paepstin]

Scheinen gute News im Anmarsch zu sein!

Päpstin

[[KERN]Codex]

..da decken sich nur ein paar shortis ein, falls gute news kommen, glasklaar und das geht heute und morgen noch weiter

*schneeballwerf*

[[KERN]Codex]

ALTI wird vorbörslich leicht gebremst, da steht eine 15k iceberg order bei 4,46$ im ask

[[KERN]Codex]

ALTI 4,48$

Die Shortis ziehen den Schwanz ein

[[KERN]Codex]

Wie ich es bereits erwartet habe "bounced" Altair heute wieder

[tomhead]

wie gestern schon jemand vermutet hatte heute noch ne kleine Info

ALTAIR NANOTECHNOLOGIES REPORTS PROJECT UPDATE IN PREPARATION FOR YEAR END RESULTS ANNOUNCEMENT
RENO, NV – February 23, 2005 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today provided a Company Projects Update in preparation for its financial results conference call scheduled Thursday, February 24, 2005. Management believes that it would be beneficial to provide a project update so that investors will have an opportunity to review this information prior to the call.

"This has been a solid year of performance for the company," commented Altair Nanotechnologies CEO Alan J. Gotcher, Ph.D. "We have made progress in the transition to an emerging growth stage nanotechnology company with revenue from sales of a variety of products. Altair has signed licensing agreements with Western Oil Sands for pigment product technology, Spectrum Pharmaceuticals for nanotechnology based phosphate binding drugs (signed in January 2005) and entered into commercial collaborations for the development of enabling electrode product technology for a new titanium manufacturing process with Titanium Metals Corporation, the second largest producer of titanium metal in the world. We are making significant advancements on many fronts and plan to discuss our progress during the conference call."

Altair Nanotechnologies Corporate Update for 2004

Altair strengthened its management team, Board of Directors and Scientific Advisory Board and increased its cash holdings:
- The Company appointed Dr. Alan J. Gotcher, Ph.D., as CEO and member of the Board of Directors. Roy Graham was named Senior Vice President of Sales and Marketing on January 7,2005
- Altair increased the number of independent members of its Board of Directors adding David King, Ph.D., President, Advanced Technology Group, Michel Bazinet, M.D., CEO of Replicor and Christopher Jones, Ph.D., Senior Vice President, Behr Coatings.
- Altair expanded its Scientific Advisory Board to include Ravi Thadhani, M.D., a well known kidney dialysis research specialist, and Michael Graetzel, Ph.D., a renowned alternative energy expert.
- On February 14, 2005, Altair raised approximately $20 million through the sale of five million shares of its common stock. Proceeds are expected to be used for increased working capital, capital expenditures, research and development activities and acceleration of our commercial development activities.
- Management is hosting a financial results conference call February 24th at 11:00 AM Eastern. The dial-in number is 888.245.7013.

Life Sciences Division Update for 2004
The division entered into licensing negotiations on its first product technology, continued to develop intellectual property and began discussions with market partners to license additional product technology:

Pharmaceutical Products
RenaZorb™ Products - Nanotechnology-based Drug Candidate for Phosphate Binding in End Stage Renal Disease
- Altair`s RenaZorb represents a second-in-class, lanthanum-based drug candidate for phosphate control in patients with end-stage renal disease (ESRD).
- January 31, 2005, Altair signed a licensing agreement with Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) giving them the exclusive worldwide rights to develop, market and sell RenaZorb for human therapeutic and diagnostic applications.

Drug Delivery Products
TiNano® Spheres™ Drug Delivery Systems
- TiNano Spheres are hollow, porous, high surface area, ceramic microstructures proposed for use in drug delivery systems. These systems have demonstrated high levels of drug and chemical loading and rapid drug and chemical release.
- Two patent applications have been filed for the drug delivery technology platform.
- Research and development efforts continue and discussions have begun to license this product technology to market partners.

Dental Nano-materials
- Altair continues to work with a research consortium sponsored by the National Institutes of Health to strengthen polymer-based dental fillings utilizing Altair`s nano-zirconia.

Performance Materials Division Update for 2004
The division licensed pigment and electrode product technologies, advanced several companies towards licensing agreements and made substantial progress in the development of new product technology:

Advanced Materials for Paints, Coatings and Sensors
Titanium Dioxide Pigment – Altair`s Hydrochloride Pigment Process (AHPP)
- Altair has successfully completed 50 percent of Phase l of the Western Oil Sands project to manufacture TiO2 pigment from tar sand tailings.
- Discussions progressed with a number of companies which may lead to new licensing agreements in 2005.
- January 25, 2005, Altair was awarded a new patent covering "Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment" by the Australian Patent Office.
Advanced Ceramic Materials for Coatings
- Altair was awarded a third contract from a (confidential) Fortune 100 company to supply testing quantities of specialized nano-sized materials for coatings.
Advanced Ceramic Materials for Sensors
- Western Michigan University and Altair received a $2 million contract from DOE for joint development of nanosensors for detecting chemical and biological weapons. Under terms of the Stage ll contract scheduled to commence this quarter, Altair will receive $672,000 over a two-year period for collaborative research and development as a subcontractor.

Air and Water Purification Systems
Altairnano TiHPC Products for Photocatalysis
- Altair is partnering with Genesis Air to develop specialized surface activated nano-sized titanium dioxide compounds for use in HVAC air cleaning systems, specifically Genesis Air`s Photocatalysis technology.
NanoCheck™ Products for Binding Phosphate in Water
- Independent and in-house laboratory testing has shown that Altair`s unique nano-structured compound, NanoCheck, safely and effectively removes phosphate from water, preventing algae growth in swimming pools and reducing the quantity of chemicals currently required for algae prevention.
- Field testing, focused on evaluating NanoCheck`s effectiveness in providing an algae-free environment for swimming pools, was delayed due primarily to hurricanes in the field testing areas. Testing has been reinitiated and results will be made public when available. Negotiations with major pool chemical companies for licensing of the product are moving forward.

Advanced Materials for Improving Process Technologies
Titanium Metal Manufacturing via Electrolysis Processing
- Altair`s development agreement with Titanium Metals Corporation (NYSE:TIE), provides Altair the opportunity to supply enough TiO2 micro porous electrodes to produce 50 pounds of titanium metal per day to meet the DARPA titanium project goals as outlined by the program. The project has met its goals and Altair is currently producing materials to order.

High Performance Materials for Alternative Energy
Lithium Ion Battery Electrode Development
- Altair has completed research work under a $100,000 SBIR Phase l grant and has applied for a $500,000 SBIR Phase ll grant from the U.S. National Science Foundation to continue work on carbon-coated, nano-structured electrodes for next-generation lithium-ion ultra capacitors with partners Hosokawa Micron and Rutgers University.
- Altair was allowed two U.S. patents for the manufacturing of products used in the development of lithium ion batteries and super capacitors. The first patent describes a "Process For Making Lithium Titanate", and the second patent describes a "Process For Making Nano-sized and Sub-micron-sized Lithium-Transition Metal Oxides".
- Altair is introducing its battery materials to battery manufacturers. These materials have the capacity to enable a new generation of rechargeable battery with three times the power of existing Lithium Ion batteries, the capability of recharging in minutes instead of hours and increased battery life.

Hydrogen Generation using Solar Energy
- University of Nevada, Las Vegas, Altair and Hydrogen Solar, LLC were awarded a $3,000,000 U.S. Department of Energy grant to pursue joint research activities related to solar hydrogen production using solar energy at a refilling station that is under development in Las Vegas. Vehicle integration, testing and demonstration are included in the project demonstration.

Thermal Spray Grade Powders
- Thermal Spray powders have use in a variety of harsh environmental applications such as aerospace propulsion systems, blades and vanes, medical applications, boilers, incinerators, and oil and gas industry uses. During the first quarter of 2004 the National Research Council completed its report evaluating the Altair thermal spray powders. The report concluded that Altair`s thermal spray powders were more abrasion resistant than conventional powders. We continue to supply sample quantities for customer testing.


tomhead

[__MarketMaker__]

@Kern

was meinst du mit "15k iceberg order bei 4,46$ im ask?"

[[KERN]Codex]

marketmaker,

ich meinte damit dass jemand vorbörslich bei 4,46$ 15.000 im ask (angebot) platziert hat

bist du neu an der börse?

[brokersvenja007]

tomhead....

vielen dank für deine info...
was hälst du selbst davon???

grüße
svenja

[__MarketMaker__]

bin seit mitte 04 dabei

verdammt "ask" hätt ich mir auch noch selbst übersetzen können...

I LOVE ALTI

[tomhead]

#290
tja, was ich davon halte! es wurde ja schon viel geschrieben über Altair und seine Informationspolitik und Äusserungen die dann doch nicht so richtig zutrafen.

Da ich aber selbst nur eine sehr kleine Position halte (warte ich mal ab, morgen der Bericht und dann vielleicht noch ein paar Gespräche mit größeren Firmen bezüglich der Batterien), sehe es aber positiv (der Shareholder sollte immer gut informiert werden) und werde vielleicht noch ein bischen aufstocken aber nicht zum Zocken sondern für Long.

Informationen von Altair gab es ja zum Schluss reichlich.

Mal sehen was zum Schluss umgesetzt wird.

tomhead

[[KERN]Codex]

Ich sagte ja bereits dass man mit ALTIs Technologien so einiges auf die Beine stellen kann

[__MarketMaker__]

WOW ALTI, legt noch mal richtig los!!!

was denkt ihr, gehts morgen wieder runter, durch den bericht?

[Paepstin]

Ich glaube, das Teilchen geht morgen erst mal richtig durch die Decke!

Päpstin

[[KERN]Codex]

4,91$ +15.53%

Glaube auch dass es morgen nochmal upwärts geht

[meislo]

Da scheint sich ja wirklich was grosses anzubahnen!

gruss meislo

[balboa]

hallo leute!

auf island.com gehts wieder runter.
nachbörslich schon 4,80$

denke dass es morgen erstmal runter geht, bevor wir den weg nach oben machen.

[turbozertifikat]

@Paepstin dich sehe ich nicht so gern hier im Thread, denn von Dir hab ich schon genug aus dem "LAM" Thread. Du bist ja noch schlimmer wie ein Analyst.
Gruss Turbo

[roger11]

könnt ihr mal die Schnauze halten bzgl. der Zukunft ?!?

ist ja nicht auszuhalten, welch fabulierende 1st-Klässler hier mitmischen zu wagen.

Raus.... oder in die Ecke !.....ihr ungeduldiges Pack !!


ps.: seid es garnicht wert, ALTI-Aktionäre zu sein...

[[KERN]Codex]

gn8 codex

p.s. Du hast mir das 300ste Posting geklaut

[roger11]

häää.?......jetzt drehen wohl alle am rad...

[turbozertifikat]

Und du wohl als erster, ungeduldig bist wohl Du, da der Kurs ja für Dich nur Einbahnstrasse laufen sollte, und erspar uns solch dumme Kommentare von wegen "garnicht wert Aktionäre zu sein" ! So Long mit Deiner Paepstin ....
Gruss Turbo

[[KERN]Codex]

Company Reports Significant Revenue Growth


RENO, NV--(MARKET WIRE)--Feb 24, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) today reported financial results for its fourth quarter and year ended December 31, 2004.

The company reported revenue of $511,003 for the fourth quarter of 2004, a considerable increase when compared to revenue of $30,822 for the fourth quarter of fiscal 2003. The net loss for the fourth quarter 2004 was $1.7 million or a loss per share of $0.03, as compared to a net loss of $2.3 million, or a net loss per share of $0.06 for the fourth quarter in 2003.

Operating expenses for the fourth quarter ended December 31, 2004 were approximately $2.18 million, down slightly when compared to operating expenses for the fourth quarter in 2003 of approximately $2.24 million.

For the year ended December 31, 2004, the company reported revenue of approximately $1.2 million, with a net loss of $7.0 million, or a net loss per share of $0.14, as compared to revenue for the year ended December 31, 2003 of approximately $73,000, with a net loss of $6.2 million, or a net loss per share of $0.19.

Operating expenses for the year ended December 31, 2004, were approximately $8.0 million, compared to operating expenses for the year ended December 31, 2003 of approximately $5.9 million.

Altair CFO Edward Dickinson noted, "Our net cash used in operations has averaged $468,000 per month during 2004 and $506,000 during the fourth quarter of 2004. We manage R&D costs and G&A expenses carefully and plan some increases in 2005 for expansion of our Life Sciences R&D projects and alternative energy initiatives as well as additional expenses associated with compliance with Sarbanes-Oxley requirements."

As of February 16, 2005, Altair`s balance sheet was strong, with a cash position of approximately $31.0 million compared to $3.9 million at December 31, 2003. The increase is due in part to the exercise of warrants and employee options during 2004 and 2005, and the sale of five million shares of the company`s common stock during February 2005. Altair`s long-term debt consists only of a promissory note of $3.0 million to purchase the land and building that houses the company`s 80,000-square-foot corporate headquarters, research and development laboratories and pilot plant facilities in Reno, Nevada. Under the terms of the promissory note, interest begins accruing in August 2005 with the first payment due February 2006.

Please join Altair`s management for a financial results and project update conference call today, February 24, 2005 at 11:00 AM Eastern. The dial-in number is 888.245.7013.




CONSOLIDATED BALANCE SHEETS
(Selected Financial Data Unaudited)

December 31, December 31,
2004 2003
------------ ------------
ASSETS

Total Current Assets $ 8,040,037 $ 3,962,180

Property, Plant and Equipment, net 6,513,907 6,618,805

Patents, net 974,877 1,060,569

Other Assets 18,200 18,200
------------ ------------
Total Assets $ 15,547,021 $ 11,659,754
============ ============


LIABILITIES AND SHAREHOLDERS` EQUITY

Total Current Liabilities $ 376,773 $ 397,141

Note Payable, Long-Term Portion 2,880,311 2,686,130

Total Shareholders` Equity 12,289,937 8,576,483
------------ ------------
Total Liabilities and Shareholders` Equity $ 15,547,021 $ 11,659,754
============ ============


ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Selected Financial Data Unaudited)

Three Months Ended Twelve Months Ended
Dec. 31, Dec. 31,
2004 2003 2004 2003
---------- ---------- ---------- ----------

Revenues $ 511,003 $ 30,822 $1,151,892 $ 72,851

Total Operating Expenses 2,183,853 2,241,911 8,056,847 5,858,061
---------- ---------- ---------- ----------

Loss from Operations 1,672,850 2,211,089 6,904,955 5,785,210

Other (Income) Expense: 24,317 45,794 97,325 452,729
---------- ---------- ---------- ----------

Net Loss 1,697,167 2,256,883 7,002,280 6,237,939

Preferential Warrant
Dividend - - - 592,486
---------- ---------- ---------- ----------

Net Loss Applicable
to Shareholders $1,697,167 $2,256,883 $7,002,280 $6,830,425
========== ========== ========== ==========

Loss per Common Share
- Basic and Diluted $ 0.03 $ 0.06 $ 0.14 $ 0.19
========== ========== ========== ==========

Weighted Average Shares
- Basic and Diluted 49,499,735 40,809,605 48,677,283 36,222,026
========== ========== ========== ==========

[tomhead]

@all
Nokia: Aus für Brennstoffzellen-Handys
Pläne für die nächsten Jahre gestoppt



Der finnische Handy-Weltmarktführer Nokia http://www.nokia.com hat seine Pläne für die Entwicklung von Brennstoffzellen-Handys vorerst ad acta gelegt. Die Entwicklung werde zumindest in den nächsten Jahren nicht mehr weiterverfolgt, sagte ein Nokia-Sprecher laut einem Bericht des Wall Street Journal (WSJ). Die Technologie sei einfach noch nicht reif genug, sagte der Sprecher. Als Gründe für den Entwicklungsstopp wurden zudem US-Sicherheitsbestimmungen bei Flugreisen genannt.

Die Absage an die Weiterentwicklung von Brennstoffzellen-Handys durch den weltgrößten Produzenten kommt etwas überraschend. Noch im Juni des Vorjahres hatte Nokias Entwicklungschef Tero Ojanpera bei einem Meeting in Helsinki den Prototypen eines methanol-betriebenen Bluetooth-Handys vorgestellt. Zu dieser Zeit hieß es noch, die Technologie sei schon weit fortgeschritten. Es werde weniger als zwei Jahre dauern, bis Brennstoffzellen-Handys zum kommerziellen Einsatz kämen.

Georg Panovsky, email: [e-mail], Tel. [phone]
tomhead

[tomhead]

ALTAIR NANOTECHNOLOGIES BEGINS SHIPMENTS OF BATTERY ELECTRODE NANOMATERIALS
Announces initial shipment of lithium titanate spinel electrode nanomaterials to Advanced Battery Technologies.

RENO, NV. – April 19, 2005 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI) announced today the initial shipment of battery electrode nanomaterials to Advanced Battery Technologies, Inc. (OTCBB: ABAT) that will be used in the manufacture and testing of prototype polymer lithium batteries. Advanced Battery designs and markets Polymer-Lithium-Ion (PLI) batteries that are manufactured in its subsidiary, based in Harbin, China. Altair previously announced a partnering agreement with ABAT on April 4, 2005.

Altair and Advanced Battery have formed a partnership and agreed to test Altair`s electrode materials for use in new, higher performance Polymer-Lithium-Ion (PLI) batteries to be manufactured by Advanced Battery for sale in China. These new batteries are being tested by the partnership to meet an emerging need for higher power, lighter weight and more rapidly recharging batteries to power a new generation of higher performance, electrically powered vehicles, including automobiles and buses.

A multi-phased material and battery performance testing program is being designed and conducted to refine the product and process specifications for the electrode materials and new battery products. Altair`s electrode nanomaterials will be incorporated into Advanced Battery`s current PLI battery production lines. The batteries will be tested in standard battery test protocols and in real world tests using electric vehicles (i.e. cars and buses) in 2005.

"Advanced Battery`s current Polymer-Lithium-Ion (PLI) battery permits a top speed of 75 mph for cars and 62.5 mph for buses and a traveling distance of approximately 200 miles per charge for cars and 150 miles for buses", commented Mr. Zhiguo Fu, Chairman of Advanced Battery.

Using Altair`s rapid charge electrode nanomaterials in PLI batteries, Altair believes that the typical battery life cycle of 1,000 recharge cycles before any degradation of performance can be increased to 20,000+ cycles. In addition to improving the battery cycle life, the recharge time is expected to be reduced, depending on battery size and power. These features may provide improved operational efficiency and lower operating costs for electric powered vehicles. Altair`s nanomaterials can be used in PLI and other lithium ion batteries extending the product range and the use of these materials to other geographic markets.

"The relationship with Advanced Battery is important to Altair`s long term strategy, as it provides Altair with an aggressive battery manufacturing partner in a rapidly growing market – polymer lithium ion batteries in China." said Dr Alan J. Gotcher, Altair CEO and President. "Lithium ion and polymer lithium ion batteries have historically been manufactured in Japan. However, over the last three years a significant shift has occurred due to lower cost manufacturing in China, which now produces about 30 percent of the worldwide $5 billion a year lithium battery supply. As well as providing Altair with an entry into this burgeoning market, the relationship with Advanced Battery provides our development team with additional insight into the requirements of a battery manufacturer with a low cost production infrastructure.
tomhead

[Boersenolly]

tomhead hier nur die gebrochene übersetzung deines Atickels,für die es in deutscher sprache besser verstehen.


ALTAIR NANOTECHNOLOGIES BEGINS SENDUNGEN VON BATTERIE-ELEKTRODE NANOMATERIALS
Verkündet anfängliche Sendung von lithium titanate spinel Elektrode nanomaterials zu fortgeschrittenen Batterie-Technologien.

RENO, NV. –Der 19. April 2005–Altair Nanotechnologies, AG (NASDAQ: ALTI) verkündete heute die anfängliche Sendung von Batterie-Elektrode-nanomaterials zu fortgeschrittenen Batterie-Technologien, AG (OTCBB: ABAT) das wird in der Herstellung benutzt werden und das Prüfen von Prototyp Polymer lithium Batterien. Anspruchsvolle Batterie entwirft und Märkte-Polymer-Lithium-Ion (PLI) Batterien, die in seiner Tochtergesellschaft hergestellt werden, die in Harbin, China, gegründet werden. Altair verkündete vorher eine partnering-Zustimmung mit ABAT am 4. April 2005.

Altair und Anspruchsvolle Batterie haben eine Partnerschaft gebildet und haben übereingestimmt, Altair `s Elektrode-Materialien für Verwendung in neuem, höherem Aufführung-Polymer-Lithium-Ion zu prüfen (PLI) Batterien, die von Anspruchsvoller Batterie für Verkauf in China hergestellt werden sollten. Diese neuen Batterien werden von der Partnerschaft geprüft, um einem entstehenden Bedürfnis für höhere Macht zu entsprechen, leichteres Gewicht und das Nachladen von Batterien schneller, um eine neue Generation höherer Aufführung anzutreiben, elektrisch angetriebene Fahrzeuge, einschließlich Autos und Busse.

Ein Multi-durchgeführtes Material und Batterie Aufführung Erprobung Programm wird entworfen und wird geführt, um das Produkt und die Prozeß-genauen Angabe für die Elektrode-Materialien und neue Batterie-Produkte zu verfeinern. Altair `s Elektrode-nanomaterials werden in die Strömung von Anspruchsvoller Batterie PLI Batterie Fertigungsstraßen integriert werden. Die Batterien werden in üblichen Batterie-Prüfung-Protokollen geprüft werden und in wirklichen Welt-Prüfungen, die elektrische Fahrzeuge benutzen, (d.h. Autos und Busse) in 2005.

Das Strömung-Polymer-Lithium-Ion von " anspruchsvoller Batterie (PLI) Batterie erlaubt eine Spitze-Geschwindigkeit von 75 mph für Autos und 62.5 mph für Busse und eine reisende Entfernung von ungefähr 200 Meilen pro Gebühr für Autos und 150 Meilen für Busse ", bemerkte Herr Zhiguo Fu, Vorsitzende Anspruchsvoller Batterie.

Altair `s schnellen Gebühr-Elektrode-nanomaterials in PLI Batterien benutzend, Altair glaubt, daß der typische Batterie-Leben-Zyklus von 1,000 Zyklen vor irgendeiner Entwürdigung von Aufführung nachlädt, kann zu 20,000+ Zyklen vergrößert werden. Zusätzlich zum Verbessern des Batterie-Zyklus-Lebens, das laden Sie nach, Zeit wird erwartet, reduziert zu werden und hängt von Batterie-Größe und Macht ab. Diese Merkmale versorgen vielleicht elektrische angetriebene Fahrzeuge mit verbesserter betriebsbereiter Tüchtigkeit und niedrigeren operierenden Preisen. Altair `s nanomaterials können in PLI und anderen lithium-Ion-Batterien benutzt werden, die die Produkt-Auswahl und die Verwendung dieser Materialien zu anderen geographischen Märkten ausstrecken.

" Die Beziehung mit Anspruchsvoller Batterie ist zu Altair `s langer Begriff Strategie wichtig, als es Altair mit einem aggressiven Batterie-Erzeugung-Partner in einem schnell wachsenden Markt versorgt,–Polymer lithium Ion Batterien in China ". sagte Doktor Alan J. Gotcher, Altair CEO und Präsidenten. " Lithium Ion und Polymer lithium Ion Batterien sind historisch in Japan hergestellt worden. Aber im Verlauf den letzten drei Jahren ist eine bedeutungsvolle Änderung wegen niedrigerer Preis-Erzeugung in China vorgekommen, von dem jetzt 30 Prozent ungefähr produziert, das weltweit $5 Milliarde pro Jahr lithium Batterie Versorgung. Sowie das Versorgen von Altair mit einem Eintritt in diesen knospenden Markt, die Beziehung mit Anspruchsvoller Batterie versorgt unser Entwicklung-Team mit zusätzlichem Einblick in die Anforderungen eines Batterie-Herstellers mit einer niedrigen Preis-Produktion-Infrastruktur.

bo

[tomhead]

@all NEWS von heute:
ALTAIR NANOTECHNOLOGIES AND BATEMAN ENGINEERING ANNOUNCE FIRST JOINT VENTURE PROJECTS

Project Range Illustrates Breadth of Altairnano Bateman Titania`s Products and Services. Solution Implementation Process is Outlined.

RENO, NV – April 25, 2005 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI), and Bateman Engineering BV, today announced two projects have been initiated in their recently formed joint venture, "Altairnano Bateman Titania, Inc.". Altairnano Bateman Titania brings together Altair`s proprietary and patented titanium dioxide (TiO2) pigment manufacturing process with Bateman`s engineering expertise to develop, design, construct and commission manufacturing plants to produce titanium dioxide pigment. Titanium dioxide pigment, a $9 billion industry worldwide, is used in a variety of applications including the manufacture of paint, plastics and paper.

The first project is funded by a multi-billion dollar conglomerate (Client) located in an emerging economy country. A confidentiality agreement prevents disclosing this client`s name to protect customer and supplier relationships. The project is a Raw Material Evaluation study to determine the suitability of Client`s resource for use in TiO2 pigment manufacturing. At the conclusion of the evaluation, the Client will determine whether it shall commit to the design and construction of a TiO2 pigment manufacturing plant.

The second project is with Randsburg International Gold Corporation, a North American exploration company. The project is also a Raw Material Evaluation study to determine the suitability of its ore body for TiO2 pigment manufacturing. Randsburg has identified TiO2 pigment as one of the high-value products to be produced from ore mined at its Titan deposit in Ontario, Canada.

These projects use the Altair Hydrochloride Pigment ("AHP") Process to extract titanium and to manufacture titanium dioxide pigment from low cost, titanium rich ore. The AHP Process is the first new, commercially viable TiO2 pigment production process in nearly half a century delivering a cost effective, environmentally friendly process to manufacture pigment. Altairnano Bateman Titania is offering technology and services to develop, design, construct and commission TiO2 pigment manufacturing plants, especially in emerging countries that increasingly use titanium dioxide based pigments in paints for housing, automobiles and in plastics. These countries have had, and continue to forecast, high growth rates (e.g. 15%) for pigment consumption.

The AHP Process is a disruptive technology because it threatens the TiO2 pigment supply chain established over the last 50 years. It enables companies in emerging markets such as China, India, Southeast Asia and Africa to enter the TiO2 pigment supply market with an environmentally friendly manufacturing process that has a cost structure substantially lower than current supply methods. The Altair Process is economic for plants producing 30,000 tons a year to large scale manufacturing exceeding 100,000 tons per year. This is an important capability in emerging economies and to specialist pigment producers as it enables these smaller companies with limited capital resources to affordably enter the market. These plants can be readily expanded to larger scale manufacturing operations as customer demands grow.

The ability to alter the worldwide supply chain for TiO2 pigment requires Altairnano Bateman Titania to not disclose commercial relationships so that its customer relationships will be protected until the new production plants are operating. In many cases this will restrict Altairnano Bateman Titania`s ability to name specific customers until the projects are at a late stage of development, particularly where the customer is an existing pigment feedstock seller or TiO2 pigment consumer.

There will typically be six phases in the evaluation, design, construction and commission of a manufacturing plant based on the AHP process:

1. Raw Material Evaluation.

This phase starts with assessing a mineral resource for suitability for TiO2 pigment production in the AHP process. Ilmenite is the world`s most abundant titanium resource and is the preferred feedstock to the AHP process. This phase involves conducting an in-depth chemical and mineralogical testing program. A pre-feasibility study may also be performed depending on the outcome of the testing program. During this phase Altairnano Bateman Titania typically receives fees from conducting the minerals evaluation, process development and pre-feasibility studies.

2. Definitive Feasibility Study.

A Definitive Feasibility Study (DFS) is prepared and will be used to raise money to pay for plant construction, commissioning and working capital. In this phase Altairnano-Bateman Titania will receive engineering fees for work performed producing the study.

3. Flow Sheet Development and TiO2 Pigment Sample Preparation.

When the DFS is approved, pilot plant operation commences in order to develop the resource specific engineering flowsheet and produce TiO2 pigment for marketing purposes. Short pilot plant campaigns are conducted using bulk samples produced from the client`s resource to determine the processing requirements to produce sample TiO2 pigment. These runs will produce pigment samples for use in market development. This phase typically will involve the use of a pilot plant at Altairnano Bateman Titania`s headquarters, or in some cases could involve the construction of a small, project-specific pilot or demonstration plant. Altairnano Bateman Titania typically receives fees for conducting this phase and for completing the detailed engineering study that will lead to the construction of a limited production plant.

4. Detailed Plant Engineering & Design.

In this phase, detailed engineering studies and designs for the TiO2 pigment manufacturing plant are completed. Altairnano Bateman Titania typically receives fees for the design of the plant.

5. Plant Construction and Commissioning.

The construction of the full production plant typically follows completion of design. During this phase, Altairnano Bateman Titania will receive fees for the construction and commissioning of the plant.

6. Ongoing Plant Operations.

Once the plant is operational, Altairnano Bateman Titania will receive ongoing royalties from the pigment revenue stream and may also receive additional fees for plant design upgrades, maintenance and operational support.

RANDSBURG INTERNATIONAL GOLD COMPANY
Randsburg is a Canadian exploration company listed on the TSX Venture Exchange (Symbol TSX-V:RGZ). The Company is engaged in exploration for base metals, platinum group metals (PGMs), gold and diamonds in Canada, Nevada and Brazil. The Company has five active, high potential projects, including their Titan Project (iron-titanium-vanadium) in Northern Ontario, which is 100% owned by Randsburg.

BATEMAN ENGINEERING BV
Bateman is an innovative solutions provider to the natural-resources industry internationally, providing a comprehensive blend of skills comprising process-orientated engineering, specialist niche technologies, financial and commercial facilitation and contracting and project management. It operates under the Bateman banner, providing total solutions for the conversion of natural resources into marketable products. Bateman has been involved in a number of beach sands and hard rock projects and studies involving the upgrade of ilmenite and other minerals, since 1991. Work has been done for several well known mining companies in that time, including Anglo American, Kumba Resources and WMC. Currently, Bateman is involved in a US$220 million lump sum turnkey contract for the Moma mineral sands project in Mozambique on behalf of Kenmare Resources. For more information, visit www.batemanbv.com.


tomhead

[weltklasse]

welch schöne nachrichten!!!!!

RENO, NV--(MARKET WIRE)--May 12, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News), a leading supplier of advanced ceramic nanomaterial products and technology, today reported financial results for the first quarter ended March 31, 2005.
ADVERTISEMENT


Total revenues increased by 635 percent, to over $1 million for the first quarter of 2005, when compared to the first quarter of 2004 which recorded revenues of $139,749. First quarter revenues in 2005 almost equal the entire annual revenues of $1.2 million reported for fiscal 2004 ended December 31, 2004.

"I`m pleased to report that Altair achieved its first million dollar revenue quarter as we continue to commercialize products and technologies from project efforts in our research and development labs," said Altair CEO and President Dr. Alan J. Gotcher. "Altair is building momentum, and we expect additional announcements relating to product roll-outs in the coming months."

For the quarter ended March 31, 2005, Altair reported a net loss of $2.2 million, representing a net loss per common share of $0.04, as compared to a net loss of $1.7 million, or $0.04 per common share in the first quarter of 2004. Operating expenses for the first quarter 2005 increased in comparison with first quarter 2004 due to two one-time expenses: 1) An increase in non-cash stock option compensation expense of approximately $532,000; and 2) A one-time $500,000 marketing and sales consulting fee made in connection with the RenaZorb(TM) licensing agreement. Investment in research and development for enhancement and expansion of products increased in the first quarter 2005 by $389,000 to $781,535.

"We are pleased with the strength of our balance sheet," commented Dr. Gotcher. "With the placement of our common stock and the exercise of warrants and options during the first quarter, our cash position as of May 12, 2005, increased significantly to $30.3 million.

"Revenue growth is expected to continue during 2005, as new products and programs are introduced," continued Gotcher. "We believe there will be continued improvement in operating results, with operating expenses rising only slightly during the year as a result of higher regulatory expenses and increased investment in product research and development."

Please join Altair`s management for a financial results and project update conference call today, May 12, 2005, at 11:00 AM Eastern. The dial-in number is 888.245

[telltom]

Sehr gute News für Altair. Sie sind auf dem richtigen Weg.

Das ist die erste Million im Quartal. Anschnallen so billig bekommt man keine Altair mehr.

[telltom]

Info entnommen von der website:www.billiger-telefonieren.de

Handys: Super-Akku

(08.05.2005/) - US-amerikanische Forscher haben einen neuen Handy-Akku entwickelt, der die Strom- und Ladewerte der bisherigen Stromspeicher deutlich übertrifft.

Der von Altair Technologies (Reno, Nevada), zum Patent angemeldete Akku kann nicht nur in sechs Minuten voll aufgeladen werden. Er soll Presseberichten zufolge auch dreimal so leistungsfähig und hundertmal so langlebig wie die heute bekannten Speicher sein. Nach Hersteller-Angaben lässt sich der Akku 20.000 Mal aufladen, im Gegensatz zu 400-facher Aufladung heute.

Neu: Eine der Stromspeicher-Elektroden besteht nicht mehr aus Kohlenstoff, sondern aus Lithium-Titanat-Nano-Kristallen. Dieses Material ist stark zerklüftet und besitzt daher eine enorm große Oberfläche: Ein Gramm erreicht eine Fläche von 100 Quadratmetern. Das ist mehr als 30-mal soviel wie bei herkömmlichen Materialien. Wegen der großen Oberfläche können Elektronen besonders schnell ausgetauscht werden.

So kann der Akku nicht nur schnell geladen werden, sondern auch in kurzer Zeit eine große Menge an Energie abgeben. Damit hätten Kamera-Handys künftig genug Leistung für Blitzlicht.

[cyberhai]

Toshiba hat doch auch so einen Akku entwickelt. Vielleicht kennt sich da von Euch jemand genauer aus, wer nun wo das Patent hat bzw. welche Wettbewerbsvorteile gegenüber Toshiba bestehen

Gruß Cyberhai

[tomhead]

@all
neue Homepage

Welcome to the new Altair Nanotechnologies website including our new branded name "Altairnano". If you have comments for improving this new website please email here.

tomhead
http://www.altairnano.com/

[tomhead]

ALTAIR NANOTECHNOLOGIES AWARDED $250,000 GRANT FOR ADVANCEMENT OF ITS ALTERNATIVE ENERGY PROGRAM

RENO, NV – November 22, 2005 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today announced that it has been awarded a $250,000 grant from the Indiana Advanced Energy Technologies Program (AETP) initiative. The Indiana Energy Group, a division of the Office of Lieutenant Governor Becky Skillman, administers the program.

The Indiana Energy Group has awarded six grants on a competitive basis from this program during 2005. The grant funding must be used to manufacture products containing products that are not currently in the U.S. market, and that are above industry standard in terms of energy efficiency (e.g. hybrid automobiles, fuel cells) and/or incorporate an innovative technology, such as nanotechnology, that allows the product to save energy.

"We would like to thank Indiana`s Lieutenant Governor Becky Skillman and the Energy Group for recognizing Altair and its achievements in the development of energy efficient technologies," said Altair President and Chief Executive Officer Alan J. Gotcher, Ph.D. "The grant funding will assist Altair to purchase and install production and test equipment for product application development in its development and manufacturing center in Anderson, Indiana. The center is open and pilot manufacturing is anticipated to begin by the end of the first quarter of 2006."

"The addition of our in-house manufacturing and testing capabilities for lithium ion cells, batteries, and battery packs is expected to reduce development time and expedite commercialization of our battery electrode materials," continued Gotcher. "This expansion will allow Altair to conduct accelerated testing of battery materials and battery products and provide application development capabilities for continued discussion and development work with large potential customers and strategic partners located in the U.S."
tomhead

[The_Future_Is_Now]

gibts was neues??

[jojobada]

Hallo@all,

Altair muss wieder steigen. Der Chart sagt zuimdest, dass
die Chance besteht. Wenn die 2,00 heute wieder erreicht werden sollte, dann kann sie wieder hochlaufen. Ein test der 2,00 ist nicht tragisch. Schaut Euch den Chart in Linie auf 3-5 jahre an und Ihr sehr, dass Alti schon zwei mal zuvor die 2,00 getestet hat. Ich persönlich rechne mit einem unvorherbaren Antsieg. Es sollte eine kaufwelle eintreten. Ob News dazu führen kann ich noch nicht sagen. Aber die 3,20$ sollten fürs erste drin sein.

Gruß www.jojobada.de

Unten im Chart sieht man deutlich, dass der Stoch am Boden ist. Der RSI liegt ebenfals sehr gut dar. Der Kurs sollte in Kürze drehen sonst taugt er nichts

Bis gleich

[jojobada]

Sorry für die Fehler oben.

Und sie werden kommen aus dem Nichts. Sie werden die Aktie hochkaufen! Der Kurs wird steigen!

jojo

[The_Future_Is_Now]

jetzt schau ich aber nicht schlecht jojo!



na mal sehen ob du mit den 3,20 € auch recht hast!

ich würd mich freun!

[tomhead]

und die news folgt auf dem Schritt:

Altair Nanotechnologies and Western Oil Sands Extend Phase One of Technology Licensing Agreement
Thursday December 29, 9:45 am ET


Extension of Phase One Program to Generate Revenue of Approximately $700,000

RENO, NV--(MARKET WIRE)--Dec 29, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) today announced that Western Oil Sands has extended the Phase I program of its technology agreement with Altairnano for an additional 12 months. Phase IB is now anticipated to be completed by January 2007. The extension of the Phase I program (Phase IB) is expected to generate additional revenues in excess of $700,000.

ADVERTISEMENT

Altairnano entered into a technology licensing agreement with Western Oil Sands Inc., in January 2004 to use the Altairnano Hydrochloride Pigment process (AHP) for extracting titanium from heavy minerals from oil sands in Alberta, Canada, to produce titanium dioxide pigment. Altairnano entered into an additional agreement with Western Oil Sands in August 2005 to provide pilot plant and office space within Altairnano`s facilities for five Western Oil Sands` employees and consultants. This agreement has facilitated on-site collaboration between the two companies and furthered the engineering study of manufacturing TiO2 pigment from Western`s oil sand tailings using Altairnano`s proprietary AHP process.

Under the terms of the extended Phase IB agreement, the two companies will expand the current investigation to prove the processing technology for recovering contained values from the Albian solvent recovery process tailings. This work is designed to demonstrate the feasibility of recycling hot water to recover residual asphaltene byproducts for further processing, producing a heavy mineral concentrate for further upgrading to salable zircon, rutile, and separating out ilmenite to produce TiO2 pigment. The outcome of Phase IB will be a preliminary technical evaluation and feasibility study.

"This project is an excellent next step demonstration of Altairnano`s AHP process," commented Altairnano President and CEO Alan J. Gotcher, Ph.D. "The tailings contain an estimated 10 percent heavy minerals, as compared to 2-4 percent typical in heavy mineral sand deposits worldwide. In addition to producing titanium dioxide pigment, the project will evaluate the economics to extract and sell zircon, rutile and to monetize valuable asphaltenes byproducts that are not currently being exploited."

"Western Oil Sands is an excellent technology partner for Altairnano`s AHP process as the Athabasca Oil Sands Project (AOSP) had an average production of approximately 165,000 barrels of oil per day for successive quarters in 2005," added Dr. Gotcher.

The Altairnano AHP Process

Altairnano`s proprietary AHP process technology is a comprehensive process for producing white titanium dioxide pigment from a variety of feedstock including hard rock ilmenite ore. It includes a novel combination of processes that extract, purify and form high quality white titanium dioxide pigment. Distinctive features of the process include projected lower operating costs, minimized environmental and health risks and the recycling of all the chemical additives used in the process. The patented technology has also provided Altairnano the unique ability to produce a wide variety of nanomaterials with narrow particle size control, chemical purity and particle morphology, at reasonably priced tonnage qualities.

ABOUT WESTERN OIL SANDS INC.

Western Oil Sands is a Canadian oil sands corporation which holds a 20 percent undivided interest in the Athabasca Oil Sands Project (AOSP) together with its partners Shell Canada Limited (60 per cent) and Chevron Canada Limited (20 per cent). The Common Shares of Western are listed on the Toronto Stock Exchange under the symbol "WTO." For additional information on Western Oil Sands, please visit www.westernoilsands.com.

tomhead

[jojobada]

Die Ahnungslosen verkaufen und sind im glauben das es wieder abwärts geht. Sie haben recht, aber ehe sie sich versehen, wird es wieder aufwärts gehen.

Es wird eine W-Formation!

[jojobada]

Von Tag zu Tag werden es hier mehr Klicks. Einer nach dem anderen wird kommen und am Ende tummeln sich gleiche und ungleiche. Versammelt zu einer großen Gemeinschaft, werden sie sich die Gewinne teilen!

Kaufe unten und verkaufe Oben und Du wirst gewinnen!

ALTI ist unten.

jojo

[circuit]

Bla Bla Bla

Dieser Artikel bringt es Mal wirklich auf den Punkt. ALTI soll sich um sein Geschäft ( hat es überhaupt eines ? )kümmern und nicht nur unwichtige news schreiben:



Yet Another Altair Press Release
Wednesday December 21, 10:32 am ET
By Jack Uldrich


It had been more than a month since Altair Nanotechnologies (Nasdaq: ALTI - News) last issued a meaningless press release. The silence was so deafening, I was beginning to think that Altair`s management might actually be focusing on the real work of building a company. Unfortunately, I was wrong.


My optimism was dampened earlier today, when company officials informed us that the U.S. Patent Office had graced them with U.S. Patent No. 6,974,566 -- a "Method For Producing Mixed Metal Oxides and Metal Oxide Compounds."

Like me, you`re probably wondering why this "news" was so noteworthy that it warranted a press release. Apparently, a number of Altair`s products, including titanium dioxide pigment, thermal coatings, and its nano-scale materials for lithium ion batteries, will benefit from this new process.

But like all releases, what is not said is often more important than what is. First off, there`s no mention of how the new process will improve things. For instance, in the area of titanium dioxide production, there is no discussion of how the new process will allow Altair to successfully compete with DuPont`s (NYSE: DD - News) Titanium Technologies division, or Lyondell Chemical (NYSE: LYO - News). Nor does the press release explain how the new method will help the company wrestle a bigger share of the thermal-coatings market away from larger and more established producers of nanomaterials, such as Nanophase (Nasdaq: NANX - News).

Why doesn`t the press release go into such detail? I suspect it`s because the new process doesn`t do squat, and it certainly doesn`t make the company any more competitive. If it did, I`m naive enough to believe that company officials would mention that fact.

What about the new process`s usefulness in making nanostructured materials for high-powered lithium ion batteries? Some of you may recall how Altair`s stock skyrocketed to nearly $6 a share earlier this year, after company officials issued a press release touting that small Chinese manufacturer Advanced Battery Technologies (Nasdaq: ABAT.OB - News) had signed a development agreement to use Altair`s nanomaterials. In that light, you might be forgiven for thinking that this new method is the company`s ace in the hole for radically improving its lithium battery technology.

Think again. Altair`s stock has now plummeted nearly 70% from those previous highs. It will likely fall even further as word gets out that small, privately held A123Systems has unveiled its own lithium-ion battery technology, which delivers life cycles up to 10 times longer, packs in five times the power, and recharges in five minutes.

You see, unlike Altair, A123Systems actually issues meaningful press releases. A few weeks ago, company officials reported that its technology had been validated by independent testing at Motorola (NYSE: MOT - News). Even more impressive, the press release informed readers that A123Systems was delivering its first products to a real customer, Black & Decker (NYSE: BDK - News).

My advice to Altair officials: Hold off on the press releases until you actually have something concrete to report. Everything else is fluff -- and no amount of press releases can change that.

[jojobada]

und in wenigen Tagen werden sie wieder kommen und den Kurs hochkaufen!

jojobada

[The_Future_Is_Now]

mal sehen ob du recht hast jojo!!

ich hoffe es auch, weil wenn es so weiter geht schaut das nicht gut aus!

[jojobada]

Vertraut der Linie, sie sagt es geht wieder hoch. die 2,00 hält in USA

jojo

[jojobada]

Hier ein Link einfach ALTI in eines der kästchen eingeben.

Dazu noch NGEN und ELN goog und rmbs für rambus

http://www.usa-aktienprofi.de/orderbuch.htm

Schaut da rein, das bid bei 2,00 füllt sich!

[Niemoney]

Altair Nanotechnologies Announces New U.S. Patent Issue for Producing Stabilized Zirconia
Friday January 6, 10:55 am ET

U.S. Patent 6,982,073 Protects Innovative Process for Applications in Thermal Spray Powders and Dental Materials

RENO, NV--(MARKET WIRE)--Jan 6, 2006 -- Altair Nanotechnologies Inc. (NasdaqSC:ALTI - News) today announced that the U.S. Patent Office issued Altair U.S. Patent 6,982,073 for a `Process for Making Nano-sized Stabilized Zirconia.` The patent specifies an economical method of making high quality, nano-sized stabilized zirconia, a material that can be used in a wide range of industrial applications.

ADVERTISEMENT
click here
"As a leader and innovator in nanotechnology, our strategy provides for dedicating significant resources to pioneer, develop and secure our advanced ceramic nanotechnology innovations," said Altairnano CEO, Alan J. Gotcher, Ph.D. "This most recent patent is very valuable in that it protects our method for economically making nano-sized stabilized zirconia, a key component in multiple, diverse applications including the substantial thermal spray coatings industry, dental materials, and alternative energy products."

The patented process is currently used for the manufacture of several Altairnano zirconia nanomaterials and products that are dependent on the toughness, wear resistance, hardness, and low thermal conductivity exhibited by the nano-sized stabilized zirconia. These materials include thermal spray-grade powders for thermal coatings where zirconia products represent over 70% of the market today, biocompatible materials such as nano zirconia ceramic dental fillings and bone cement for improved medical applications, and materials for use in secondary alternative energy initiatives such as solid oxide fuel cells (SOFC).

ABOUT ALTAIR NANOTECHNOLOGIES INC.

Altairnano is a leading supplier and innovator of advanced ceramic nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a unique team of materials scientists who, coupled in collaborative ventures with industry partners and leading academic centers, have pioneered an array of intellectual property and products.

Altairnano`s robust proprietary technology platforms produce a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has scalable manufacturing capability to meet emerging nanomaterials demands. Altairnano`s two divisions, Life Sciences and Performance Materials, are focused on applications where its nanotechnology may enable new high growth markets. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials and other medical markets. The Performance Materials Division is focused on market applications in advanced materials for paints and coatings; air and water treatment and alternative energy including new lithium ion battery electrode materials. For additional information on Altairnano and its nanomaterials, visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company`s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that any patents granted to Altairnano may be invalidated or circumvented, that competitors may develop alternative processes that are similar or superior to those patented by Altairnano, that the products referenced in this release (or end products incorporating such products) will not be developed to the point of commercialization, that, even if commercialized, no market will exist for such products or that Altair or its partners will fail to effectively market to end products produced using Altairnano`s proprietary processes. In addition, other risks are identified in the company`s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.


Contact:

For Additional Information:

Investor and Financial Relations:
Marty Tullio or Mark D. Tullio
McCloud Communications, LLC
949.553.9748
Email Contact
Email Contact

Company Contact:
Robert Pedraza
VP Strategy & Business Development
775.856.2500
Email Contact


Source: Altair Nanotechnologies Inc.

[emovere]

Es ist wieder Zeit um Altair anzusschauen. Meiner Meinung nach sehr guter Einstiegchance. 100% möglich.

[jojobada]

Ziel in USA 2,60$

jojo

[weltklasse]

guten morgen!

ist ja recht ruhig um altair geworden, ist ja auch verständlich, nach diesem längeren rückwärtsgang...

doch die letzten 2 tage bäumt sich die perle ja wieder richtig auf! wenn ich mir das volumen anschaue, könnte man davon ausgehen, dass da in den kommenden tagen was auf uns zukommt!!!

vergleicht mal den chart, haben 2 fast identische langzeit-bewegungen, kommt jetzt umgehend eine dritte??? bei der nächsten hammer-meldung, wird das teil auf bis auf die 4-5 dollar-marke steigen!

nur mal so.... :-)

[tomhead]

na heute geht es auf jedenfall nach oben

tomhead

siehe news

http://biz.yahoo.com/iw/060117/0106527.html

[Buddah]

[brokersvenja007]

das warten hat sich gelohnt, jetzt sehen wir ganz bald die 10us$.
auf dieses ergebnisse haben alle gewartet.
grüße und einen schönen abend
svenja

[jojobada]

Und seid Ihr zufrieden mit mir?

Hatte doch gesagt das sie steigen wird. Vertraut der Linie!

Hier ab und an mal bei mir reinschauen ok?

Danke..www.jojobada.de

Gruß jojobada

[emovere]

Altair. Eine Super Firma. Es ist alles möglich um Altair.

[The_Future_Is_Now]

was meint was das jetzt bedeutet??

werden wir wirklich die 10 Dollar Marke sehen so wie von Svenja prophezeit??

dann wäre es ja gut noch mal nach zu legen??

Bitte um Meinungen...

[Freeee]

Servus Svenja und all die Anderen!
Zeit wird´s, daß unser neues Babe an Fahrt gewinnt, also mal kräftig anschieben!!!!! Wir brauchen mehr threads, denn das Ding kann supergut werden (riesiger Markt, wenig Konkurrenz, der Chart etc.)
apropos CHART! wenn man sich den 3-Jahres-Chart anschaut ist ein Ausbruch auf 4 Euro in den nächsten Wochen kein Problem - und dann haben wir eine schöne W-Formation, welche dann nach oben durchbrochen wird....und schon haben wir die prophezeiten 10 € von Svenja(noch in 2006!!!)Das wünsche ich mir auf jeden Fall von Altair zu meinem heutigen 39. Geburtstag!

[supersieben]

guten tag, beobachte dieses forum schon eine ganze weile.........und habe gedacht, da mach ich mit.

ich halte altair schon ca. 3 jahre und habe schon einiges mitgenommen. bin fest davon überzeugt das sie nun bald den durchbruch schaffen. dieses mal, denke ich, werde ich über 10€ aussteigen.

[emovere]

Würde auch meinen, es ist Zeit zum kaufen. Es ist eine Meganews herausgekommen.

[jog_]

Mustergültig: eben noch so schnell einmal das GAP geschlossen.

fast kurios.

[beobachter47]

super

[LADAQ]

[Freeee]

..außer smileys noch was anderes? gibt´s informatives....aber Ihr habt schon recht, der Altair thread braucht mehr Zugriffe und Beiträge. Altair wird´s Wert sein

[Hufeland]

RT in USA $ 3,53

Gibz news?



Hufe

[Hufeland]

Jetzt 3,67 $ + 19,93 %



Hufe

[Hufeland]

SK 3,67 Bid 3,67

Tageshoch 3,705

Montag geht es w
eiter, irgend was ist da im busch,
auch das Volumen ist stark

3.67 alti - ALTAIR NANOTECHNOLOGIES INC
Change:

+0.61 % Change:

+19.93% High:

3.705 Low:

3.05 Volume:

4,885,272

Price Data Table
Open 3.08
Previous Close 3.67
Exchange of Last Sale Nasdaq NM
Time of Last Sale 16:01:31
Tick Unchanged
Bid 3.67
Ask
Size Bid/Ask 20x160
Symbol Type Equity

Fundamental Data Table
52 Week High 6.52
52 Week Low 1.93
EPS -0.14
P/E Ratio 0.00
Shares Outstanding 49,000,000
Market Cap 181,099,000
Beta 3.056
Dividend Frequency
Ex-Dividend Date
Dividend Amount
Yield 0.00
Primary Exchange Nasdaq SC

schönes wochenende


Hufe

[beobachter47]

[posting]19.799.771 von Freeee am 20.01.06 12:33:22[/posting]altair ist es wert, für Langfristanleger, und braucht auch nicht mehr Beiträge

[The_Future_Is_Now]

glaubt ihr es geht am montag weiter???

oder ist es zu spät für einen einstieg?

[emovere]

Beim Altair ist nie zu spät. Aus den USA STRONG BUY. Quelle BygCharts

[weltklasse]

einfach hier mal alti eingeben... :-))))

http://www.stock100.com/

[Paepstin]

Eine wunderschöne Woche?

Päpstin

[The_Future_Is_Now]

und jetzt??

[beobachter47]

[posting]19.977.391 von The_Future_Is_Now am 31.01.06 17:01:07[/posting]sieht doch gut aus. Wo ist Dein Problem?

[The_Future_Is_Now]

wo ist der große ausbruch?? hab bei 3 € nochmal nachgelegt und jetzt gehts nicht weiter!

oder läuft das so wie immer eine kleine korrektur und dann wieder aufwärts??

[Garachico]

Vier Schritte vor und drei wieder zurück. ist doch normal so.

[beobachter47]

geht doch weiter. weiß gar nicht, was ihr habt. erwartet ihr, dass altair schon in wenigen Tagen auf 10 steht??
Umsätze sehen klasse aus. dürfte jetzt mit einigen Rücksetzern stabil weiter nach oben gehen

[einelez]

Gibts irgendwelche Kursziele??

[jog_]

ALTAIR NANOTECHNOLOGIES BEGINS MANUFACTURING OF HIGH-POWER LITHIUM ION BATTERY CELLS AND ANNOUNCES NEW TEST RESULTS


ALTAIR NANOTECHNOLOGIES BEGINS MANUFACTURING OF HIGH-POWER LITHIUM ION BATTERY CELLS AND ANNOUNCES NEW TEST RESULTS



Batteries Perform at 90 Percent of Capacity at Extreme Temperatures



RENO, NV – February 1, 2006 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today announced that its facility in Anderson, Indiana has begun manufacturing and testing the first batch of lithium ion battery cells manufactured at that facility utilizing its nano-structured electrode materials. The Anderson facility is a rapid design, prototyping and applications lab for high power, lithium ion cells, batteries and battery packs.



In the latest testing of its nano-structured battery cells, Altairnano has demonstrated that 90 percent of room temperature charge retention has been achieved at minus 30°C. Recharge at this temperature is unachievable in conventional lithium batteries. In addition, conventional lithium ion batteries have the potential to suffer from thermal runaway issues potentially leading to catastrophic battery failure at temperatures above 130°C. Lithium ion batteries utilizing Altairnano`s nano-structured lithium titanate spinel electrodes do not experience thermal runaway at temperatures below 250°C, significantly improving the safety performance of the batteries.



This performance characteristic as well as the batteries other attributes of rapid charge and discharge cycles, extended cycle life and environmental friendliness should be of interest in applications requiring performance at temperature extremes, such as in the aerospace and military markets.



"Completing our first cell manufacturing run is a major milestone," commented Altairnano President and CEO Alan J. Gotcher, Ph.D. "Altairnano continues to develop its nano-structured electrode materials and to work with its commercial partners and their customers to develop high power, safe, large format lithium ion batteries that are expected to meet the needs of electric and hybrid electric vehicles and other power applications. The latest test data also supports our expectation that our battery materials could appeal to new or existing markets that require high power in extreme temperatures."



Altairnano is delivering battery technology that provides a unique combination of very high specific power (Watts per kilogram) and high specific energy (Watt-hours per kilogram) relative to other batteries conventionally used in power applications. The battery materials have demonstrated charge rates in a few minutes, lifecycles that exceed 10 years and power characteristics that we expect will enable them to be used in electric vehicles requiring fast acceleration and extended range.





INFORMATION REGARDING COMPETITIVE BATTERY TECHNOLOGIES



Today`s production hybrid electric vehicles and similar products use NiMH (Nickel Metal Hydride) battery cells because of their performance, safety and cost. However, manufacturers of hybrid electric vehicles and other products are seeking alternatives to NiMH batteries:



Shortcomings of NiMH Cells

Poor low temperature charge and discharge performance. Because NiMH cells use a water-based electrolyte, the battery becomes sluggish below freezing temperatures.
Marginal life. Panasonic is predicting 6 year life for the newest and best NiMH (the best in the world), but the life still falls short of a 10 year vehicle life (12 years is the industry standard lifespan for commercial vehicles).


An alternative to NiMH are lithium ion cells, which offer the promise of performance advantages, yet this technology has shortcomings:



Shortcomings of Conventional Lithium Ion Cells

Poor safety record. Because of safety concerns, US Department of Transportation and the United Nations have passed protocols that severely limit the size of conventional lithium batteries. These batteries can spontaneously combust if any internal "hot spot" exceeds 130°C.
Inability to charge below freezing. If charged, a severe safety hazard may occur (metallic lithium formation).
Marginal specific power. The best conventional lithium ion battery is comparable to the best NiMH battery.


The Altairnano nano-structured lithium ion cells address these shortcomings:



Strengths of Altairnano Nano-structured Lithium Ion Cells

Safety. The thermal runaway threshold is raised to 250°C, which improves safety performance in most failure scenarios (where "failures" are specifically defined by national and international regulatory standards).
Excellent cold temperature performance. Altairnano batteries can be charged and discharged with excellent performance to temperatures of minus 30°C, well below freezing.
Life. Accelerated cycle life data promises long battery cell life increasing battery life to meet consumer and commercial vehicle life spans.
Power density. Altairnano cells demonstrate higher power densities than conventional lithium-ion and NiMH batteries.
Rapid charge and discharge rates. Allows the battery cells to charge in minutes depending upon the charging station capabilities.


Altairnano cells have a specific energy density that is lower than traditional lithium ion batteries. Altairnano, its commercial partners and their customers are interested in the strengths of the Altairnano cells in other areas of performance essential for hybrid electric vehicle function make this technology a strong alternative for the hybrid electric vehicle market, as well as other aerospace and military applications.



ABOUT ALTAIR NANOTECHNOLOGIES INC.

Altairnano is a leading supplier and innovator of advanced ceramic nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a unique team of materials scientists who, coupled in collaborative ventures with industry partners and leading academic centers, have pioneered an array of intellectual property and products.



Altairnano`s robust proprietary technology platforms produce a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. Altairnano`s two divisions, Life Sciences and Performance Materials, are focused on applications where its nanotechnology may enable new high growth markets. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials and other medical markets. The Performance Materials Division is focused on market applications in advanced materials for paints and coatings, air and water treatment, and alternative energy including new Li Ion battery electrode materials. For additional information on Altairnano and its nanomaterials, visit www.Altairnano.com




Advertisements
• Low Rate Source: $200k for $643/month! Refinance now!
• Try Livecharts free for 14 days!

« ALTI Message list | Reply to msg. | Post new msg. « Older | Newer »

You can also:

Ignore/Hide this poster on all boards
Email this post to a friend
Report TOS violation

Get powerful streaming charts ...
Try LiveCharts™ for free
Real-time market information. No software to download.
Explore QCharts™
The ultimate trading software for the serious active trader.




45 technical analysis tools!

Quote (del. 15 min.)
11:51 AM ET
3.90
+0.45 (+13.04 %)
Volume: 2,403,488
- - - - -
Full quote | LiveChart


Get real-time streaming quotes

Ads by Google
IT Portfolio Management
Free Whitepaper - Maturing Your
IT Processes
www.pacificedge.com
Visibility over projects
Project Portfolio Mgt web solution
Augeo5â„¢ - Plan, analyse, optimize
www.augeo.com
My Boardmarks Help
Board New
- - - - -
Add ALTI
- - - - -

You haven`t added any boardmarks.
- - - - -
Add or remove boards »




Keyboard shortcuts
Pressing these keys is the same as clicking their link equivalents. Note: Netscape users don`t have to press enter after the shortcut. Mac users - use the CTRL key. Alt Z [Enter] Previous or Older
Alt X [Enter] Next or Newer

[jog_]

#358
...tut mir leid, habe nicht aufgepasst.
Es hängt etwas Schrott am Ende der Meldung.

[jog_]

was ist denn nun los??????

gibt´s etwa negative Meldung, weshalb ALTI so krass

abstürzt?

[beobachter47]

wahrscheinlich wegen des Schrottes am Ende der von Dir reinkopierten Meldung
Ne, sind nur normale Gewinnmitnahmen. Und ist auch gut, wenn das Teil nicht gliech wieder überhitzt

[beobachter47]

nun kann man sich entspannter zurücklehnen die kommenden Monate

[jojobada]

Und es wird nicht lange dauern, dann kommen sie wieder aus dem nichts und kaufen Altair nach oben! Ziel in USA 4,40 Dollar.

Gruß jojobada